<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="review-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">926258</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2022.926258</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>New strategies for a sustainable <sup>99m</sup>Tc supply to meet increasing medical demands: Promising solutions for current problems</article-title>
<alt-title alt-title-type="left-running-head">Nawar and T&#xfc;rler</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2022.926258">10.3389/fchem.2022.926258</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Nawar</surname>
<given-names>Mohamed F.</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1776948/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>T&#xfc;rler</surname>
<given-names>A.</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1817829/overview"/>
</contrib>
</contrib-group>
<aff>
<institution>Department of Chemistry, Biochemistry, and Pharmaceutical Sciences (DCBP)</institution>, <institution>Faculty of Science</institution>, <institution>University of Bern</institution>, <addr-line>Bern</addr-line>, <country>Switzerland</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/666987/overview">Gordon James Thorogood</ext-link>, Australian Nuclear Science and Technology Organisation, Australia</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1600795/overview">Paul Ellison</ext-link>, University of Wisconsin-Madison, United States</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1198284/overview">Thies Thiemann</ext-link>, United Arab Emirates University, United Arab Emirates</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Mohamed F. Nawar, <email>mohamed.nawar@unibe.ch</email>, <email>mohamedfnawar@yahoo.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inorganic Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>07</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>926258</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>04</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>06</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Nawar and T&#xfc;rler.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Nawar and T&#xfc;rler</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The continuing rapid expansion of <sup>99m</sup>Tc diagnostic agents always calls for scaling up <sup>99m</sup>Tc production to cover increasing clinical demand. Nevertheless, <sup>99m</sup>Tc availability depends mainly on the fission-produced <sup>99</sup>Mo supply. This supply is seriously influenced during renewed emergency periods, such as the past <sup>99</sup>Mo production crisis or the current COVID-19 pandemic. Consequently, these interruptions have promoted the need for <sup>99m</sup>Tc production through alternative strategies capable of providing clinical-grade <sup>99m</sup>Tc with high purity. In the light of this context, this review illustrates diverse production routes that either have commercially been used or new strategies that offer potential solutions to promote a rapid production growth of <sup>99m</sup>Tc. These techniques have been selected, highlighted, and evaluated to imply their impact on developing <sup>99m</sup>Tc production. Furthermore, their advantages and limitations, current situation, and long-term perspective were also discussed. It appears that, on the one hand, careful attention needs to be devoted to enhancing the <sup>99</sup>Mo economy. It can be achieved by utilizing <sup>98</sup>Mo neutron activation in commercial nuclear power reactors and using accelerator-based <sup>99</sup>Mo production, especially the photonuclear transmutation strategy. On the other hand, more research efforts should be devoted to widening the utility of <sup>99</sup>Mo/<sup>99m</sup>Tc generators, which incorporate nanomaterial-based sorbents and promote their development, validation, and full automization in the near future. These strategies are expected to play a vital role in providing sufficient clinical-grade <sup>99m</sup>Tc, resulting in a reasonable cost per patient dose.</p>
</abstract>
<kwd-group>
<kwd>
<sup>99m</sup>Tc radiopharmaceuticals</kwd>
<kwd>
<sup>99</sup>Mo/<sup>99m</sup>Tc generators</kwd>
<kwd>nano-materials</kwd>
<kwd>photonuclear reaction</kwd>
<kwd>electrochemical separation</kwd>
<kwd>
<sup>99</sup>Mo supply chain</kwd>
<kwd>solvent extraction</kwd>
<kwd>column chromatography</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Short-lived radionuclides continue to prove their crucial role in the development of nuclear medicine utilization in both diagnostic and therapeutic procedures. Effective therapy involves the delivery of a specific radiation dose to the tumor tissues either by the use of an external radiation source or internal radiotherapy techniques. For the former, hard gamma-ray emitters are favorably used, while a great need for the radionuclides with a low range of highly ionizing radiation emissions, such as alpha, beta and/or Auger electrons, are required to achieve internal therapy successfully (<xref ref-type="bibr" rid="B100">IAEA, 2009</xref>; <xref ref-type="bibr" rid="B159">Qaim, 2019</xref>). Definitely, a profitable therapy protocol strongly depends on the delivery of accurate information about the cancer lesion, such as the shape, size, and blood flow to the affected organ. To achieve this step, high-quality tumor imaging must be performed with the help of <italic>in-vivo</italic> diagnostic investigation tools. This method can be divided into two main categories, Positron Emission Tomography (PET), which includes the use of several positron emitters, and Single Photon Emission Computed Tomography (SPECT), in which radionuclides emitting low energetic gamma radiation are of great interest (<xref ref-type="bibr" rid="B157">Pimlott and Sutherland, 2011</xref>).</p>
<p>Particularly, SPECT radionuclides should have one or at least one main gamma energy line in the range of 100&#x2013;200&#xa0;keV. <xref ref-type="table" rid="T1">Table 1</xref> displays the most commonly used radionuclides in SPECT imaging processes (<xref ref-type="bibr" rid="B157">Pimlott and Sutherland, 2011</xref>; <xref ref-type="bibr" rid="B182">T&#xe0;rk&#xe0;nyi et al., 2019</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>The predominantly used radionuclides in SPECT processes and their nuclear characteristics.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Radionuclide</th>
<th align="left">Half-life</th>
<th align="left">Mode of decay</th>
<th align="left">Main photon energy, keV</th>
<th align="left">Branching ratio (intensity), %</th>
<th align="left">Availability</th>
<th align="left">Remark</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">
<sup>99m</sup>Tc</td>
<td rowspan="3" align="left">6.01&#xa0;h</td>
<td rowspan="3" align="left">IT (99.996%)</td>
<td rowspan="3" align="left">140.51</td>
<td rowspan="2" align="left">89</td>
<td align="left">
<sup>99</sup>Mo &#x2192; <sup>99m</sup>Tc (<sup>99</sup>Mo/<sup>99m</sup>Tc generator)</td>
<td rowspan="3" align="left"/>
</tr>
<tr>
<td align="left">
<sup>100</sup>Mo(p,2n)<sup>99m</sup>Tc</td>
</tr>
<tr>
<td/>
<td align="left">
<sup>100</sup>Mo(d,3n)<sup>99m</sup>Tc</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>123</sup>I</td>
<td rowspan="2" align="left">13.27&#xa0;h</td>
<td rowspan="2" align="left">EC, &#x3b2;<sup>&#x2b;</sup> (100%)</td>
<td rowspan="2" align="left">158.97</td>
<td rowspan="2" align="left">83</td>
<td align="left">
<sup>122</sup>Te(d,n)<sup>123</sup>I</td>
<td align="left">&#x2022; High cost</td>
</tr>
<tr>
<td align="left">
<sup>123</sup>Te(p,n)<sup>123</sup>I</td>
<td align="left">&#x2022; Low availability</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>111</sup>In</td>
<td rowspan="2" align="left">2.80&#xa0;d</td>
<td rowspan="2" align="left">EC (100%)</td>
<td align="left">171.28</td>
<td align="left">90</td>
<td align="left">
<sup>112</sup>Cd(p,2n)<sup>111</sup>In</td>
<td rowspan="2" align="left">&#x2022; Relatively long half-life</td>
</tr>
<tr>
<td align="left">245.39</td>
<td align="left">94</td>
<td align="left">
<sup>111</sup>Cd(p,n)<sup>111</sup>In</td>
</tr>
<tr>
<td align="left">
<sup>201</sup>Tl</td>
<td align="left">3.04&#xa0;d</td>
<td align="char" char="(">EC (100%)</td>
<td align="left">167.43</td>
<td align="left">10</td>
<td align="left">
<sup>203</sup>Tl(p,3n)<sup>201</sup>Pb &#x2192; <sup>201</sup>Tl</td>
<td align="left">&#x2022; Relatively long half-life</td>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>67</sup>Ga</td>
<td rowspan="3" align="left">3.26&#xa0;d</td>
<td rowspan="3" align="left">EC (100%)</td>
<td align="left">93.31</td>
<td align="left">39.2</td>
<td align="left">
<sup>68</sup>Zn(p,2n)<sup>67</sup>Ga</td>
<td rowspan="2" align="left">&#x2022; Relatively long half-life</td>
</tr>
<tr>
<td align="left">184.57</td>
<td align="left">21.2</td>
<td align="left">
<sup>67</sup>Zn(p,n)<sup>67</sup>Ga</td>
</tr>
<tr>
<td align="left">300.21</td>
<td align="left">16.8</td>
<td align="left"/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The data were deduced from:</p>
</fn>
<fn id="Tfn1">
<label>a</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/relnsd/vcharthtml/VChartHTML.html">https://www-nds.iaea.org/relnsd/vcharthtml/VChartHTML.html</ext-link>
</p>
</fn>
<fn id="Tfn2">
<label>b</label>
<p>
<ext-link ext-link-type="uri" xlink:href="http://nucleardata.nuclear.lu.se/toi/">http://nucleardata.nuclear.lu.se/toi/</ext-link>
</p>
</fn>
<fn id="Tfn3">
<label>c</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/radionuclides/gamma_emitters.html">https://www-nds.iaea.org/radionuclides/gamma_emitters.html</ext-link>
</p>
</fn>
<fn id="Tfn4">
<label>d</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/relnsd/vcharthtml/MEDVChart.html">https://www-nds.iaea.org/relnsd/vcharthtml/MEDVChart.html</ext-link>
</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>To describe the pivotal role of <sup>99m</sup>Tc, S. Esarey called it a vitally crucial diagnostic isotope used nearly once a second worldwide (<xref ref-type="bibr" rid="B92">IAEA, 2011</xref>). Undoubtedly, <sup>99m</sup>Tc is the most extensively used diagnostic radionuclide in the SPECT family. It is currently involved in 80&#x2013;85% of all <italic>in-vivo</italic> nuclear medicine diagnostic examinations (<xref ref-type="bibr" rid="B23">Boschi et al., 2017</xref>; <xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>; <xref ref-type="bibr" rid="B121">Martini et al., 2018</xref>; <xref ref-type="bibr" rid="B149">Osso et al., 2012</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B169">Sakr et al., 2017</xref>). Annually, 30&#x2013;40 million SPECT imaging studies have been conducted worldwide using <sup>99m</sup>Tc solely (half of which in the United States). <sup>99m</sup>Tc utilization is estimated to increase by 3&#x2013;8% every year (<xref ref-type="bibr" rid="B14">Banerjee et al., 2000</xref>; <xref ref-type="bibr" rid="B57">Eckelman, 2009</xref>; <xref ref-type="bibr" rid="B72">Guerin et al., 2010</xref>; <xref ref-type="bibr" rid="B96">IAEA, 2013a</xref>; <xref ref-type="bibr" rid="B33">Chakravarty et al., 2013</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B54">Dilworth and Pascu, 2015</xref>; <xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>; <xref ref-type="bibr" rid="B78">Haroon and Nichita, 2021</xref>). <sup>99m</sup>Tc decays by a relatively short half-life (T<sub>1/2</sub> &#x3d; 6.01&#xa0;h) and emits only one-gamma photon at low energy of 140.51&#xa0;keV. This energy is ideally suited to penetrate the tissues and can be efficiently detected through SPECT cameras from outside the body, resulting in a high-quality image of the target organs with minimum radiation exposure dose to the patient. In addition, <sup>99m</sup>Tc has unique coordination chemistry, which allows conjugation with a broad spectrum of diverse pharmaceutical molecules (<xref ref-type="bibr" rid="B100">IAEA, 2009</xref>; <xref ref-type="bibr" rid="B54">Dilworth and Pascu, 2015</xref>; <xref ref-type="bibr" rid="B23">Boschi et al., 2017</xref>; <xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>). These <sup>99m</sup>Tc-labelled compounds have been involved in the visualization of most organs (<xref ref-type="bibr" rid="B193">Vallabhajosula et al., 1989</xref>; <xref ref-type="bibr" rid="B201">Zolle, 2007</xref>; <xref ref-type="bibr" rid="B117">Leggett and Giussani, 2015</xref>; <xref ref-type="bibr" rid="B9">Araz et al., 2020</xref>; <xref ref-type="bibr" rid="B191">Urbano et al., 2020</xref>; <xref ref-type="bibr" rid="B152">Parihar et al., 2021</xref>). Moreover, the global on-demand availability of <sup>99m</sup>Tc through the user-friendly <sup>99</sup>Mo/<sup>99m</sup>Tc generators with reasonable cost-effectiveness has greatly encouraged nuclear medicine departments to conduct many research studies to explore its pivotal role in diagnostic imaging in detail (<xref ref-type="bibr" rid="B125">Mikaeili et al., 2018</xref>; <xref ref-type="bibr" rid="B68">Gan et al., 2020</xref>; <xref ref-type="bibr" rid="B11">&#xc1;vila-S&#xe1;nchez et al., 2020</xref>). <xref ref-type="table" rid="T2">Table 2</xref> highlights the wide-scale applicability of <sup>99m</sup>Tc-based radiopharmaceuticals and provides the injection activity and the estimated exposure dose for each diagnostic procedure. Furthermore, based on its accessible availability and favorable nuclear properties, <sup>99m</sup>Tc received considerable attention in multi-disciplinary fields. Recently, it has been involved in a variety of industrial radiotracer applications (<xref ref-type="bibr" rid="B62">Fauquex et al., 1983</xref>; <xref ref-type="bibr" rid="B106">Kantzas et al., 2000</xref>; <xref ref-type="bibr" rid="B13">Bandeira et al., 2002</xref>; <xref ref-type="bibr" rid="B22">Borroto et al., 2003</xref>; <xref ref-type="bibr" rid="B17">Berne and Thereska, 2004</xref>; <xref ref-type="bibr" rid="B86">Hughes et al., 2004</xref>; <xref ref-type="bibr" rid="B187">Thyn and Zitny, 2004</xref>; <xref ref-type="bibr" rid="B50">Dash et al., 2012</xref>; <xref ref-type="bibr" rid="B154">Pavlovicl et al., 2020</xref>).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>The most commonly used <sup>99m</sup>Tc-based radiopharmaceuticals with their recommended injection activity and the estimated exposure dose.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Organ</th>
<th rowspan="2" align="left">
<sup>99m</sup>Tc radiopharmaceuticals</th>
<th colspan="2" align="center">Recommended adult injected activity, MBq<xref ref-type="table-fn" rid="Tfn5">
<sup>a</sup>
</xref>
</th>
<th colspan="2" align="left">Radiation dose estimation<xref ref-type="table-fn" rid="Tfn6">
<sup>b</sup>
</xref>
</th>
</tr>
<tr>
<th align="left">SNMMI</th>
<th align="left">ENAM</th>
<th align="left">Injected activity, MBq</th>
<th align="left">Effective dose, mSv</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="left">Brain</td>
<td align="left">
<sup>99m</sup>Tc-ECD</td>
<td align="left">555&#x2013;1110</td>
<td align="left">555&#x2013;725</td>
<td align="left">700</td>
<td align="left">5.4</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-HMPAO</td>
<td align="left">555&#x2013;1110</td>
<td align="left">555&#x2013;725</td>
<td align="left">700</td>
<td align="left">6.5</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-MAA</td>
<td align="left">40.7&#x2013;151.7</td>
<td align="left">60&#x2013;78</td>
<td align="left">78</td>
<td align="left">0.9</td>
</tr>
<tr>
<td rowspan="2" align="left">Bone and bone marrow</td>
<td align="left">
<sup>99m</sup>Tc-MDP</td>
<td align="left">740&#x2013;1110</td>
<td align="left">375&#x2013;490</td>
<td align="left">740</td>
<td align="left">4.2</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-HMPAO (WBC)</td>
<td align="left">185&#x2013;370</td>
<td align="left">375&#x2013;490</td>
<td align="left">370</td>
<td align="left">4.1</td>
</tr>
<tr>
<td rowspan="12" align="left">Heart</td>
<td align="left">
<sup>99m</sup>Tc-Pyrophosphate</td>
<td align="left">370&#x2013;555</td>
<td align="left">N.A</td>
<td align="left">370</td>
<td align="left">2.1</td>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>99m</sup>Tc-Tetrofosmin/sestaMIBI (exercise)</td>
<td rowspan="3" align="left">740&#x2013;1480</td>
<td align="left">900&#x2013;1176 (One-day protocol)</td>
<td rowspan="3" align="left">740</td>
<td rowspan="3" align="left">5.2</td>
</tr>
<tr>
<td align="left">450&#x2013;588 (2-day protocol min)</td>
</tr>
<tr>
<td align="left">675&#x2013;882 (2-day protocol max)</td>
</tr>
<tr>
<td rowspan="3" align="left">
<sup>99m</sup>Tc-Tetrofosmin / sestaMIBI (resting)</td>
<td rowspan="3" align="left">740&#x2013;1480</td>
<td align="left">300&#x2013;392 (One-day protocol)</td>
<td rowspan="3" align="left">740</td>
<td rowspan="3" align="left">5.6</td>
</tr>
<tr>
<td align="left">450&#x2013;588 (2-day protocol min)</td>
</tr>
<tr>
<td align="left">675&#x2013;882 (2-day protocol max)</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-RBC</td>
<td align="left">555&#x2013;1110</td>
<td align="left">600&#x2013;784 (Blood pool)</td>
<td align="left">555</td>
<td align="left">3.9</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-DMSA</td>
<td align="left">74&#x2013;222</td>
<td align="left">73&#x2013;95</td>
<td align="left">90</td>
<td align="left">0.8</td>
</tr>
<tr>
<td rowspan="2" align="left">
<sup>99m</sup>Tc-DTPA (IV)</td>
<td rowspan="2" align="left">37&#x2013;1110</td>
<td align="left">166&#x2013;196 (normal renal function)</td>
<td rowspan="2" align="left">190</td>
<td rowspan="2" align="left">0.9</td>
</tr>
<tr>
<td align="left">150&#x2013;196 (abnormal renal function)</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-MAG3</td>
<td align="left">37&#x2013;370</td>
<td align="left">58&#x2013;69</td>
<td align="left">58</td>
<td align="left">0.4</td>
</tr>
<tr>
<td rowspan="3" align="left">Liver</td>
<td align="left">
<sup>99m</sup>Tc-Sulfur/albumin colloid (IV)</td>
<td align="left">148&#x2013;222</td>
<td align="left">N.A</td>
<td align="left">185</td>
<td align="left">2.6</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-Sulfur/albumin colloid (oral)</td>
<td align="left">18&#x2013;74</td>
<td align="left">N.A</td>
<td align="left">46</td>
<td align="left">1.0</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-IDA</td>
<td align="left">N.A</td>
<td align="left">112&#x2013;147</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
</tr>
<tr>
<td rowspan="2" align="left">Lung</td>
<td align="left">
<sup>99m</sup>Tc-DTPA (Inhalation)</td>
<td align="left">19.98&#x2013;40.70</td>
<td align="left">N.A</td>
<td align="left">30</td>
<td align="left">0.2</td>
</tr>
<tr>
<td align="left">
<sup>99m</sup>Tc-Technegas</td>
<td align="left">18.5&#x2013;37</td>
<td align="left">525&#x2013;686</td>
<td align="left">37</td>
<td align="left">0.6</td>
</tr>
<tr>
<td align="left">Spleen</td>
<td align="left">
<sup>99m</sup>Tc-RBCs</td>
<td align="left">555&#x2013;1110</td>
<td align="left">30&#x2013;39 (Denatured RBC)</td>
<td align="left">555</td>
<td align="left">3.9</td>
</tr>
<tr>
<td align="left">Stomach</td>
<td align="left">
<sup>99m</sup>Tc-Pertechnetate</td>
<td align="left">N.A</td>
<td align="left">112&#x2013;147</td>
<td align="left">112</td>
<td align="left">1.5</td>
</tr>
<tr>
<td align="left">Thyroid</td>
<td align="left">
<sup>99m</sup>Tc-Pertechnetate</td>
<td align="left">74&#x2013;370</td>
<td align="left">60&#x2013;78</td>
<td align="left">78</td>
<td align="left">1.0</td>
</tr>
<tr>
<td align="left">Parathyroid</td>
<td align="left">
<sup>99m</sup>Tc-MIBI</td>
<td align="left">740&#x2013;1480</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">Cancer cells identification</td>
<td align="left">
<sup>99m</sup>Tc-SestaMIBI</td>
<td align="left">N.A</td>
<td align="left">675&#x2013;882</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>(ENAM), European Association of Nuclear Medicine; (SNMMI), the Society of Nuclear Medicine and Molecular Imaging.</p>
</fn>
<fn id="Tfn5">
<label>a</label>
<p>The activity doses were calculated for body weights from 50 to 68&#xa0;Kg.</p>
</fn>
<fn id="Tfn6">
<label>b</label>
<p>The exposure doses are based on (<xref ref-type="bibr" rid="B103">ICRP, 2015</xref>).</p>
</fn>
<fn>
<p>The activity doses were taken from <ext-link ext-link-type="uri" xlink:href="https://www.eanm.org/publications/dosage-calculator/">https://www.eanm.org/publications/dosage-calculator/</ext-link> and <ext-link ext-link-type="uri" xlink:href="http://www.snmmi.org/ClinicalPractice/doseTool.aspx">http://www.snmmi.org/ClinicalPractice/doseTool.aspx</ext-link> (accessed 8.6.2022).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Despite the central role of <sup>99m</sup>Tc for different diagnostic medical investigations as well as recent industrial implementations, its limited availability at the usage sites is a real difficulty. The primary objective of this review paper is to provide a detailed and comprehensive evaluation of the different production routes of <sup>99m</sup>Tc that have commercially been exploited. In addition, new production strategies that could potentially promote efficient utilization of <sup>99m</sup>Tc in the near future are highlighted. In the following sections, the paper discusses the different production routes of the parent <sup>99</sup>Mo either by nuclear reactors or particle accelerators, the direct production technology of <sup>99m</sup>Tc at a cyclotron, and the different <sup>99</sup>Mo/<sup>99m</sup>Tc generator systems and their role in supplying <sup>99m</sup>Tc. Furthermore, the paper underlines the advantages, outcomes, and technical challenges of the different <sup>99m</sup>Tc production approaches along with their current situation and the possible future perspectives.</p>
</sec>
<sec id="s2">
<title>2 Production and supply of <sup>99</sup>Mo</title>
<p>The increasing interest in <sup>99m</sup>Tc-labelled radiopharmaceuticals for diagnostic purposes has heightened the need for securing a sufficient supply of <sup>99</sup>Mo. Practically, almost all of the used clinical-grade <sup>99m</sup>Tc in nuclear medicine is derived from <sup>99</sup>Mo/ <sup>99m</sup>Tc generators. In this system, <sup>99</sup>Mo (T<sub>1/2</sub> &#x3d; 65.94&#xa0;h) yields <sup>99m</sup>Tc by beta &#x3b2;<sup>&#x2212;</sup> decay, as shown in <xref ref-type="fig" rid="F1">Figure 1</xref> (<xref ref-type="bibr" rid="B26">Boyd, 1982a</xref>; <xref ref-type="bibr" rid="B83">Hidalgo et al., 1967</xref>; <xref ref-type="bibr" rid="B89">IAEA, 2017</xref>, <xref ref-type="bibr" rid="B96">2013a</xref>; <xref ref-type="bibr" rid="B143">NEA, 2017</xref>, <xref ref-type="bibr" rid="B145">2010</xref>). <sup>99</sup>Mo is produced with the use of one of two main facilities; nuclear reactors or particle accelerators. <xref ref-type="fig" rid="F2">Figure 2</xref> displays the potential production routes of <sup>99</sup>Mo and <sup>99m</sup>Tc.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The decay scheme of <sup>99</sup>Mo and <sup>99m</sup>Tc (<xref ref-type="bibr" rid="B83">Hidalgo et al., 1967</xref>).</p>
</caption>
<graphic xlink:href="fchem-10-926258-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The potential production routes of <sup>99</sup>Mo and <sup>99m</sup>Tc. Abbreviations: HEU: Highly Enriched Uranium; LEU: Low Enriched Uranium.</p>
</caption>
<graphic xlink:href="fchem-10-926258-g002.tif"/>
</fig>
<sec id="s2-1">
<title>2.1 Reactor-based <sup>99</sup>Mo production</title>
<p>The medical isotope <sup>99</sup>Mo can be produced in nuclear reactors through two primary routes (<xref ref-type="bibr" rid="B97">IAEA, 1999</xref>):</p>
<sec id="s2-1-1">
<title>2.1.1 Fission-produced <sup>99</sup>Mo</title>
<p>Undoubtedly, the neutron-induced uranium fission technique is widely considered the &#x201c;gold standard&#x201d; for the large-scale <sup>99</sup>Mo supply for medical applications. Actually, over 95% of all <sup>99</sup>Mo used for the production of medical-grade <sup>99m</sup>Tc is available from the fission of uranium targets in nuclear reactors. These targets can be categorized according to the content of the fissile <sup>235</sup>U radioisotope (<xref ref-type="bibr" rid="B97">IAEA, 1999</xref>, <xref ref-type="bibr" rid="B93">2002</xref>, <xref ref-type="bibr" rid="B94">2005</xref>; <xref ref-type="bibr" rid="B138">NAP, 2016</xref>):<list list-type="simple">
<list-item>
<p>1. Natural uranium: <sup>235</sup>U content is about 0.72%.</p>
</list-item>
<list-item>
<p>2. Low Enriched Uranium (LEU): 0.72% &#x3c; <sup>235</sup>U content &#x3c;20%.</p>
</list-item>
<list-item>
<p>3. Highly Enriched Uranium (HEU): 20% &#x2264; <sup>235</sup>U content &#x2264;90%.</p>
</list-item>
<list-item>
<p>4. Weapons-grade Enriched Uranium: <sup>235</sup>U content &#x2265;90%.</p>
</list-item>
</list>
</p>
<p>Generally, a neutron-induced fission reaction occurs when a target of a heavy fissionable element, such as <sup>235</sup>U, is introduced into the reactor core. Hence, the <sup>235</sup>U nucleus absorbs a thermal neutron and undergoes a fission reaction, resulting in two fission fragments. These comprise about 200 different radionuclides, including <sup>99</sup>Mo, according to the reaction <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>U</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>235</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>f</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>. The resulting <sup>99</sup>Mo is called a Non-Carrier Added (NCA) product and possesses high specific activity defined as the <sup>99</sup>Mo radioactivity per unit molybdenum mass. The fission yield for this reaction is about 6.132% (<xref ref-type="bibr" rid="B78">Haroon and Nichita, 2021</xref>; <xref ref-type="bibr" rid="B71">Grummitt and Wilkinson, 1946</xref>; <xref ref-type="bibr" rid="B87">Hyde, 1964</xref>; <xref ref-type="bibr" rid="B96">IAEA, 2013a</xref>, <xref ref-type="bibr" rid="B91">2008</xref>, 2003). Other molybdenum isotopes, namely <sup>97</sup>Mo, <sup>98</sup>Mo, and <sup>100</sup>Mo, are also produced with a total fission yield of 18.1%. These stable isotopes may dilute the <sup>99</sup>Mo final activity. However, the specific activity of fission <sup>99</sup>Mo is 1000 folds higher than the specific activity of <sup>99</sup>Mo produced from neutron-activated <sup>98</sup>Mo, as detailed in <xref ref-type="sec" rid="s2-1-2">Section 2.1.2</xref> below (<xref ref-type="bibr" rid="B170">Sameh and Ache, 1989</xref>). <xref ref-type="table" rid="T3">Table 3</xref> shows a comparison between the production routes of <sup>99</sup>Mo in a nuclear reactor.</p>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The evaluation of reactor-based <sup>99</sup>Mo production technologies.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">Criteria</th>
<th colspan="2" align="left">Uranium fission</th>
<th colspan="3" align="left">Neutron activation</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="5" align="left">Target</td>
<td rowspan="4" align="left">Material</td>
<td rowspan="2" align="left">LEU</td>
<td align="left">U-Al alloy</td>
<td rowspan="2" align="left">Natural <sup>98</sup>Mo</td>
<td colspan="2" align="left">MoO<sub>3</sub>
</td>
</tr>
<tr>
<td align="left">U-metallic foil</td>
<td colspan="2" align="left">Mo metal</td>
</tr>
<tr>
<td rowspan="2" align="left">HEU</td>
<td rowspan="2" align="left">U-Al alloy</td>
<td rowspan="2" align="left">Enriched <sup>98</sup>Mo</td>
<td colspan="2" align="left">MoO<sub>3</sub>
</td>
</tr>
<tr>
<td colspan="2" align="left">Mo metal</td>
</tr>
<tr>
<td align="left">Availability</td>
<td colspan="2" align="left">Restricted to few producers</td>
<td colspan="3" align="left">Broadly available</td>
</tr>
<tr>
<td rowspan="8" align="left">Production process</td>
<td align="left">Nuclear reaction</td>
<td colspan="2" align="left">
<sup>235</sup>U (n,f)<sup>99</sup>Mo</td>
<td colspan="3" align="left">
<sup>98</sup>Mo (n,&#x3b3;)<sup>99</sup>Mo</td>
</tr>
<tr>
<td rowspan="2" align="left">Cross-section, barn</td>
<td rowspan="2" colspan="2" align="center">586 (&#xd7; 6% fission yield)</td>
<td align="left">Thermal flux</td>
<td colspan="2" align="left">0.13</td>
</tr>
<tr>
<td align="left">Epithermal flux</td>
<td colspan="2" align="left">6.7&#xb1;0.3</td>
</tr>
<tr>
<td rowspan="2" align="left">Yield</td>
<td rowspan="2" colspan="2" align="center">&#x3e;10,000&#xa0;Ci <sup>99</sup>Mo/g Mo</td>
<td align="left">Natural <sup>98</sup>Mo target</td>
<td align="left">&#x223c;0.2&#x2013;1 Ci <sup>99</sup>Mo/g Mo</td>
<td rowspan="2" align="left">Influenced by the neutron flux capacity</td>
</tr>
<tr>
<td align="left">Enriched <sup>98</sup>Mo target</td>
<td align="left">&#x2265;4 Ci <sup>99</sup>Mo/g Mo</td>
</tr>
<tr>
<td align="left">Specific activity</td>
<td colspan="2" align="left">High specific activity product</td>
<td colspan="3" align="left">Low specific activity product</td>
</tr>
<tr>
<td align="left">Production facility</td>
<td colspan="2" align="left">Limited to a small number of irradiation sites</td>
<td colspan="3" align="left">More than 50 reactors with high neutron flux (&#x3e;10<sup>14</sup> n/cm<sup>2</sup>s) are geographically well-distributed</td>
</tr>
<tr>
<td align="left">Co-production isotopes</td>
<td colspan="2" align="left">200 different radioisotopes such as <sup>131</sup>I and <sup>133</sup>Xe</td>
<td colspan="3" align="left">
<sup>99</sup>Mo solely</td>
</tr>
<tr>
<td rowspan="3" align="left">Chemical Processing</td>
<td align="left">Separation step</td>
<td colspan="2" align="left">Mandatory</td>
<td colspan="3" align="left">Can be avoided</td>
</tr>
<tr>
<td align="left">Feasibility</td>
<td colspan="2" align="left">Complicated and involves hazardous materials</td>
<td colspan="3" align="left">Simple and does not include any hazardous substances</td>
</tr>
<tr>
<td align="left">Laboratories</td>
<td colspan="2" align="left">Limited</td>
<td colspan="3" align="left">Globally available</td>
</tr>
<tr>
<td rowspan="3" align="left">Concerns</td>
<td align="left">Proliferation risks</td>
<td colspan="2" align="left">High</td>
<td colspan="3" align="left">Negligible</td>
</tr>
<tr>
<td align="left">Cost</td>
<td colspan="2" align="left">High</td>
<td colspan="3" align="left">Low</td>
</tr>
<tr>
<td align="left">Waste</td>
<td colspan="2" align="left">50 Ci waste per production of only 1 Ci <sup>99</sup>Mo</td>
<td colspan="3" align="left">Negligible</td>
</tr>
<tr>
<td rowspan="2" align="left">Maturity</td>
<td align="left">Status</td>
<td colspan="2" align="left">Well-established technology</td>
<td colspan="3" align="left">Growing technology</td>
</tr>
<tr>
<td align="left">Capability</td>
<td colspan="2" align="left">Covers &#x3e;95% of the global demand</td>
<td colspan="3" align="left">Used on small-scale production in some countries</td>
</tr>
<tr>
<td align="left">Licensing and approval</td>
<td align="left">Nuclear regulatory</td>
<td colspan="2" align="left">Approved</td>
<td colspan="3" align="left">Approved</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s2-1-1-1">
<title>2.1.1.1 Global supply chain of fission-produced <sup>99</sup>Mo</title>
<p>The availability of a sufficient <sup>99</sup>Mo supply involves a sequence of connected steps with high complexity. These steps can be defined as the <sup>99</sup>Mo supply chain. In the first step, uranium targets are fabricated and tested. Then, these targets are shipped to the irradiation facilities where the production of <sup>99</sup>Mo takes place. After that, the irradiated targets are transported to well-equipped processing facilities comprising hot cells, where the separation and purification of <sup>99</sup>Mo from other fission products are accomplished. Afterward, the purified carrier-free <sup>99</sup>Mo solutions are eventually used for the <sup>99</sup>Mo/<sup>99m</sup>Tc generator assembly process. Subsequently, these generators are globally distributed to provide <sup>99m</sup>Tc of high quality, ready to use for different medical needs (<xref ref-type="bibr" rid="B139">NAP, 2018</xref>, <xref ref-type="bibr" rid="B138">2016</xref>).</p>
<p>Based on the fact that <sup>99</sup>Mo decays with a relatively short half-life (T<sub>1/2</sub> &#x3d; 65.94&#xa0;h), all previous steps need to be achieved as rapidly as possible to minimize radioactive decay losses. The quantity of <sup>99</sup>Mo produced is defined with the term &#x201c;six-day Curie&#x201d;. This term represents how much <sup>99</sup>Mo radioactivity remains 6&#xa0;days after the end of processing. <xref ref-type="fig" rid="F3">Figure 3</xref> highlights the six-day Curie concept through the <sup>99</sup>Mo supply chain (<xref ref-type="bibr" rid="B153">Paterson et al., 2015</xref>). The &#x201c;six-day Curie&#x201d; concept has been introduced by the manufacturers as a base for calibrating the sales price. However, it is not very suitable to express the losses of <sup>99</sup>Mo from the end of bombardment to arrival at the end user since neither transport to the processing facility, processing time, chemical yield, and transport times to the end user are accounted for.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>The schematic demonstration of the fission-produced <sup>99</sup>Mo supply chain, including target irradiation, the production of <sup>99</sup>Mo, and the 6-day Curie expression. The produced <sup>99</sup>Mo activity from the supply chain is approximately 22% of the total irradiated activity in case of 100% recovery of <sup>99</sup>Mo from the irradiated targets. In the same manner, if the processing efficiency is 90%, the expected remaining activity is about 17% of the total produced activity.</p>
</caption>
<graphic xlink:href="fchem-10-926258-g003.tif"/>
</fig>
<p>Close to 10,000 uranium targets (among them 8,000 targets involving HEU) are consumed annually to afford a <sup>99</sup>Mo supply for nuclear medicine utilization. There are, at present, only four agencies that can manufacture and supply targets to the irradiation facilities. These laboratories are operated under the authority of the Atomic Energy Commission of <italic>Argentina</italic> (CNEA), <italic>Argentina</italic>; Canadian Nuclear Laboratories (CNL), Canada; Company for the Study and Production of Atomic Fuels (CERCA), France; and Nuclear Technology Products Radioisotopes (NTP), South Africa (<xref ref-type="bibr" rid="B139">NAP, 2018</xref>, <xref ref-type="bibr" rid="B138">2016</xref>).</p>
<p>The neutron bombardment of the targets can be carried out in research reactors of high neutron flux, which is usually in the range of &#x2265; 10<sup>14</sup>&#xa0;n/cm<sup>2</sup>s. <xref ref-type="table" rid="T4">Table 4</xref> illustrates the potential irradiation reactors and their production volume (<xref ref-type="bibr" rid="B200">Zhuikov, 2014</xref>; <xref ref-type="bibr" rid="B139">NAP, 2018</xref>; <xref ref-type="bibr" rid="B144">NEA, 2019</xref>). The <sup>99</sup>Mo production capability of these reactors covers more than 95% of the global medical need for <sup>99</sup>Mo. The target irradiation process typically lasts five to 7&#xa0;days until the <sup>99</sup>Mo growth reaches 80% of the saturation yield. At this point, the overall <sup>99</sup>Mo activity remains unchanged. That is because the quantity of <sup>99</sup>Mo produced by the target irradiation equals the loss of <sup>99</sup>Mo activity due to the radioactive decay (<xref ref-type="bibr" rid="B153">Paterson et al., 2015</xref>; <xref ref-type="bibr" rid="B143">NEA, 2017</xref>).</p>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>The producers of fission <sup>99</sup>Mo and their global production volume.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="3" align="left">Irradiation facility<xref ref-type="table-fn" rid="Tfn7">
<sup>a</sup>
</xref>
</th>
<th align="left">Country</th>
<th align="left">Irradiated target</th>
<th align="left">Neutron flux, n/cm<sup>2</sup>S</th>
<th align="left">Year commissioned</th>
<th align="left">Estimated available capacity, six-day Ci/week</th>
<th align="left">Production of <sup>99</sup>Mo, Week/year</th>
<th align="left">Estimated available production capacity by 2024<xref ref-type="table-fn" rid="Tfn8">
<sup>b</sup>
</xref>, six-day Ci/year</th>
<th align="left">Estimated global market share, %</th>
<th align="left">Expected shutdown, year</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="9" align="left">Global producers</td>
<td colspan="2" align="left">BR-2</td>
<td align="left">Belgium</td>
<td align="left">HEU/LEU</td>
<td align="left">1.0E15</td>
<td align="left">1961</td>
<td align="left">6,500</td>
<td align="left">21</td>
<td align="left">136,500</td>
<td align="left">17</td>
<td align="left">2026</td>
</tr>
<tr>
<td colspan="2" align="left">HFR</td>
<td align="left">Netherlands</td>
<td align="left">HEU/LEU</td>
<td align="left">2.7E14</td>
<td align="left">1961</td>
<td align="left">6,200</td>
<td align="left">39</td>
<td align="left">241,800</td>
<td align="left">29</td>
<td align="left">2026</td>
</tr>
<tr>
<td colspan="2" align="left">LVR-15</td>
<td align="left">Czech Republic</td>
<td align="left">HEU/LEU</td>
<td align="left">1.5E14</td>
<td align="left">1957</td>
<td align="left">3,000</td>
<td align="left">30</td>
<td align="left">90,000</td>
<td align="left">11</td>
<td align="left">2028</td>
</tr>
<tr>
<td colspan="2" align="left">Maria</td>
<td align="left">Poland</td>
<td align="left">HEU</td>
<td align="left">3.5E14</td>
<td align="left">1974</td>
<td align="left">2,200</td>
<td align="left">36</td>
<td align="left">79,200</td>
<td align="left">9</td>
<td align="left">2040</td>
</tr>
<tr>
<td rowspan="2" colspan="2" align="left">OPAL</td>
<td rowspan="2" align="left">Australia</td>
<td rowspan="2" align="left">LEU</td>
<td rowspan="2" align="left">3.0E14</td>
<td rowspan="2" align="left">2006</td>
<td align="left">2,150</td>
<td rowspan="2" align="left">43</td>
<td align="left">92,450</td>
<td align="left">11</td>
<td rowspan="2" align="left">2057</td>
</tr>
<tr>
<td align="left">&#x2b;1,350<xref ref-type="table-fn" rid="Tfn9">
<sup>c</sup>
</xref>
</td>
<td align="left">&#x2b;58,050<xref ref-type="table-fn" rid="Tfn9">
<sup>c</sup>
</xref>
</td>
<td align="left">7</td>
</tr>
<tr>
<td colspan="2" align="left">Safari-1</td>
<td align="left">South Africa</td>
<td align="left">LEU</td>
<td align="left">2.4E14</td>
<td align="left">1965</td>
<td align="left">3,000</td>
<td align="left">44</td>
<td align="left">130,700</td>
<td align="left">16</td>
<td align="left">2030</td>
</tr>
<tr>
<td colspan="2" align="left">NRU</td>
<td align="left">Canada</td>
<td align="left">HEU</td>
<td align="left">4.0E14</td>
<td align="left">1957</td>
<td align="left">40% (Global market)</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">2018 Retired</td>
</tr>
<tr>
<td colspan="2" align="left">Osiris</td>
<td align="left">France</td>
<td align="left">HEU</td>
<td align="left">1.7E14</td>
<td align="left">1966</td>
<td align="left">8% (Global market)</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">2015 Retired</td>
</tr>
<tr>
<td rowspan="4" align="left">Regional producers</td>
<td rowspan="2" align="left">RIAR</td>
<td align="left">RBT-6</td>
<td rowspan="3" align="center">Russia</td>
<td align="left">HEU</td>
<td align="left">1.4E14</td>
<td align="left">1975</td>
<td rowspan="2" align="left">540</td>
<td rowspan="2" align="left">50</td>
<td rowspan="2" align="left">27,000</td>
<td rowspan="2" align="left">Domestic use</td>
<td align="left">2025</td>
</tr>
<tr>
<td align="left">RBT-10</td>
<td align="left">HEU</td>
<td align="left">1.5E14</td>
<td align="left">1983</td>
<td align="left">2025</td>
</tr>
<tr>
<td align="left">KAPROV</td>
<td align="left">WWR-c</td>
<td align="left">HEU</td>
<td align="left">2.5E13</td>
<td align="left">1959</td>
<td align="left">350</td>
<td align="left">48</td>
<td align="left">16,800</td>
<td align="left">Domestic use</td>
<td align="left">2025</td>
</tr>
<tr>
<td colspan="2" align="left">RA-3</td>
<td align="left">
<italic>Argentina</italic>
</td>
<td align="left">HEU</td>
<td align="left">4.8E13</td>
<td align="left">1961</td>
<td align="left">500</td>
<td align="left">46</td>
<td align="left">23,000</td>
<td align="left">Domestic use</td>
<td align="left">2027</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The information is derived from:</p>
</fn>
<fn>
<p>The IAEA&#x2019;s Research Reactor Database (RRDB): <ext-link ext-link-type="uri" xlink:href="https://nucleus.iaea.org/rrdb/">https://nucleus.iaea.org/rrdb/&#x23;/home</ext-link> (accessed 8.6.2022), <xref ref-type="bibr" rid="B144">NEA, 2019</xref>, <xref ref-type="bibr" rid="B200">Zhuikov, 2014</xref>, and <xref ref-type="bibr" rid="B139">NAP, 2018</xref>.</p>
</fn>
<fn id="Tfn7">
<label>a</label>
<p>BR-2, Belgian Reactor 2; HFR, high flux reactor; OPAL, open pool australian light water; NRU, national research universal; SAFARI-1, South African Fundamental Atomic Research Installation 1; RIAR, the Research Institute of Atomic Reactors; and N.A, Not Available.</p>
</fn>
<fn id="Tfn8">
<label>b</label>
<p>Available production capacity: is the upper limit of <sup>99</sup>Mo production capability that can be achieved on a routine operating schedule.</p>
</fn>
<fn id="Tfn9">
<label>c</label>
<p>Additional <sup>99</sup>Mo production capability owing to the engagement of a new processing facility, namely, the ANSTO, Nuclear Medicine (ANM) project, which started in May 2019.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>After the irradiation step, the targets are left to cool down, allowing short-lived and ultra-short-lived fission products to decay. Then, the irradiated targets are moved to the processing facilities where the recovery of <sup>99</sup>Mo from other fission products is conducted, and a pure <sup>99</sup>Mo-molybdate solution is prepared. Currently, there exist only five large-scale processing centers that can perform this task. <xref ref-type="table" rid="T5">Table 5</xref> shows the five main processing facilities and their global <sup>99</sup>Mo supply (<xref ref-type="bibr" rid="B96">IAEA, 2013a</xref>, <xref ref-type="bibr" rid="B90">2015</xref>; <xref ref-type="bibr" rid="B138">NAP, 2016</xref>,; <xref ref-type="bibr" rid="B144">NEA, 2019</xref>).</p>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>The main uranium fission processing facilities and their <sup>99</sup>Mo supply capacities.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="left">Processing facility<xref ref-type="table-fn" rid="Tfn10">
<sup>a</sup>
</xref>
</th>
<th align="left">Country</th>
<th align="left">Target</th>
<th align="left">Chemical process<xref ref-type="table-fn" rid="Tfn11">
<sup>b</sup>
</xref>
</th>
<th align="left">Estimated available supply capacity, six-day Ci/week</th>
<th align="left">Production of <sup>99</sup>Mo, week/year</th>
<th align="left">Estimated available supply capacity by 2024<xref ref-type="table-fn" rid="Tfn12">
<sup>c</sup>
</xref>, six-day Ci/year</th>
<th align="left">Estimated global market share, %</th>
<th align="left">Expected shutdown, year</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="7" align="left">Global producers</td>
<td align="left">ANSTO</td>
<td rowspan="2" align="left">Australia</td>
<td rowspan="2" align="left">LEU</td>
<td rowspan="2" align="left">Alkaline</td>
<td align="left">2,150</td>
<td rowspan="2" align="left">43</td>
<td align="left">92,450</td>
<td align="left">13</td>
<td rowspan="2" align="left">2057</td>
</tr>
<tr>
<td align="left">
<xref ref-type="table-fn" rid="Tfn13">
<sup>d</sup>
</xref>ANM project</td>
<td align="left">&#x2b;1,350&#xa0;<sup>
<bold>C</bold>
</sup>
</td>
<td align="left">&#x2b;58,050&#xa0;<sup>
<bold>C</bold>
</sup>
</td>
<td align="left">8</td>
</tr>
<tr>
<td align="left">
<xref ref-type="table-fn" rid="Tfn14">
<sup>e</sup>
</xref>Curium</td>
<td align="left">Netherlands</td>
<td align="left">LEU</td>
<td align="left">Alkaline</td>
<td align="left">5,000</td>
<td align="left">52</td>
<td align="left">260,000</td>
<td align="left">37</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">IRE</td>
<td align="left">Belgium</td>
<td align="left">HEU</td>
<td align="left">Alkaline process</td>
<td align="left">3,500</td>
<td align="left">49</td>
<td align="left">171,500</td>
<td align="left">24</td>
<td align="left">2028</td>
</tr>
<tr>
<td align="left">NTP</td>
<td align="left">South Africa</td>
<td align="left">LEU</td>
<td align="left">Alkaline</td>
<td align="left">3,000</td>
<td align="left">44</td>
<td align="left">130,700</td>
<td align="left">18</td>
<td align="left">2030</td>
</tr>
<tr>
<td align="left">
<xref ref-type="table-fn" rid="Tfn15">
<sup>f</sup>
</xref>CNL/Nordion</td>
<td align="left">Canada</td>
<td align="left">HEU</td>
<td align="left">Acidic</td>
<td align="left">29% (Global market)</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">stopped</td>
</tr>
<tr>
<td align="left">Mallinckrodt</td>
<td align="left">Netherlands</td>
<td align="left">HEU</td>
<td align="left">Alkaline</td>
<td align="left">24% (Global market)</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">stopped</td>
</tr>
<tr>
<td rowspan="3" align="left">Regional producers</td>
<td align="left">RIAR</td>
<td rowspan="2" align="left">Russia</td>
<td align="left">HEU</td>
<td align="left">Alkaline</td>
<td align="left">540</td>
<td align="left">50</td>
<td align="left">27,000</td>
<td align="left">Domestic use</td>
<td align="left">2025</td>
</tr>
<tr>
<td align="left">KAPROV</td>
<td align="left">HEU</td>
<td align="left">Alkaline</td>
<td align="left">350</td>
<td align="left">48</td>
<td align="left">16,800</td>
<td align="left">Domestic use</td>
<td align="left">2025</td>
</tr>
<tr>
<td align="left">CNEA</td>
<td align="left">
<italic>Argentina</italic>
</td>
<td align="left">LEU</td>
<td align="left">Alkaline</td>
<td align="left">500</td>
<td align="left">46</td>
<td align="left">23,000</td>
<td align="left">Domestic use</td>
<td align="left">2027</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The information is derived from: 1 <xref ref-type="bibr" rid="B144">NEA, 2019</xref>, 2 <xref ref-type="bibr" rid="B139">NAP, 2018</xref>.</p>
</fn>
<fn id="Tfn10">
<label>a</label>
<p>ANSTO: australian nuclear science and technology organization; ANM: ANSTO, nuclear medicine; IRE: national institute for radioelements; NTP: nuclear technology products radioisotopes; RIAR: the Research Institute of Atomic Reactors; and N.A: Not Available.</p>
</fn>
<fn id="Tfn11">
<label>b</label>
<p>The alkaline process is fully compatible with the U-Al alloy targets and offers the advantage of <sup>131</sup>I co-production capability.</p>
</fn>
<fn id="Tfn12">
<label>c</label>
<p>Available supply capacity: is the upper limit of <sup>99</sup>Mo supply capability that can be achieved on a routine operation framework.</p>
</fn>
<fn id="Tfn13">
<label>d</label>
<p>Additional <sup>99</sup>Mo supply capability owing to the engagement of a new processing facility, namely, ANSTO, Nuclear Medicine (ANM), which started in May 2019.</p>
</fn>
<fn id="Tfn14">
<label>e</label>
<p>Curium was established through a merger between Mallinckrodt Nuclear Medicine and Ion Beam Applications Molecular (IBAM). <ext-link ext-link-type="uri" xlink:href="http://www.mallinckrodt.com/about/news-and-media/2197068">http://www.mallinckrodt.com/about/news-and-media/2197068</ext-link> (accessed 8.6.2022).</p>
</fn>
<fn id="Tfn15">
<label>f</label>
<p>CNL/Nordion terminated their <sup>99</sup>Mo processing activities at the end of 2016.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>The uranium fission method deserves careful attention owing to its capability to provide adequate amounts of <sup>99</sup>Mo in a carrier-free form with high specific activity, which can satisfy the global medical need. However, the application of this technology faces inherent critical challenges. For instance, proliferation concerns are dramatically growing owing to the use of massive amounts of HEU targets. Nearly 80% of the global demand of <sup>99</sup>Mo is produced using uranium targets containing up to 93% of enriched <sup>235</sup>U. During the production steps, about 50&#xa0;kg of weapons-grade HEU are usually handled, and only a very minute amount (&#x223c;3%) is utilized in the entire process (<xref ref-type="bibr" rid="B137">NAP, 2009</xref>; <xref ref-type="bibr" rid="B145">NEA, 2010</xref>; <xref ref-type="bibr" rid="B90">IAEA, 2015</xref>). In order to eliminate these nuclear proliferation issues, HEU targets have to be fully substituted by LEU or natural uranium targets (<xref ref-type="bibr" rid="B196">Wu et al., 1995</xref>; <xref ref-type="bibr" rid="B46">Cols et al., 2000</xref>; <xref ref-type="bibr" rid="B47">Conner et al., 2000</xref>). In addition, the aging fleet of the currently used irradiation facilities is also of concern. Approximately 95% of the global supply of <sup>99</sup>Mo depends on only six reactors. With the exclusion of OPAL, all the other five reactors have been in service for more than 50&#xa0;years. Lately, a number of unplanned shutdowns have taken place, and consequently, the international medical community has severely suffered from a <sup>99</sup>Mo shortage (<xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>). In case of any unexpected future interruption, a renewed <sup>99</sup>Mo supply crisis cannot be ruled out and could seriously affect many countries due to the expected rise in the cost of dose per patient (<xref ref-type="bibr" rid="B146">NEA, 2011</xref>).</p>
<p>Moreover, the separation and purification of <sup>99</sup>Mo from fission products is a sophisticated process and calls for large and complex infrastructures, professional technical skills, and well-equipped laboratories. Only few centers worldwide are well-prepared to conduct this task (<xref ref-type="bibr" rid="B2">Ali and Ache, 1987</xref>; <xref ref-type="bibr" rid="B138">NAP, 2016</xref>, <xref ref-type="bibr" rid="B139">2018</xref>; <xref ref-type="bibr" rid="B144">NEA, 2019</xref>). Furthermore, the generation of massive quantities of toxic radioactive waste containing medium and long-lived radionuclides has to be considered. A significant number of Curies (&#x223c;50&#xa0;Ci) of fission radioactive waste are generated per production of one&#xa0;Curie (Ci) of <sup>99</sup>Mo (<xref ref-type="bibr" rid="B25">Boyd, 1987</xref>; <xref ref-type="bibr" rid="B95">IAEA, 1998</xref>; <xref ref-type="bibr" rid="B189">Tur, 2000</xref>). The difficulties mentioned above are clearly reflected in the continuing need for long-term capital investments and routine operating expenditures. As a result, the production cost of 1&#xa0;Ci of <sup>99</sup>Mo from the fission route is four times higher than that of 1&#xa0;Ci of neutron-capture-produced <sup>99</sup>Mo (<xref ref-type="bibr" rid="B26">Boyd, 1982a</xref>).</p>
</sec>
</sec>
<sec id="s2-1-2">
<title>2.1.2 Neutron-capture-produced <sup>99</sup>Mo</title>
<p>
<sup>99</sup>Mo can also be produced through the neutron activation of natural or enriched <sup>98</sup>Mo targets in the thermal flux of typical research reactors. This technology has been used for <sup>99</sup>Mo production for more than five&#xa0;decades. Molybdenum has seven different naturally occurring stable isotopes, as shown in <xref ref-type="table" rid="T6">Table 6</xref>. <sup>98</sup>Mo is the most naturally abundant molybdenum isotope with 24.13%.</p>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>The naturally occurring molybdenum isotopes (<xref ref-type="bibr" rid="B118">Magill et al., 2022</xref>).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Isotope</th>
<th align="left">Abundance, %</th>
<th align="left">Thermal (n,&#x3b3;) cross-section, barn</th>
<th align="left">Half-life</th>
<th align="left">Mode of decay</th>
<th align="left">Decay product</th>
<th align="left">Remark</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">
<sup>92</sup>Mo</td>
<td rowspan="2" align="left">14.649</td>
<td align="left">2E-7<xref ref-type="table-fn" rid="Tfn16">
<sup>a</sup>
</xref>
</td>
<td rowspan="2" align="left">Stable</td>
<td rowspan="2" align="left">N.A</td>
<td rowspan="2" align="left">N.A</td>
<td align="left">
<sup>92</sup>Mo(n,&#x3b3;)<sup>93m</sup>Mo</td>
</tr>
<tr>
<td align="left">0.08</td>
<td align="left">
<sup>92</sup>Mo(n,&#x3b3;)<sup>93g</sup>Mo</td>
</tr>
<tr>
<td align="left">
<sup>94</sup>Mo</td>
<td align="left">9.187</td>
<td align="left">0.34</td>
<td align="left">Stable</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>95</sup>Mo</td>
<td align="left">15.873</td>
<td align="left">13.4</td>
<td align="left">Stable</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>96</sup>Mo</td>
<td align="left">16.673</td>
<td align="left">0.55</td>
<td align="left">Stable</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>97</sup>Mo</td>
<td align="left">9.582</td>
<td align="left">2.2</td>
<td align="left">Stable</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>98</sup>Mo</td>
<td align="left">24.292</td>
<td align="left">0.130</td>
<td align="left">Stable</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left"/>
</tr>
<tr>
<td align="left">
<sup>100</sup>Mo</td>
<td align="left">9.744</td>
<td align="left">0.199</td>
<td align="left">7.01E18&#xa0;years</td>
<td align="left">Double &#x3b2;<sup>-</sup>
</td>
<td align="left">
<sup>100</sup>Ru (Stable)</td>
<td align="left">The only unstable naturally occurring isotope of Mo</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn16">
<label>a</label>
<p>This value is deduced from (<xref ref-type="bibr" rid="B69">Gedeonov and Nosov, 1989</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>During the irradiation process, the target nucleus, <sup>98</sup>Mo, captures one thermal neutron and emits gamma rays to form <sup>99</sup>Mo according to the nuclear reaction <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>98</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>n</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>&#x3b3;</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>98</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>. The produced <sup>99</sup>Mo is a Carrier-Added (CA) product (not carrier-free) with low specific activity, as only a small portion of molybdenum is converted to <sup>99</sup>Mo. In other words, the <sup>99</sup>Mo activity is diluted with the inactive bulk of the <sup>98</sup>Mo target (<xref ref-type="bibr" rid="B129">Molinski, 1982</xref>). The specific activity of the produced <sup>99</sup>Mo can be determined from the following equation:<disp-formula id="e1">
<mml:math id="m3">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mo>&#x2205;</mml:mo>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>&#x3c3;</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mn>3.7</mml:mn>
<mml:mo>&#xd7;</mml:mo>
<mml:msup>
<mml:mrow>
<mml:mn>10</mml:mn>
</mml:mrow>
<mml:mn>7</mml:mn>
</mml:msup>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>A</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3bb;</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#x2003;</mml:mtext>
<mml:mi>m</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>i</mml:mi>
<mml:mo>/</mml:mo>
<mml:mi>g</mml:mi>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>
<disp-formula id="e2">
<mml:math id="m4">
<mml:mrow>
<mml:mi>S</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>L</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mo>&#x2205;</mml:mo>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>&#x3c3;</mml:mi>
<mml:mo>&#xd7;</mml:mo>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mi>A</mml:mi>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>&#x3bb;</mml:mi>
<mml:mi>t</mml:mi>
<mml:mo>&#xa0;</mml:mo>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mtext>&#x2003;</mml:mtext>
<mml:mi>B</mml:mi>
<mml:mi>q</mml:mi>
<mml:mo>/</mml:mo>
<mml:mi>g</mml:mi>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
</p>
<p>Where;<list list-type="simple">
<list-item>
<p>
<bold>S</bold> is the specific activity of the produced <sup>99</sup>Mo in mCi/g or Bq/g,</p>
</list-item>
<list-item>
<p>
<bold>L</bold> is the Avogadro number (6.022 &#xd7; 10<sup>23</sup>),</p>
</list-item>
<list-item>
<p>
<bold>&#x3c3;</bold> is the thermal activation cross-section (0.13 barns, i.e., 0.13 &#xd7; 10<sup>&#x2013;24</sup>&#xa0;cm<sup>2</sup>),</p>
</list-item>
<list-item>
<p>
<inline-formula id="inf3">
<mml:math id="m5">
<mml:mi>&#x3d5;</mml:mi>
</mml:math>
</inline-formula> is the thermal neutron flux in n/cm<sup>2</sup>s,</p>
</list-item>
<list-item>
<p>
<bold>a</bold> is the abundance of <sup>98</sup>Mo isotope (&#x223c;24.14%),</p>
</list-item>
<list-item>
<p>
<bold>A</bold> is the atomic mass of molybdenum (95.94),</p>
</list-item>
<list-item>
<p>
<bold>t</bold> is the total irradiation time,</p>
</list-item>
<list-item>
<p>
<bold>&#x3bb;</bold> is the radioactive decay constant (ln2/T<sub>1/2</sub>),</p>
</list-item>
<list-item>
<p>
<bold>T</bold>
<sub>
<bold>1/2</bold>
</sub> is the half-life of the <sup>99</sup>Mo product (T<sub>1/2</sub> &#x3d; 65.94&#xa0;h), and it is in the same unit as <bold>t.</bold>
</p>
</list-item>
</list>
</p>
<p>Based on <xref ref-type="disp-formula" rid="e1">Eq 1</xref>, <xref ref-type="disp-formula" rid="e2">2</xref>, the <sup>99</sup>Mo specific activity at the End of Bombardment (EOB) mainly depends on some essential parameters, such as the value of the neutron flux in the irradiation channel, the effective cross-section, the irradiation period, and the <sup>98</sup>Mo content in the irradiated target (<xref ref-type="bibr" rid="B21">Binney and Scherpdz, 1978</xref>; <xref ref-type="bibr" rid="B82">Hetherington and Boyd, 1999</xref>).</p>
<p>The use of enriched <sup>98</sup>Mo target material provides an adequate opportunity to enhance the specific activity. This increase is proportional to the enrichment factor. Therefore, the specific activity yield of the produced <sup>99</sup>Mo can be improved by a factor of four using enriched targets, which have a <sup>98</sup>Mo content &#x2265;96%.</p>
<p>
<sup>98</sup>Mo targets can also be defined according to the chemical form of the target material, which involves the use of MoO<sub>3</sub> or Mo metal. The irradiated MoO<sub>3</sub> powder can be easily dissolved compared to Mo metal. However, when molybdenum metal is used, the amount of <sup>98</sup>Mo in the same irradiation space is higher, resulting in higher <sup>99</sup>Mo yields per Gram material.</p>
<p>One of the main parameters that limit the specific activity that results from this method is the small neutron capture cross-section of <sup>98</sup>Mo targets, which is 0.13 barns for thermal neutrons. However, this value can be increased for the same target to 6.7 barns when the irradiation is conducted in the epithermal energy region (<xref ref-type="bibr" rid="B114">Lavi, 1978</xref>; <xref ref-type="bibr" rid="B96">IAEA, 2013a</xref>). In practice, specific activities of 10&#x2013;15&#xa0;Ci/g Mo have been achieved (<xref ref-type="bibr" rid="B167">Ryabchikov et al., 2004</xref>). The produced specific activity of <sup>99</sup>Mo from neutron irradiation of <sup>98</sup>Mo targets is particularly low compared to <sup>99</sup>Mo provided by the uranium fission method (see <xref ref-type="table" rid="T3">Table 3</xref>). However, the specific activity can be increased by a factor of eight if an enriched <sup>98</sup>Mo target of a particular geometry is irradiated in a high flux reactor (<xref ref-type="bibr" rid="B2">Ali and Ache, 1987</xref>; <xref ref-type="bibr" rid="B82">Hetherington and Boyd, 1999</xref>; <xref ref-type="bibr" rid="B80">Hasan and Prelas, 2020</xref>).</p>
<p>In principle, commercial power reactors offer an adequate neutron spectrum and neutron flux for producing Low Specific Activity (LSA) <sup>99</sup>Mo. However, power reactors are usually not equipped for the introduction of samples for irradiation during operation. This fact significantly limits the use of power reactors as irradiation sources. There are exceptions. The new EPR reactors and the older KONVOI type Pressurized Water Reactors (PWR) have a built-in, so-called aeroball system for <italic>in-situ</italic> flux measurements. During operation, <sup>51</sup>V spheres of 1.7&#xa0;mm diameter can be filled in columns in the reactor, irradiated for a short time period, and extracted again. The produced activity is then measured on a so-called measuring table (<xref ref-type="bibr" rid="B111">Konheiser et al., 2016</xref>; <xref ref-type="bibr" rid="B65">Framatome, 2019a</xref>). This system could be repurposed to introduce metallic Mo-spheres or MoO<sub>3</sub> ceramic spheres for irradiation (<xref ref-type="bibr" rid="B66">Framatome, 2019b</xref>). As the columns are several meters long and there are a large number of columns, sufficient amounts of Mo can be irradiated.</p>
<p>Furthermore, one of the potential projects that utilize neutron-capture-produced <sup>99</sup>Mo has been implemented by Northstar Company in the United States. Northstar uses the Missouri University Research Reactor (MURR) to irradiate both natural and enriched <sup>98</sup>Mo targets. The estimated production capacity of this project will be about 4500 six-day Curie <sup>99</sup>Mo per week by 2024 (<xref ref-type="bibr" rid="B144">NEA, 2019</xref>). Northstar is supplying LSA <sup>99</sup>Mo solution to be used with a generator system of RadioGenix, which produces <sup>99m</sup>Tc in a computer-controlled generator system.</p>
<p>Clearly, the neutron activation technology eliminates proliferation concerns, as it offers a clean method to provide <sup>99</sup>Mo without the need to handle any fissile materials. In addition, it asks for fewer technological requirements and financial budgets compared to the uranium fission approach (<xref ref-type="bibr" rid="B26">Boyd, 1982a</xref>). Moreover, based on the fact that only molybdenum targets are irradiated, this process involves less demanding chemical separation and purification steps as well as the generated radioactive waste level can be neglected. Furthermore, the good global distribution of reactors with high neutron flux capability could significantly support the <sup>99</sup>Mo economy. The method is fast, and a time span of 3 days from the EOB to the arrival of the generator to the end-user is feasible. On the one hand, the <sup>99</sup>Mo decay loss can be minimized, as the <sup>99</sup>Mo activity can be delivered in a short period directly after production. On the other hand, a stable supply of <sup>99</sup>Mo can be guaranteed even in case of any unplanned interruptions that may arise from the fission production line.</p>
<p>Despite the potential advantages of producing neutron-capture-produced <sup>99</sup>Mo, its utility for the production of <sup>99m</sup>Tc generators faces some potential challenges, especially with conventional alumina columns. Using such materials leads to a large elution volume with a very low <sup>99m</sup>Tc radioactive concentration and a significant <sup>99</sup>Mo breakthrough risk. Recently, extensive research efforts have been conducted for alternative strategies to overcome these problems. In this regard, the challenges and the current progress are therefore discussed in more detail in <xref ref-type="sec" rid="s3-3">Sections 3.2, 3.3</xref>.</p>
</sec>
</sec>
<sec id="s2-2">
<title>2.2 Accelerator-based <sup>99</sup>Mo production</title>
<p>Recently, there has been a growing interest in using modern particle accelerators as a promising solution to produce <sup>99</sup>Mo for medical applications. This approach allows the production of <sup>99</sup>Mo without the need for HEU targets and generates relatively low amounts of radioactive waste compared to nuclear reactors (<xref ref-type="bibr" rid="B194">Van der Marck et al., 2010</xref>). The idea is built on the acceleration of charged particles, such as protons, deuterons, or electrons, to induce nuclear reactions in the target material. In some cases, the accelerated particles can interact with the target material and directly produce <sup>99</sup>Mo or even <sup>99m</sup>Tc. In other cases, the reaction becomes more complex and takes place in two steps. In the first step, the primary charged particles are successfully accelerated and strike an intermediate target material to produce secondary particles, such as neutrons or high-energy photons. Then, the secondary particles interact with the main target material to produce <sup>99</sup>Mo (<xref ref-type="bibr" rid="B145">NEA, 2010</xref>). The choice of one of these techniques mainly depends on the post-irradiation <sup>99</sup>Mo production capability. The primary accelerator-based <sup>99</sup>Mo &#x2212; or direct <sup>99m</sup>Tc production approaches are summarized in <xref ref-type="table" rid="T7">Table 7</xref>. In <xref ref-type="table" rid="T7">Table 7</xref>, the irradiation yields were calculated under modern-day, realistic assumptions concerning beam intensities using publicly available nuclear codes. For photonuclear reactions, it was assumed that the electron beam is delivered by an IBA TT-300 HE rhodotron (<xref ref-type="bibr" rid="B102">IBA, 2018</xref>) impinging on a high-power converter target (<xref ref-type="bibr" rid="B190">T&#xfc;rler et al., 2021</xref>). The photon spectrum and the yield of <sup>99</sup>Mo were calculated by Vagheian (<xref ref-type="bibr" rid="B192">Vagheian, 2022</xref>). For proton and deuteron-induced reactions, it was assumed that the beam is being delivered by a IBA Cyclone IKON-1000 cyclotron as a typical representative of accelerators in the 30&#xa0;MeV energy range (<xref ref-type="bibr" rid="B101">IBA, 2022</xref>). It was assumed that a solid target station could accept a maximum proton beam current of 400&#xa0;&#x3bc;A (i.e., Nirta High Power Solid target (90&#x2013;400&#xa0;&#x3bc;A)), since molybdenum is a very refractive element. For the calculations, the web-based &#x201c;Medical Isotope Browser&#x201d; was employed (see the footnote in <xref ref-type="table" rid="T7">Table 7</xref>). As can be seen from <xref ref-type="table" rid="T7">Table 7</xref>, the production of <sup>99</sup>Mo with an electron accelerator from <sup>100</sup>Mo appears to be most promising due to the large activities that can be produced. Proton irradiations of <sup>100</sup>Mo yield significantly less yield of <sup>99</sup>Mo, while producing more undesired by-products. The direct production of <sup>99m</sup>Tc from <sup>100</sup>Mo is a viable option but significantly reduces the distribution radius of the product (see <xref ref-type="sec" rid="s3">Section 3.1</xref>). In the following, the accelerator-based production of <sup>99</sup>Mo is discussed in more detail.</p>
<table-wrap id="T7" position="float">
<label>TABLE 7</label>
<caption>
<p>The main accelerator-based <sup>99</sup>Mo and <sup>99m</sup>Tc production routes and their production capabilities per day.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">Facility</th>
<th rowspan="2" align="left">Accelerated particle</th>
<th rowspan="2" align="left">Incident particle</th>
<th rowspan="2" align="left">Target material</th>
<th rowspan="2" align="left">Nuclear reaction</th>
<th colspan="3" align="left">Reaction parameters</th>
<th rowspan="2" align="left">Thick target yield at EOB, Ci</th>
<th rowspan="2" align="left">Available activity at calibration, Ci</th>
</tr>
<tr>
<th align="center">Target thickness, mm</th>
<th align="center">Incident energy, MeV</th>
<th align="center">Incident current<xref ref-type="table-fn" rid="Tfn17">
<sup>a</sup>
</xref>, &#xb5;A</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="2" align="left">Electron accelerator</td>
<td align="left">Electron</td>
<td align="left">Photon</td>
<td align="left">
<sup>nat.</sup>U</td>
<td align="left">
<sup>238</sup>U(&#x3b3;, f)<sup>99</sup>Mo</td>
<td align="left">3.17<xref ref-type="table-fn" rid="Tfn18">
<sup>b</sup>
</xref>
</td>
<td align="left">40</td>
<td align="left">3125</td>
<td align="left">2.30<xref ref-type="table-fn" rid="Tfn19">
<sup>c</sup>
</xref>
</td>
<td align="left">1.08</td>
</tr>
<tr>
<td align="left">Electron</td>
<td align="left">Photon</td>
<td align="left">
<sup>100</sup>Mo</td>
<td align="left">
<sup>100</sup>Mo(&#x3b3;,n)<sup>99</sup>Mo</td>
<td align="left">9.96<xref ref-type="table-fn" rid="Tfn18">
<sup>b</sup>
</xref>
</td>
<td align="left">40</td>
<td align="left">3125</td>
<td align="left">137<xref ref-type="table-fn" rid="Tfn19">
<sup>c</sup>
</xref>
</td>
<td align="left">64.34</td>
</tr>
<tr>
<td rowspan="9" align="left">Deuteron accelerator</td>
<td align="left">Deuteron</td>
<td align="left">Neutron</td>
<td align="left">
<sup>100</sup>Mo</td>
<td align="left">
<sup>100</sup>Mo(n,2n)<sup>99</sup>Mo</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
</tr>
<tr>
<td rowspan="4" align="left">Deuteron</td>
<td rowspan="4" align="left">Deuteron</td>
<td rowspan="4" align="left">
<sup>100</sup>Mo</td>
<td rowspan="4" align="left">
<sup>100</sup>Mo(d,p2n) <sup>99</sup>Mo</td>
<td align="left">0.17</td>
<td align="left">15</td>
<td align="left">100</td>
<td align="left">0.02</td>
<td align="left">0.01</td>
</tr>
<tr>
<td align="left">0.20</td>
<td align="left">16</td>
<td align="left">100</td>
<td align="left">0.03</td>
<td align="left">0.01</td>
</tr>
<tr>
<td align="left">0.24</td>
<td align="left">17</td>
<td align="left">100</td>
<td align="left">0.05</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left">0.28</td>
<td align="left">18</td>
<td align="left">100</td>
<td align="left">0.07</td>
<td align="left">0.034</td>
</tr>
<tr>
<td rowspan="4" align="left">Deuteron</td>
<td rowspan="4" align="left">Deuteron</td>
<td rowspan="4" align="left">
<sup>100</sup>Mo</td>
<td rowspan="4" align="left">
<sup>100</sup>Mo(d,3n)<sup>99m</sup>Tc</td>
<td align="left">0.14</td>
<td align="left">15</td>
<td align="left">100</td>
<td align="left">0.35</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">0.18</td>
<td align="left">16</td>
<td align="left">100</td>
<td align="left">0.67</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">0.21</td>
<td align="left">17</td>
<td align="left">100</td>
<td align="left">1.12</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">0.25</td>
<td align="left">18</td>
<td align="left">100</td>
<td align="left">1.73</td>
<td align="left">N.A</td>
</tr>
<tr>
<td rowspan="11" align="left">Proton accelerator</td>
<td rowspan="5" align="left">Proton</td>
<td rowspan="5" align="left">Proton</td>
<td rowspan="5" align="left">
<sup>100</sup>Mo</td>
<td rowspan="5" align="left">
<sup>100</sup>Mo(p,pn)<sup>99</sup>Mo <sup>100</sup>Mo (p,2p)<sup>99</sup>Nb &#x2192;<sup>99</sup>Mo</td>
<td align="left">0.30</td>
<td align="left">15</td>
<td align="left">400</td>
<td align="left">0.26</td>
<td align="left">0.12</td>
</tr>
<tr>
<td align="left">0.61</td>
<td align="left">20</td>
<td align="left">400</td>
<td align="left">2.52</td>
<td align="left">1.18</td>
</tr>
<tr>
<td align="left">0.99</td>
<td align="left">25</td>
<td align="left">400</td>
<td align="left">7.36</td>
<td align="left">3.46</td>
</tr>
<tr>
<td align="left">1.43</td>
<td align="left">30</td>
<td align="left">400</td>
<td align="left">13.85</td>
<td align="left">6.50</td>
</tr>
<tr>
<td align="left">1.92</td>
<td align="left">35</td>
<td align="left">400</td>
<td align="left">21.44</td>
<td align="left">10.07</td>
</tr>
<tr>
<td align="left">Proton</td>
<td align="left">Proton</td>
<td align="left">
<sup>232</sup>Th</td>
<td align="left">
<sup>232</sup>Th(p,f)<sup>99</sup>Mo</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
<td align="left">N.A</td>
</tr>
<tr>
<td rowspan="5" align="left">Proton</td>
<td rowspan="5" align="left">Proton</td>
<td rowspan="5" align="left">
<sup>100</sup>Mo</td>
<td rowspan="5" align="left">
<sup>100</sup>Mo(p,2n)<sup>99m</sup>Tc</td>
<td align="left">0.32</td>
<td align="left">15</td>
<td align="left">400</td>
<td align="left">21.67</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">0.63</td>
<td align="left">20</td>
<td align="left">400</td>
<td align="left">48.01</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">1.01</td>
<td align="left">25</td>
<td align="left">400</td>
<td align="left">62.23</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">1.45</td>
<td align="left">30</td>
<td align="left">400</td>
<td align="left">68.18</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left">1.94</td>
<td align="left">35</td>
<td align="left">400</td>
<td align="left">73.04</td>
<td align="left">N.A</td>
</tr>
<tr>
<td align="left"/>
<td align="left">Proton</td>
<td align="left">Proton</td>
<td align="left">
<sup>98</sup>Mo</td>
<td align="left">
<sup>98</sup>Mo(p,&#x3b3;) <sup>99m</sup>Tc</td>
<td align="left">2.07</td>
<td align="left">35</td>
<td align="left">400</td>
<td align="left">0.01</td>
<td align="left">N.A</td>
</tr>
<tr>
<td rowspan="5" align="left">&#x3b1;-particle accelerator</td>
<td rowspan="5" align="left">&#x3b1;-particle</td>
<td rowspan="5" align="left">&#x3b1;-particle</td>
<td rowspan="5" align="left">
<sup>96</sup>Zr</td>
<td rowspan="5" align="left">
<sup>96</sup>Zr(&#x3b1;,n)<sup>99</sup>Mo</td>
<td align="left">0.06</td>
<td align="left">15</td>
<td align="left">100</td>
<td align="left">0.03</td>
<td align="left">0.01</td>
</tr>
<tr>
<td align="left">0.11</td>
<td align="left">20</td>
<td align="left">100</td>
<td align="left">0.04</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left">0.16</td>
<td align="left">25</td>
<td align="left">100</td>
<td align="left">0.04</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left">0.22</td>
<td align="left">30</td>
<td align="left">100</td>
<td align="left">0.04</td>
<td align="left">0.02</td>
</tr>
<tr>
<td align="left">0.29</td>
<td align="left">35</td>
<td align="left">100</td>
<td align="left">0.05</td>
<td align="left">0.02</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>The data were calculated using &#x201c;Medical Isotope Browser&#x201d; of IAEA: <ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/relnsd/isotopia/isotopia.html">https://www-nds.iaea.org/relnsd/isotopia/isotopia.html</ext-link> (accessed on 08.06.2022) utilizing recommended cross section data from (<xref ref-type="bibr" rid="B182">Tarkanyi et al., 2019</xref>).</p>
</fn>
<fn id="Tfn17">
<label>a</label>
<p>
<ext-link ext-link-type="uri" xlink:href="https://www.iba-radiopharmasolutions.com/cyclotrons-equipment">https://www.iba-radiopharmasolutions.com/cyclotrons-equipment</ext-link> (accessed on 08.06.2022).</p>
</fn>
<fn id="Tfn18">
<label>b</label>
<p>Thickness of 1 radiation length (1 X<sub>0</sub>).</p>
</fn>
<fn id="Tfn19">
<label>c</label>
<p>Yield of a cylindrical target of 1 X<sub>0</sub> thickness and 2&#xa0;cm diameter at a distance of 2&#xa0;cm from a distributed Ta converter of 4.5&#xa0;mm thickness. The thick target yield can be obtained by multiplication by a factor of about 4.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="s2-2-1">
<title>2.2.1 Photonuclear reactions</title>
<p>With electron accelerators, a high-intensity electron beam is allowed to impinge on a dense target material to produce Bremsstrahlung photons. These photons can be used to produce <sup>99</sup>Mo by two main strategies:<list list-type="simple">
<list-item>
<p>1- Photon-induced fission (photofission) reaction.</p>
</list-item>
<list-item>
<p>2- Photon-induced nuclear (photonuclear) reaction.</p>
</list-item>
</list>
</p>
<p>In the photo-fission method, high specific activity <sup>99</sup>Mo can be obtained from the reaction <inline-formula id="inf4">
<mml:math id="m6">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>U</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>238</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>&#x3b3;</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>f</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>. The <sup>99</sup>Mo production output is approximately 3700&#xa0;times lower than the neutron-induced uranium fission method, attributed to the considerably lower reaction cross-section (0.16 barn) (<xref ref-type="bibr" rid="B194">van der Marck, 2010</xref>; <xref ref-type="bibr" rid="B158">Qaim, 2012</xref>). After the irradiation process is accomplished, <sup>99</sup>Mo is chemically separated from the <sup>238</sup>U targets in the same way as the previously described technique for irradiated HEU targets in nuclear reactors (<xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>). For commercial production, high energy accelerators need to be used (<xref ref-type="bibr" rid="B164">Ruth, 2009</xref>). However, this option is still under demonstration. Using <sup>235</sup>U targets increase the <sup>99</sup>Mo yield (<xref ref-type="bibr" rid="B204">Krishichayan et al., 2017</xref>). Nonetheless, this option does not have enough justification due to higher production costs, high process complexity, and proliferation issues (<xref ref-type="bibr" rid="B18">Bertsche, 2010</xref>).</p>
<p>The photonuclear transmutation reaction offers a promising strategy for <sup>99</sup>Mo production according to the reaction <inline-formula id="inf5">
<mml:math id="m7">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>&#x3b3;</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>. The maximum cross-section of this reaction is 0.15 barn at a photon energy of 14&#xa0;MeV (<xref ref-type="bibr" rid="B194">van der Marck, 2010</xref>; <xref ref-type="bibr" rid="B48">Crasta et al., 2011</xref>), which is larger than the <sup>238</sup>U photo-fission reaction for producing <sup>99</sup>Mo, which results in a higher <sup>99</sup>Mo yield by a factor of about 17 in case highly enriched <sup>100</sup>Mo targets are used (<xref ref-type="bibr" rid="B18">Bertsche, 2010</xref>). Specific activities of about 5&#xa0;Ci/G of <sup>100</sup>Mo can be achieved, resulting in production capacities of more than 100&#xa0;Ci per day. <xref ref-type="bibr" rid="B119">Mang&#x2019;era et al. (2015</xref>) reported the production of 2.4&#x2013;3 GBq/h/g/mA <sup>99</sup>Mo from 97.39% enriched <sup>100</sup>Mo targets. Commercially available electron accelerators can deliver up to 3&#xa0;mA of beam at energies up to 40&#xa0;MeV. Also, a high-power converter target design has recently been submitted as patent application (<xref ref-type="bibr" rid="B190">T&#xfc;rler et al., 2021</xref>). Therefore, future production of 100&#xa0;Ci per day with a specific activity of 5&#xa0;Ci/g appears feasible. Nevertheless, the specific activity yield is still lower than for the <inline-formula id="inf6">
<mml:math id="m8">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>U</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>238</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>&#x3b3;</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>f</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> reaction. In order to achieve a sustainable long-term <sup>99</sup>Mo supply, two main difficulties need to be urgently solved. First, while high power electron accelerators are commercially available, suitable converter targets that can accept more than 100&#xa0;kW beam power still need to be developed (<xref ref-type="bibr" rid="B190">T&#xfc;rler et al., 2021</xref>). Second, the possibility of reusing the valuable <sup>100</sup>Mo target material should receive intensive research consideration (<xref ref-type="bibr" rid="B18">Bertsche, 2010</xref>).</p>
</sec>
<sec id="s2-2-2">
<title>2.2.2 14.1&#xa0;MeV neutron-induced reactions</title>
<p>
<sup>99</sup>Mo can also be produced through the bombardment of a <sup>100</sup>Mo target with high energy neutrons according to the nuclear reaction <sup>100</sup>
<italic>Mo</italic>(<italic>n</italic>,2<italic>n</italic>)<sup>99</sup>
<italic>Mo</italic>. Here, the 14.1&#xa0;MeV neutrons are generated in the reaction <sup>3</sup>
<italic>H</italic>(<italic>d</italic>,<italic>n</italic>)<sup>4</sup>
<italic>He</italic>. The reaction cross-section for the reaction <sup>100</sup>
<italic>Mo</italic>(<italic>n</italic>,2<italic>n</italic>)<sup>99</sup>
<italic>Mo</italic> is about 1.5 barn at the neutron energy level of 14.1 MeV, which is ten times higher than the cross-section of the <sup>98</sup>Mo(n,&#x3b3;)<sup>99</sup>Mo reaction in the thermal region. In addition, a long irradiation period of more than 8&#xa0;days and a high-intensity neutron flux &#x2265; 10<sup>13</sup> n/cm<sup>2</sup>s is required (<xref ref-type="bibr" rid="B136">Nagai and Hatsukawa, 2009</xref>). Even so, the production of low specific <sup>99</sup>Mo with large amounts of inactive carrier is still present even with <sup>100</sup>Mo targets of 100% enrichment. Under the conditions mentioned above, the specific activity of the produced <sup>99</sup>Mo was estimated at about 2&#xa0;Ci/g (79 GBq/g).</p>
<p>In another approach, 14&#xa0;MeV neutrons from a D-T generator are directed at a low enriched <sup>235</sup>U salt solution, where <sup>99</sup>Mo is produced as a fission product and periodically separated. This approach is being commercially exploited by Shine Medical Technologies Inc. (Wisconsin, United States) (<xref ref-type="bibr" rid="B166">Ruth, 2020</xref>).</p>
</sec>
<sec id="s2-2-3">
<title>2.2.3 Spallation neutron-induced reactions</title>
<p>Similar to the concept of neutron-induced fission or capture reactions in a nuclear reactor, <sup>99</sup>Mo can be produced with the use of an Accelerator-Driven Subcritical Reactor (ADSR) through <sup>235</sup>
<italic>U</italic>(<italic>n</italic>,<italic>f</italic>)<sup>99</sup>
<italic>Mo</italic> and <sup>98</sup>
<italic>Mo</italic>(<italic>n</italic>,<italic>&#x3b3;</italic>)<sup>99</sup>
<italic>Mo</italic> reactions (<xref ref-type="bibr" rid="B1">Abderrahim et al., 2010</xref>; <xref ref-type="bibr" rid="B18">Bertsche, 2010</xref>; <xref ref-type="bibr" rid="B145">NEA, 2010</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B179">Syarip et al., 2018</xref>). However, the used neutrons have a different origin. High-intensity neutron flux can be generated following the bombardment of a heavy mass target material with an accelerated proton beam, such as lead, uranium, tungsten, or tantalum. This reaction produces fast neutrons with a kinetic energy level of more than 1&#xa0;MeV up to almost the beam energy of the proton beam, which then is slowed down to the epithermal energy level with the help of a moderator. These conditions offer a unique opportunity to obtain a reasonable <sup>99</sup>Mo yield with a relatively high specific activity using the <sup>98</sup>
<italic>Mo</italic>(<italic>n</italic>,<italic>&#x3b3;</italic>)<sup>99</sup>
<italic>Mo</italic> option. Uranium targets have to undergo routine chemical processing to provide purified <inline-formula id="inf7">
<mml:math id="m9">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> active solution (<xref ref-type="bibr" rid="B156">Pillai et al., 2013</xref>).</p>
</sec>
<sec id="s2-2-4">
<title>2.2.4 Other production methods</title>
<p>Many research groups have proposed other possibilities through proton- or deuteron-induced <sup>99</sup>Mo production (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>; <xref ref-type="bibr" rid="B81">Hermanne et al., 2007</xref>). For example, the <inline-formula id="inf8">
<mml:math id="m10">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>p</mml:mi>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> reaction has a small cross-section and yields low amounts of <sup>99</sup>Mo. Meanwhile, the reaction <inline-formula id="inf9">
<mml:math id="m11">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>p</mml:mi>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> has a twofold higher reaction cross-section than the former. Nonetheless, both require high-power accelerators. Despite using enriched <sup>100</sup>Mo targets and high-energy power accelerators, these two strategies seem to be not satisfactory for stable long-term production of <sup>99</sup>Mo for medical use.</p>
</sec>
</sec>
</sec>
<sec id="s3">
<title>3 <sup>99m</sup>Tc production and supply strategies: Challenges and progress</title>
<sec id="s3-1">
<title>3.1 Cyclotron-produced <sup>99m</sup>Tc</title>
<p>The severe <sup>99</sup>Mo production shortage during the past few years, along with the widespread concerns of unexpected future <sup>99</sup>Mo supply inadequacy, have generated a growing need for establishing an independent sustainable supply of <sup>99m</sup>Tc. Consequently, many research projects have been established to promote the direct production of <sup>99m</sup>Tc exploiting cyclotron production. The cyclotron-based <sup>99m</sup>Tc production can provide an independent option for domestic utilization (<xref ref-type="bibr" rid="B97">IAEA, 1999</xref>; <xref ref-type="bibr" rid="B164">Ruth, 2009</xref>, <xref ref-type="bibr" rid="B165">2014</xref>; <xref ref-type="bibr" rid="B67">Gagnon et al., 2011</xref>; <xref ref-type="bibr" rid="B77">Hanemaayer et al., 2014</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B124">Metello, 2015</xref>; <xref ref-type="bibr" rid="B23">Boschi et al., 2017</xref>; <xref ref-type="bibr" rid="B121">Martini et al., 2018</xref>).</p>
<p>Several approaches have been proposed for direct <sup>99m</sup>Tc production, such as <sup>100</sup>
<italic>Mo</italic>(<italic>p,2n</italic>)<sup>99m</sup>
<italic>Tc</italic>, <sup>98</sup>
<italic>Mo</italic>(<italic>p,&#x3b3;</italic>)<sup>99m</sup>
<italic>Tc</italic>, <sup>100</sup>
<italic>Mo</italic>(<italic>d,3n</italic>)<sup>99m</sup>
<italic>Tc</italic>, <sup>98</sup>
<italic>Mo</italic>(<italic>d,n</italic>)<sup>99m</sup>
<italic>Tc</italic>, <sup>97</sup>
<italic>Mo</italic>(<italic>d,&#x3b3;</italic>)<sup>99m</sup>
<italic>Tc</italic>, and <sup>96</sup>
<italic>Mo</italic>(<italic>&#x3b1;,p</italic>)<sup>99m</sup>
<italic>Tc</italic>. It is pertinent to point out that the proton-induced reactions produce the highest production yields compared to deuteron or alpha particle-induced reactions. In addition, accelerators with high beam intensity of deuterons or alpha particles are currently rare. For these reasons, they received less attention (<xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>, <xref ref-type="bibr" rid="B89">2017</xref>; <xref ref-type="bibr" rid="B181">Tak&#xe1;cs et al., 2003</xref>; <xref ref-type="bibr" rid="B72">Guerin et al., 2010</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B178">Stolarz et al., 2015</xref>).</p>
<p>The direct production of the <sup>99m</sup>Tc using energetic proton beams involves two reactions; <inline-formula id="inf10">
<mml:math id="m12">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>98</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>&#x3b3;</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> and <inline-formula id="inf11">
<mml:math id="m13">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>. The former has a very small reaction cross-section and produces a low <sup>99m</sup>Tc yield, which is not convenient for large-scale production (<xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B181">Tak&#xe1;cs et al., 2003</xref>). The <inline-formula id="inf12">
<mml:math id="m14">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> is more promising for large-scale production because it has a higher cross-section, and its optimum proton energy range is compatible with most conventionally used cyclotrons. Therefore, it has been attracting considerable attention from the scientific community (<xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B181">Tak&#xe1;cs et al., 2003</xref>; <xref ref-type="bibr" rid="B121">Martini et al., 2018</xref>). This approach was first mentioned by Beaver and Hupf at the University of Miami School of Medicine in 1971 using enriched <sup>100</sup>Mo targets (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>). Afterward, the possibility of using natural <sup>100</sup>Mo targets was evaluated by Almeida and Helus in 1977 (<xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>). Recently, many attempts have been conducted to explore the most appropriate conditions to produce considerable amounts of high specific activity of <sup>99m</sup>Tc with the least possible impurity level. These studies concluded that the final <sup>99m</sup>Tc product greatly depends on three primary factors: the <sup>100</sup>Mo target enrichment quality, the irradiation conditions, and the duration of the chemical processing.</p>
<p>The most commonly used molybdenum target material is the Mo metal. In addition, the utilization of MoO<sub>3</sub> and Mo<sub>2</sub>C is also possible (<xref ref-type="bibr" rid="B162">Richards et al., 2013</xref>). The fabrication of the molybdenum targets can be developed with the help of several technical advances. These approaches involve preparing foils, pressing and thermal sintering of molybdenum powder, vacuum sputtering technology, laser beam pressed molybdenum powder method, electrochemical plating technique, and electrophoretic deposition followed by thermal sintering process (<xref ref-type="bibr" rid="B162">Richards et al., 2013</xref>; <xref ref-type="bibr" rid="B77">Hanemaayer et al., 2014</xref>; <xref ref-type="bibr" rid="B178">Stolarz et al., 2015</xref>; <xref ref-type="bibr" rid="B85">Hou et al., 2016</xref>; <xref ref-type="bibr" rid="B121">Martini et al., 2018</xref>). The target purity plays a crucial role and greatly affects the quality of the final <sup>99m</sup>Tc product. The contribution of other molybdenum isotopes with <sup>100</sup>Mo in the target material leads to producing different impurities such as Tc, Nb, Ru, and Zr (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>; <xref ref-type="bibr" rid="B72">Guerin et al., 2010</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B85">Hou et al., 2016</xref>). To reduce the impurity level, the isotopic abundance of <sup>100</sup>Mo targets must not be less than 99.5%. Some of the produced impurities can be removed during the separation and purification processes. However, the different Tc isotopes have the same chemical behavior as <sup>99m</sup>Tc. Therefore, the separation of these isotopes poses considerable laborious challenges, especially with current conventional separation technology. The Tc isotopes can be classified into two groups. The first group involves the long-lived radioisotopes, such as <sup>99g</sup>Tc (T<sub>1/2</sub> &#x3d; 2.11&#xd7;10<sup>5</sup>&#xa0;y), <sup>98</sup>Tc (T<sub>1/2</sub> &#x3d; 4.2&#xd7;10<sup>6</sup>&#xa0;y), and <sup>97g</sup>Tc (T<sub>1/2</sub> &#x3d; 4.21&#xd7;10<sup>6</sup>&#xa0;y). These radioisotopes decrease the final specific activity of the product, but they may not be involved in an additional dose for the patient (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>). On the other hand, the second group contains the shorter half-lives radioisotopes, such as <sup>93m</sup>Tc (T<sub>1/2</sub> &#x3d; 43.5&#xa0;min), <sup>93g</sup>Tc (T<sub>1/2</sub> &#x3d; 2.75&#xa0;h), <sup>94m</sup>Tc (T<sub>1/2</sub> &#x3d; 52&#xa0;min), <sup>94g</sup>Tc (T<sub>1/2</sub> &#x3d; 4.9&#xa0;h), <sup>95m</sup>Tc (T<sub>1/2</sub> &#x3d; 61&#xa0;d), <sup>95g</sup>Tc (T<sub>1/2</sub> &#x3d; 20&#xa0;h), <sup>96m</sup>Tc (T<sub>1/2</sub> &#x3d; 51.5&#xa0;min), <sup>96g</sup>Tc (T<sub>1/2</sub> &#x3d; 4.28&#xa0;h), and <sup>100</sup>Tc (T<sub>1/2</sub> &#x3d; 15.8&#xa0;s). This group not only substantially drops the specific activity of the final product, but also delivers up to 30% extra unjustified dose to the patient (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B112">Lagunas-Solar et al., 1991</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>, <xref ref-type="bibr" rid="B89">2017</xref>; <xref ref-type="bibr" rid="B84">Hou et al., 2012</xref>; <xref ref-type="bibr" rid="B115">Lededa et al., 2012</xref>; <xref ref-type="bibr" rid="B151">Owen et al., 2014</xref>; <xref ref-type="bibr" rid="B123">Mel&#xe9;ndez-Alafort et al., 2019</xref>). Accordingly, the optimization of irradiation parameters offers another opportunity to minimize the produced technetium impurities. These parameters include the bombarding beam energy, irradiation time, and incident beam intensity.</p>
<p>As a generic rule, the higher the proton energy and the longer irradiation time, the higher the production yield. However, these two factors have to be well-controlled to reduce the co-production of undesirable impurities, resulting in a high level of specific activity product obtained. The threshold proton energy for the reactions <inline-formula id="inf13">
<mml:math id="m15">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>, <inline-formula id="inf14">
<mml:math id="m16">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>3</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>98</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula>, and <inline-formula id="inf15">
<mml:math id="m17">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>100</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mo>,</mml:mo>
<mml:mn>4</mml:mn>
<mml:mi>n</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>97</mml:mn>
<mml:mi>g</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:math>
</inline-formula> are 7.7, 17, and 24&#xa0;MeV, respectively. In addition, further side reactions can take place in the energy range above 24&#xa0;MeV. Therefore, the optimum bombarding energy is preferably maintained at an energy level lower than 24&#xa0;MeV and applies the shortest possible irradiation time that can satisfy the production demand plan (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B59">Esposito et al., 2013</xref>; <xref ref-type="bibr" rid="B89">IAEA, 2017</xref>, <xref ref-type="bibr" rid="B97">1999</xref>).</p>
<p>In order to achieve a high production yield, the beam power intensity should be set to the highest possible value. This beam current crucially depends on the target material, the applied incident beam angle, and the cooling system during the irradiation process (<xref ref-type="bibr" rid="B16">Beaver and Hupf, 1971</xref>; <xref ref-type="bibr" rid="B97">IAEA, 1999</xref>). It is worth mentioning that molybdenum targets have preferable chemical and physical properties reflected by their high melting point and excellent thermal conductivity. Therefore, they can withstand high beam currents. The target cooling process is also influenced by the thermal conductivity of the target material and the temperature of the used cooling item. Effective target cooling can be achieved by applying helium flow on the front side and water-cooling of the supporting material of the target during the irradiation process. Some research studies proposed the use of liquid nitrogen instead of water-cooling for more effective target cooling (<xref ref-type="bibr" rid="B89">IAEA, 2017</xref>, <xref ref-type="bibr" rid="B97">1999</xref>).</p>
<p>After completing the irradiation process, the target is left to cool down to reduce the incorporation of short-lived impurities in the final product, followed by chemical processing. This step is crucial and should be achieved in the shortest possible time to minimize <sup>99m</sup>Tc decay loss (<xref ref-type="bibr" rid="B158">Qaim, 2012</xref>). The post-production target processing can be achieved in two steps: target dissolution and chemical separation and purification. The efficient dissolution of the molybdenum targets is paramount for an effective <sup>99m</sup>Tc recovery. The target dissolution can be performed either by chemical or electrochemical procedures. The chemical dissolution can be performed with the help of concentrated sodium hydroxide, hydrogen peroxide, and heating. In the case of foil targets, concentrated acids can also be used. The electrochemical dissolution system consists of the molybdenum target as an anode, a platinum layer as a cathode, and potassium hydroxide, which works as an electrolyte. Electrochemical methods may involve violent reactions and need double the time to achieve the same task compared to chemical methods (<xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>; <xref ref-type="bibr" rid="B89">IAEA, 2017</xref>, <xref ref-type="bibr" rid="B97">1999</xref>).</p>
<p>Many potential techniques have been implemented for the <sup>99m</sup>Tc recovery from dissolved <sup>100</sup>Mo targets. Because of the short half-live of <sup>99m</sup>Tc, a fast separation reaction is a key to selecting the extraction method. The most commonly used methods include solvent extraction, which can be carried out with the use of Methyl Ethyl Ketone (MEK) or Cetyl Trimethyl Ammonium Bromide (CTAB) (<xref ref-type="bibr" rid="B121">Martini et al., 2018</xref>). Column chromatographic separation methods involve the use of ion exchanger sorbent materials with high radiation resistance, such as Dowex-1 or Polyethylene Glycol (PEG). Some other techniques have also been proposed, such as dry thermo-chromatographic extraction and the chemical precipitation of the molybdenum as a hetero-poly acid salt. The former generates small quantities of waste, and the latter could provide a reasonable separation yield. Nevertheless, both strategies are not widely utilized (<xref ref-type="bibr" rid="B97">IAEA, 1999</xref>; <xref ref-type="bibr" rid="B23">Boschi et al., 2017</xref>; <xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>).</p>
<p>Based on these discussions and as mentioned earlier, the cyclotron-produced <sup>99m</sup>Tc technology has been extensively studied in recent years, and some success has been achieved. Therefore, this method can be regarded as a backup solution for <sup>99m</sup>Tc supply to deal with emergencies. However, its potential is inadequate to replace the current <sup>99</sup>Mo/<sup>99m</sup>Tc generator production completely; as the following critical issues still call for convincing answers:<list list-type="simple">
<list-item>
<p>&#x2022; Only for regional consumption: The short half-life of <sup>99m</sup>Tc (T<sub>1/2</sub> &#x3d; 6.01&#xa0;h) restricts its wide-scale distribution. As a result, the delivery advantage is only limited to hospitals located near the production sites. Therefore, the implementation of this supply strategy necessarily asks for an even geographic distribution of cyclotrons.</p>
</list-item>
<list-item>
<p>&#x2022; High cost per dose: The end-user should receive the required dose at a reasonable price, and the dose price should be competitive with that delivered from a <sup>99</sup>Mo/<sup>99m</sup>Tc generator. The use of enriched <sup>100</sup>Mo targets to ensure the production of high<sup>-</sup>quality <sup>99m</sup>Tc increases the production cost. In addition, the recycling process of the used target material adds an extra production expenditure. Furthermore, the long post-irradiation processing step and the transportation requirements are reflected by the loss of <sup>99m</sup>Tc radioactivity. All these parameters can be translated into a significant cost factor.</p>
</list-item>
<list-item>
<p>&#x2022; A low specific activity product delivers extra radiation dose to the patients: The utilization of highly enriched <sup>100</sup>Mo targets is vital to produce <sup>99m</sup>Tc with high specific activity suitable for imaging applications. A 100% isotopic purity of <sup>100</sup>Mo targets is hard to achieve, and small quantities of other stable Mo isotopes are constantly incorporated into the target material. Consequently, considerable amounts of different technetium isotopes are always co-produced. On the one hand, these impurities reduce the specific activity of the produced <sup>99m</sup>Tc product, which significantly affects the labeling efficacy of <sup>99m</sup>Tc-radiopharmaceutical kits. On the other hand, it may contribute to additional radiation exposure to the patient (<xref ref-type="bibr" rid="B84">Hou et al., 2012</xref>; <xref ref-type="bibr" rid="B115">Lededa et al., 2012</xref>; <xref ref-type="bibr" rid="B175">Selivanova et al., 2015</xref>; <xref ref-type="bibr" rid="B123">Mel&#xe9;ndez-Alafort et al., 2019</xref>).</p>
</list-item>
<list-item>
<p>&#x2022; Uncertainty of long-term supply capability: The direct production of <sup>99m</sup>Tc has been proposed since 1971, and it has not been thoughtfully implemented as a long-term supply strategy. Many recent efforts have focused on establishing a large-scale <sup>99m</sup>Tc supply on a daily routine basis. However, several problems need to be solved. These challenges can be briefly summarized in the need for a sufficient daily availability of patient doses at a reasonable price. Additionally, this strategy continues asking for a realistic supply plan design that can deal with the production difficulties and find innovative logistic solutions to meet the rapid product delivery requirements.</p>
</list-item>
</list>
</p>
</sec>
<sec id="s3-2">
<title>3.2 <sup>99</sup>Mo/<sup>99m</sup>Tc generators</title>
<p>Despite the fast global spread of diagnostic scans using <sup>99m</sup>Tc-radiopharmaceuticals, the <sup>99m</sup>Tc availability at the hospitals and nuclear pharmacies continues to be a potential challenge. These challenges include the production difficulties, notable price, and remarkable radioactivity loss due to frequent deliveries to the usage sites. Accordingly, its effective utilization is only restricted to sites with a well and close connection to the production centers (<xref ref-type="bibr" rid="B169">Sakr et al., 2017</xref>). In the light of this perceived need, different <sup>99</sup>Mo/<sup>99m</sup>Tc generator strategies have been proposed and developed. <sup>99m</sup>Tc generators are considered the most widely used strategy to ensure the ease of <sup>99m</sup>Tc availability in a cost-efficient manner. In other words, it allows conducting a variety of <sup>99m</sup>Tc scans independently of on-site production requirements (<xref ref-type="bibr" rid="B110">Knapp and Mirzadeh, 1994</xref>; <xref ref-type="bibr" rid="B32">Chakravarty et al., 2012a</xref>, <xref ref-type="bibr" rid="B28">2012b</xref>; <xref ref-type="bibr" rid="B109">Knapp and Baum, 2012</xref>; <xref ref-type="bibr" rid="B31">Chakravarty and Dash, 2013</xref>; <xref ref-type="bibr" rid="B169">Sakr et al., 2017</xref>).</p>
<sec id="s3-2-1">
<title>3.2.1 <sup>99</sup>Mo/<sup>99m</sup>Tc radioactive equilibrium in the generator system</title>
<p>The <sup>99</sup>Mo/<sup>99m</sup>Tc generator technology has been developed to offer an easy and repetitive on-site supply of <sup>99m</sup>Tc at desirable time intervals. Historically, <sup>99</sup>Mo/<sup>99m</sup>Tc generators were named &#x201c;cows&#x201d;, from which a fresh <sup>99m</sup>Tc radioactivity can be periodically &#x201c;milked&#x201d; or extracted. Based on the fact that <sup>99</sup>Mo and <sup>99m</sup>Tc are radioisotopes of two different elements, they have unique differences in their chemical and physical properties, and the generator system can supply <sup>99m</sup>Tc with high specific activity, i.e., Non-Carrier-Added grade (NCA) and with high radionuclidic purity acceptable for radiopharmaceutical preparations (<xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B129">Molinski, 1982</xref>; <xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>).</p>
<p>
<sup>99</sup>Mo/<sup>99m</sup>Tc generators are efficient radiochemical separation tools, by which a convincingly purified yield of the daughter, <sup>99m</sup>Tc, can be effectively extracted from the decay of the parent <sup>99</sup>Mo. In other words, the <sup>99</sup>Mo/<sup>99m</sup>Tc generator concept is based on housing <sup>99</sup>Mo to decay. Then, a complete separation of the generated <sup>99m</sup>Tc can be performed without any disturbance of <sup>99</sup>Mo. This separation process is managed through the <sup>99</sup>Mo-decay/<sup>99m</sup>Tc-growth concept (<xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B129">Molinski, 1982</xref>; <xref ref-type="bibr" rid="B73">Guillaume and Brihaye, 1986</xref>; <xref ref-type="bibr" rid="B168">Saha, 1992</xref>; <xref ref-type="bibr" rid="B150">Osso and Knapp, 2011</xref>; <xref ref-type="bibr" rid="B109">Knapp and Baum, 2012</xref>; <xref ref-type="bibr" rid="B31">Chakravarty and Dash, 2013</xref>; <xref ref-type="bibr" rid="B74">Gumiela, 2018</xref>).</p>
<p>Generally, the generator concept is based on the parent/daughter relationship, by which the parent, with a longer half-life, decays to yield its shorter-lived daughter. Hence, a sort of radioactive equilibrium is established. This state is called secular or transient equilibrium, depending on the ratio between the two physical half-lives of the parent and its daughter. The secular equilibrium arises when the parent&#x2019;s half-life is 100 times longer than the half-life of the daughter. Whereas the transient equilibrium, as in the <sup>99</sup>Mo/<sup>99m</sup>Tc generator system, is recognized when the parent&#x2019;s half-life is ten-fold longer than that of the daughter (<xref ref-type="bibr" rid="B169">Sakr et al., 2017</xref>). <xref ref-type="fig" rid="F4">Figure 4</xref> illustrates the transient equilibrium between <sup>99</sup>Mo and <sup>99m</sup>Tc.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Transient radioactive equilibrium in <sup>99</sup>Mo/<sup>99m</sup>Tc generator system. A<sub>el</sub>: Eluted <sup>99m</sup>Tc activity. A<sub>0</sub>: <sup>99</sup>Mo activity at calibration.</p>
</caption>
<graphic xlink:href="fchem-10-926258-g004.tif"/>
</fig>
<p>The equilibrium between <sup>99</sup>Mo and <sup>99m</sup>Tc is reached after approximately four elapsed half-lives of <sup>99m</sup>Tc. During the <sup>99m</sup>Tc ingrowth, its production is remarkably faster than its decay. After the equilibrium is established, the <sup>99m</sup>Tc growth and decay rates are equal. At this point, <sup>99m</sup>Tc apparently decays with the longer half-live of <sup>99</sup>Mo. This advantage considerably reduces the <sup>99m</sup>Tc radioactivity loss during shipment to remote users. However, it decays with its physical half-life directly after its elution from the generator. Directly after the elution, the generator starts the same process from the beginning, as <sup>99</sup>Mo decays to give rise to new fresh <sup>99m</sup>Tc. Accordingly, <sup>99m</sup>Tc begins to be re-built-up again (<xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>). The growth, extraction, and regrowth of <sup>99m</sup>Tc are non-stop procedures. Consequently, the elution step can be repeated as long as sufficient <sup>99</sup>Mo radioactivity is available to conduct the required applications. Therefore, <sup>99m</sup>Tc can be eluted from the generator at periodical elution batches.</p>
<p>The mathematical correlation that describes the <sup>99m</sup>Tc growth from the decay of <sup>99</sup>Mo can be explained using the Batemann equations, as follows (<xref ref-type="bibr" rid="B83">Hidalgo et al., 1967</xref>; <xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B113">Lamson et al., 1976</xref>; <xref ref-type="bibr" rid="B56">Ekelman and Coursey, 1982</xref>; <xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>):</p>
<p>The decay of <sup>99</sup>Mo can be expressed as<disp-formula id="e3">
<mml:math id="m18">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>d</mml:mi>
<mml:mi>t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>
<disp-formula id="e4">
<mml:math id="m19">
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(4)</label>
</disp-formula>
</p>
<p>Where:<list list-type="simple">
<list-item>
<p>&#x3bb;: is the <sup>99</sup>Mo decay constant,</p>
</list-item>
<list-item>
<p>
<inline-formula id="inf16">
<mml:math id="m20">
<mml:mrow>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula>: indicates the number of <sup>99</sup>Mo atoms at the time (t).</p>
</list-item>
<list-item>
<p>
<inline-formula id="inf17">
<mml:math id="m21">
<mml:mrow>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>: refers to the number of <sup>99</sup>Mo atoms when t &#x3d; 0.</p>
</list-item>
</list>
</p>
<p>The production of <sup>99m</sup>Tc is the same as the decay of <sup>99</sup>Mo. Considering that <sup>99m</sup>Tc decays at a rate of. Hence, the <sup>99m</sup>Tc growth rate can be represented by:<disp-formula id="e5">
<mml:math id="m22">
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>d</mml:mi>
<mml:mi>t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
<label>(5)</label>
</disp-formula>
<disp-formula id="e6">
<mml:math id="m23">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x2b;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(6)</label>
</disp-formula>
</p>
<p>
<inline-formula id="inf18">
<mml:math id="m24">
<mml:mo>&#x2235;</mml:mo>
</mml:math>
</inline-formula> If only <sup>99</sup>Mo is present initially<disp-formula id="equ1">
<mml:math id="m25">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Accordingly, the <xref ref-type="disp-formula" rid="e6">Eq 6</xref> can be reformulated as:<disp-formula id="e7">
<mml:math id="m26">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(7)</label>
</disp-formula>
</p>
<p>Taking into account that only about 87.5% of <sup>99</sup>Mo decays to <sup>99m</sup>Tc (<xref ref-type="bibr" rid="B89">IAEA, 2017</xref>).<disp-formula id="e8">
<mml:math id="m27">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(8)</label>
</disp-formula>
</p>
<p>In order to give units of disintegration per second (A) rather than atoms (N), both sides of <xref ref-type="disp-formula" rid="e8">Eq 8</xref> are multiplied by <inline-formula id="inf19">
<mml:math id="m28">
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
</inline-formula>
<disp-formula id="e9">
<mml:math id="m29">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(9)</label>
</disp-formula>
<disp-formula id="equ2">
<mml:math id="m30">
<mml:mrow>
<mml:mo>&#x2235;</mml:mo>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi>N</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>,</mml:mo>
<mml:mtext>&#x2003;</mml:mtext>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mo>&#x3d;</mml:mo>
<mml:msubsup>
<mml:mi>N</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="e10">
<mml:math id="m31">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(10)</label>
</disp-formula>
</p>
<p>At the time (t), when the radioactive equilibrium between <sup>99</sup>Mo and <sup>99m</sup>Tc activities is reached, the growth rate of <sup>99m</sup>Tc is equal to its decay rate:<disp-formula id="equ3">
<mml:math id="m32">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>d</mml:mi>
<mml:mi>t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math>
</disp-formula>
<disp-formula id="e11">
<mml:math id="m33">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>d</mml:mi>
<mml:msub>
<mml:mi>A</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>d</mml:mi>
<mml:mi>t</mml:mi>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>0</mml:mn>
</mml:mrow>
</mml:math>
<label>(11)</label>
</disp-formula>
<disp-formula id="e12">
<mml:math id="m34">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.875</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msubsup>
<mml:mi>A</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>&#xb0;</mml:mo>
</mml:msubsup>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(12)</label>
</disp-formula>
<disp-formula id="e13">
<mml:math id="m35">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
<mml:mrow>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(13)</label>
</disp-formula>
<disp-formula id="e14">
<mml:math id="m36">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(14)</label>
</disp-formula>
<disp-formula id="e15">
<mml:math id="m37">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mi mathvariant="italic">ln</mml:mi>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(15)</label>
</disp-formula>
</p>
<p>Hence, the maximum activity of the <sup>99m</sup>Tc, which is present at the time (t), can be calculated from the following equation:<disp-formula id="e16">
<mml:math id="m38">
<mml:mrow>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mrow>
<mml:mi>max</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mi mathvariant="italic">ln</mml:mi>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(16)</label>
</disp-formula>
<disp-formula id="e17">
<mml:math id="m39">
<mml:mrow>
<mml:mo>&#x2235;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>1</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mtext>T</mml:mtext>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>,</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.693</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>65.94</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>0.01051</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>h</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(17)</label>
</disp-formula>
<disp-formula id="e18">
<mml:math id="m40">
<mml:mrow>
<mml:mo>&#x2235;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>&#x3bb;</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mtext>T</mml:mtext>
<mml:mrow>
<mml:mn>1</mml:mn>
<mml:mo>/</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>,</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mn>0.693</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>6.01</mml:mn>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>0.1153</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>h</mml:mi>
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(18)</label>
</disp-formula>
<disp-formula id="equ4">
<mml:math id="m41">
<mml:mrow>
<mml:mo>&#x2234;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>T</mml:mi>
<mml:mrow>
<mml:mi>max</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>22.9</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>h</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Clearly, the radioactive relationship between <sup>99</sup>Mo and <sup>99m</sup>Tc offers an excellent opportunity to introduce an ideal generator system, by which the separation of the short-lived <sup>99m</sup>Tc at favorable time intervals can easily be achieved. The eluted radioactivity can be quantified using equation number (6). Nevertheless, it is significantly influenced by the elution process efficiency. Hence, the maximum <sup>99m</sup>Tc radioactivity can be eluted on a daily basis, which is one of the potential advantages of the generator system.</p>
</sec>
<sec id="s3-2-2">
<title>3.2.2 Criteria of a clinical <sup>99</sup>Mo/<sup>99m</sup>Tc generator</title>
<p>The effective <sup>99</sup>Mo/<sup>99m</sup>Tc generator system should fulfill the following characteristics (<xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B169">Sakr et al., 2017</xref>; <xref ref-type="bibr" rid="B98">IAEA, 2018</xref>):<list list-type="simple">
<list-item>
<p>&#x2022; Use simple, safe, and user-friendly operational protocols that avoid any violent chemical reactions and support a feasible implementation at hospitals and nuclear medicine centers.</p>
</list-item>
<list-item>
<p>&#x2022; Assure rapid radiochemical separation to minimize the <sup>99m</sup>Tc radioactivity decay loss.</p>
</list-item>
<list-item>
<p>&#x2022; Provide the highest possible elution yield with a reproducible separation efficiency over the generator operation lifetime.</p>
</list-item>
<list-item>
<p>&#x2022; Capable of sustainable elutions with a negligible amount of radioactive waste.</p>
</list-item>
<list-item>
<p>&#x2022; Provide a carrier-free <sup>99m</sup>Tc radioactivity with high specific activity without any need for purification processes.</p>
</list-item>
<list-item>
<p>&#x2022; Supply sterile, isotonic, and pyrogen-free <sup>99m</sup>Tc radioactive solution at any elution cycle without any further need for chemical treatment.</p>
</list-item>
<list-item>
<p>&#x2022; Produce <sup>99m</sup>Tc with high radioactive concentration adequate for the radiopharmaceuticals synthesis without any need for post-elution concentration steps.</p>
</list-item>
<list-item>
<p>&#x2022; Supply the <sup>99m</sup>Tc radioactivity with high chemical, radiochemical, and radionuclidic purities. The chemical purity expresses how much of the produced <sup>99m</sup>Tc is free from inactive impurities that arise from the target material and/or the used chemicals. The radiochemical purity is the percentage of <sup>99m</sup>Tc radioactivity present in the pertechnetate chemical form, <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup>. The radionuclidic purity represents the percentage of the <sup>99m</sup>Tc radioactivity to the total radioactivity of its solution.</p>
</list-item>
<list-item>
<p>&#x2022; Minimize the personnel involved during the elution process to reduce the radiation exposure dose.</p>
</list-item>
<list-item>
<p>&#x2022; Involve the use of chemical solutions and materials with high radiation stabilities to avoid any possible contamination to <sup>99m</sup>Tc radioactivity.</p>
</list-item>
</list>
</p>
</sec>
<sec id="s3-2-3">
<title>3.2.3 Production technologies of <sup>99</sup>Mo/<sup>99m</sup>Tc generators</title>
<p>Historically, the idea of a <sup>99</sup>Mo/<sup>99m</sup>Tc generator system was first proposed in the middle of the 1950<sub>S</sub> during the development of <sup>132</sup>Te/<sup>132</sup>I generators at Brookhaven National Laboratory (BNL). In this experiment, the <sup>99m</sup>Tc was detected as a trace impurity in the <sup>132</sup>I eluted solution. Afterward, it was understood that this <sup>99m</sup>Tc was produced from its parent, <sup>99</sup>Mo, which took the same separation path of <sup>132</sup>Te throughout the chemical processing of the fission products. This unique parent-daughter chemistry between <sup>99</sup>Mo and <sup>99m</sup>Tc has encouraged the fabrication of the first <sup>99</sup>Mo/<sup>99m</sup>Tc generator (<xref ref-type="bibr" rid="B161">Richards et al., 1982</xref>; <xref ref-type="bibr" rid="B5">Anderson et al., 2019</xref>). In 1957, the first <sup>99</sup>Mo/<sup>99m</sup>Tc generator was produced at BNL (<xref ref-type="bibr" rid="B188">Tucker et al., 1958</xref>; <xref ref-type="bibr" rid="B129">Molinski, 1982</xref>; <xref ref-type="bibr" rid="B161">Richards et al., 1982</xref>). Then, in early 1960, the first <sup>99</sup>Mo/<sup>99m</sup>Tc generator was used for clinical research at Brookhaven medical department, which paved the way for the first utilization of <sup>99</sup>Mo/<sup>99m</sup>Tc generators in clinical investigations at Argonne Cancer Research Hospital in 1961 (<xref ref-type="bibr" rid="B160">Richards, 1965</xref>; <xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B10">Atkins, 1975</xref>). Later on, through the following seven&#xa0;decades, the idea was developed, and several <sup>99</sup>Mo/<sup>99m</sup>Tc generator structures were established based on the different physical and chemical behaviors of <sup>99</sup>Mo and <sup>99m</sup>Tc radionuclides (<xref ref-type="bibr" rid="B3">Allen, 1965</xref>; <xref ref-type="bibr" rid="B25">Boyd, 1987</xref>; <xref ref-type="bibr" rid="B88">IAEA, 1995</xref>, <xref ref-type="bibr" rid="B99">2013b</xref>; <xref ref-type="bibr" rid="B120">Maoliang, 1997</xref>; <xref ref-type="bibr" rid="B150">Osso and Knapp, 2011</xref>; <xref ref-type="bibr" rid="B109">Knapp and Baum, 2012</xref>; <xref ref-type="bibr" rid="B135">Mostafa et al., 2016</xref>).</p>
<p>The careful selection of the radiochemical separation strategy is considered the cornerstone for the fundamental development of <sup>99m</sup>Tc generators. In fact, this selection focuses explicitly on simplifying the extraction process and avoiding any technical complexities for the users. In addition, it supplies the possible maximum <sup>99m</sup>Tc yield with the minimum quantity of radioactive waste. Furthermore, it supports a rapid <sup>99m</sup>Tc elution with high-performance quality, which consequently; can be easily adopted as a mature commercial technology. In the light of this context, the following subsidiary sections underline the critical features of potential <sup>99</sup>Mo/<sup>99m</sup>Tc generators production strategies. <xref ref-type="table" rid="T8">Table 8</xref> highlights a comparison between the potential development technologies of <sup>99m</sup>Tc radioisotope generators.</p>
<table-wrap id="T8" position="float">
<label>TABLE 8</label>
<caption>
<p>The potential production strategies of <sup>99</sup>Mo/<sup>99m</sup>Tc generators.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="4" align="left">Production technology</th>
<th align="left">Separation technique</th>
<th align="left">Advantages</th>
<th align="left">Disadvantages</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="11" align="left">Column chromatography</td>
<td rowspan="3" align="left">Based on alumina</td>
<td rowspan="3" colspan="2" align="left">Using (n,f)<sup>99</sup>Mo</td>
<td rowspan="11" align="left">Selective sorption of <sup>99</sup>Mo (solid-phase extraction)</td>
<td align="left">&#x2022; Well-established technology</td>
<td align="left">&#x2022; Increases the nuclear proliferation concerns</td>
</tr>
<tr>
<td align="left">&#x2022; Produces clinical-grade <sup>99m</sup>Tc in high radionuclidic, radiochemical, and chemical purities</td>
<td align="left">&#x2022; Produces large quantities of long-lived radioactive wastes</td>
</tr>
<tr>
<td align="left">&#x2022; Supplies <sup>99m</sup>Tc in high RAC</td>
<td align="left"/>
</tr>
<tr>
<td rowspan="4" align="left">Based on gel matrices</td>
<td rowspan="4" colspan="2" align="left">Using (n,&#x3b3;)<sup>99</sup>Mo</td>
<td align="left">&#x2022; Eliminates proliferation concerns</td>
<td align="left">&#x2022; Supply <sup>99m</sup>Tc with very low RAC</td>
</tr>
<tr>
<td rowspan="2" align="left"/>
<td align="left">&#x2022; Retention of <sup>99m</sup>Tc on the column matrix</td>
</tr>
<tr>
<td align="left">&#x2022; Production of undesirable radioactive impurities</td>
</tr>
<tr>
<td align="left"/>
<td align="left">&#x2022; A multi-step procedure leads to the loss of the <sup>99</sup>Mo radioactivity</td>
</tr>
<tr>
<td colspan="2" rowspan="4" align="left">Based on nano-sorbents</td>
<td rowspan="4" align="left">Using (n,&#x3b3;)<sup>99</sup>Mo</td>
<td align="left">&#x2022; Eliminates proliferation concerns</td>
<td align="left">&#x2022; Not yet demonstrated at activity scale necessary for clinical use</td>
</tr>
<tr>
<td align="left">&#x2022; The production of a <sup>99m</sup>Tc with desirable RAC</td>
<td align="left">&#x2022; Is not currently standard practice in <sup>99</sup>Mo/<sup>99m</sup>Tc generators</td>
</tr>
<tr>
<td align="left">&#x2022; Improves <sup>99</sup>Mo economy</td>
<td align="left"/>
</tr>
<tr>
<td align="left">&#x2022; Inexpensive</td>
<td align="left"/>
</tr>
<tr>
<td rowspan="3" colspan="4" align="left">Sublimation</td>
<td rowspan="3" align="left">Differences in the sublimation temperatures of <sup>99</sup>Mo and <sup>99m</sup>Tc oxides</td>
<td rowspan="3" align="left">&#x2022; Generates a <sup>99m</sup>Tc radionuclide of high purity</td>
<td align="left">&#x2022; Complex procedure</td>
</tr>
<tr>
<td align="left">&#x2022; Require high degree of safety standards</td>
</tr>
<tr>
<td align="left">&#x2022; Low <sup>99m</sup>Tc separation efficiency yield from <sup>99</sup>Mo</td>
</tr>
<tr>
<td rowspan="3" colspan="4" align="left">Solvent extraction</td>
<td rowspan="3" align="left">Difference in the solubility of <sup>99</sup>Mo and <sup>99m</sup>Tc in two immiscible liquid phases</td>
<td align="left">&#x2022; Low stability of the organic solvents</td>
</tr>
<tr>
<td align="left">&#x2022; Low separation efficiency</td>
</tr>
<tr>
<td align="left">&#x2022; Requires a very high degree of radiation safety considerations</td>
</tr>
<tr>
<td rowspan="2" colspan="4" align="left">Electrochemical</td>
<td rowspan="2" align="left">Difference in the reduction potential of <sup>99</sup>Mo and <sup>99m</sup>Tc</td>
<td rowspan="2" align="left">&#x2022; The capacity is not limited by the amount of sorbent or extractant</td>
<td align="left">&#x2022; Expensive</td>
</tr>
<tr>
<td align="left">&#x2022; Generate H<sub>2</sub> and O<sub>2,</sub> leading to explosion danger</td>
</tr>
<tr>
<td rowspan="5" colspan="4" align="left">Supported Liquid Membrane (SLM)</td>
<td rowspan="5" align="left">Selective extraction of the <sup>99m</sup>Tc using porous hydrophobic membrane</td>
<td rowspan="5" align="left"/>
<td align="left">&#x2022; Slow separation kinetics</td>
</tr>
<tr>
<td align="left">&#x2022; Unsatisfactory <sup>99m</sup>Tc yield</td>
</tr>
<tr>
<td align="left">&#x2022; <sup>99</sup>Mo breakthrough</td>
</tr>
<tr>
<td align="left">&#x2022; Radiation instability of the membrane and the extractant</td>
</tr>
<tr>
<td align="left">&#x2022; Generates significant amounts of radioactive waste</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="s3-2-3-1">
<title>3.2.3.1 Sublimation generators</title>
<p>Sublimation is a physical phenomenon, which can be defined as the direct conversion of solids into a gas without moving through the liquid state. Perrier and Segr&#xe8; were the first who described the possibility of a <sup>99m</sup>Tc thermal extraction from <sup>99</sup>Mo based on the difference in the sublimation temperatures or volatilities of their oxides (<xref ref-type="bibr" rid="B155">Perrier and Segr&#xe8;, 1937</xref>). Tc<sub>2</sub>O<sub>7</sub> and MoO<sub>3</sub> become volatile at temperatures of 550 and 1,000&#xb0;C, respectively (<xref ref-type="bibr" rid="B155">Perrier and Segr&#xe8;, 1937</xref>; <xref ref-type="bibr" rid="B44">Childs, 2017</xref>). The separation steps were reported through several research studies. The irradiated <sup>99</sup>MoO<sub>3</sub> target is carefully placed inside a muffle furnace, in which a flow of oxygen stream is allowed to pass through. Then, the temperature is gradually elevated to about 800&#xa0;&#xb0;C. On heating, Tc<sub>2</sub>O<sub>7</sub> is formed, which sublimates at 550&#xb0;C. After that, the volatile Tc<sub>2</sub>O<sub>7</sub> vapors are carried by the oxygen stream and trapped using a cooled surface. Finally, they are allowed to be completely dissolved in water or saline solution to obtain <sup>99m</sup>TcO<sub>4</sub>
<sup>&#x2212;</sup> (<xref ref-type="bibr" rid="B76">Hallaba and El-Asrag, 1975</xref>; <xref ref-type="bibr" rid="B129">Molinski, 1982</xref>; <xref ref-type="bibr" rid="B202">Zsinka, 1987</xref>; <xref ref-type="bibr" rid="B126">Miller, 1995</xref>; <xref ref-type="bibr" rid="B45">Christian et al., 2000</xref>; <xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>).</p>
<p>This generator strategy generates a small volume of radioactive waste. In addition, it provides high specific activity <sup>99m</sup>Tc even if <sup>99</sup>Mo of low specific activity origin is available. However, attempts to implement this technique in nuclear medicine departments as a clinical-based generator system suffered from several critical constraints. For instance, it includes the manipulation of bulk, complex, and fragile equipment, which needs a meticulous operational methodology and an advanced level of precautions and safety standards. Moreover, the <sup>99m</sup>Tc separation yield is very low. Furthermore, it uses high heating temperatures, which may lead to a serious radiation contamination risk in case of any operational failure. Accordingly, these potential drawbacks discouraged further development plans in this direction.</p>
</sec>
<sec id="s3-2-3-2">
<title>3.2.3.2 Solvent extraction generators</title>
<p>The solvent extraction-based generator is a multi-step separation technique by which <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> can be recovered from an aqueous solution that contains the <sup>99</sup>Mo/<sup>99m</sup>Tc mixture by the extraction into an organic solvent (<xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>). The separation of <sup>99m</sup>Tc from its parent with the help of organic extractants was originally demonstrated by Gerlit in 1956 (<xref ref-type="bibr" rid="B70">Gerlit, 1956</xref>; <xref ref-type="bibr" rid="B4">Anders, 1960</xref>; <xref ref-type="bibr" rid="B116">Lebowitz and Richards, 1974</xref>; <xref ref-type="bibr" rid="B129">Molinski, 1982</xref>).</p>
<p>The separation process involves the dissolution of the irradiated <sup>99</sup>Mo target in an alkaline solution. Then, an organic solvent is added, which is followed by multiple-extraction cycles. Each cycle includes a vigorous shaking of the two immiscible phases to allow the <sup>99m</sup>TcO<sub>4</sub>
<sup>&#x2212;</sup> to migrate from the original aqueous solution to the organic extractant phase leaving its parent behind. After that, the extractant is segregated, washed several times, and thermally evaporated. Finally, the residual precipitate is redissolved in a saline solution. The process efficiency strongly depends on the selective capability of the extractant solvent for the <sup>99</sup>Mo/<sup>99m</sup>Tc pair. In other words, the process relies on the relative distribution or solubility ratio of the two radionuclides between the extractor and the original aqueous solution (<xref ref-type="bibr" rid="B40">Chattopadhyay et al., 2010</xref>, <xref ref-type="bibr" rid="B39">2014</xref>; <xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>; <xref ref-type="bibr" rid="B128">Mitra et al., 2020</xref>).<disp-formula id="e19">
<mml:math id="m42">
<mml:mrow>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>e</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>q</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(19)</label>
</disp-formula>
<disp-formula id="e20">
<mml:math id="m43">
<mml:mrow>
<mml:msub>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>e</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mrow>
<mml:msub>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>a</mml:mi>
<mml:mi>q</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>s</mml:mi>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(20)</label>
</disp-formula>
</p>
<p>Therefore, the ideal extractant should show a considerable selective affinity towards <sup>99m</sup>Tc and neglected distribution selectivity for <sup>99</sup>Mo. The first used organic extractant to achieve the extraction process was Methyl Ethyl Ketone (MEK). After that, various organic solvents were reported (<xref ref-type="bibr" rid="B3">Allen, 1965</xref>; <xref ref-type="bibr" rid="B8">Anwar et al., 1968</xref>; <xref ref-type="bibr" rid="B12">Baker, 1971</xref>; <xref ref-type="bibr" rid="B180">Tachimori et al., 1971</xref>; <xref ref-type="bibr" rid="B104">Iqbal and Ejaz, 1974</xref>; <xref ref-type="bibr" rid="B147">Noronha, 1986</xref>; <xref ref-type="bibr" rid="B19">Bhatia and Turel, 1989</xref>; <xref ref-type="bibr" rid="B19">Bhatia and Turel, 1989</xref>; <xref ref-type="bibr" rid="B127">Minh and Lengyel, 1989</xref>; <xref ref-type="bibr" rid="B183">Taskaev et al., 1995</xref>; <xref ref-type="bibr" rid="B43">Chen and Tomasberger, 2001</xref>; <xref ref-type="bibr" rid="B203">Zykov et al., 2001</xref>; <xref ref-type="bibr" rid="B177">Skuridin and Chibisov, 2010</xref>). Even so, MEK is still considered the predominant extractant of choice because of its highly selective behavior for <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup>, which permits the production of <sup>99m</sup>Tc with high specific activity (<xref ref-type="bibr" rid="B89">IAEA 2017</xref>).</p>
<p>Practically, the solvent extraction generators are associated with a number of serious drawbacks that impede their wide-scale utilization; it is a complicated multi-step process with low extraction efficiency and requires a long separation time, resulting in the loss of <sup>99m</sup>Tc radioactivity. Moreover, the separation step consumes large volumes of the organic extractant, creating significant radioactive waste. In addition, a strong possibility of fire hazards that result from the flammable nature of MEK. Furthermore, the poor radiation stability of organic solvents may heighten the contamination risk of the final <sup>99m</sup>Tc product with some organic impurities.</p>
</sec>
<sec id="s3-2-3-3">
<title>3.2.3.3 Electrochemical generators</title>
<p>The electrochemical-based <sup>99m</sup>Tc generator can be introduced as a separation technique built on an oxidation-reduction reaction. This reaction is mainly governed by the difference in the formal reduction potential of the <sup>99</sup>Mo/<sup>99m</sup>Tc pair. Herein, the generator system consists of an electrochemical cell, in which the <sup>99m</sup>Tc radionuclide can be separated from the <sup>99</sup>Mo/<sup>99m</sup>Tc equilibrium mixture by a reduction reaction on the surface of an electrode under the effect of an external voltage in accordance with its electrochemical reduction potential, i.e., electrochemical deposition. The <sup>99</sup>Mo/<sup>99m</sup>Tc pair exhibits different electrochemical reduction potentials, and their electrochemical reduction reactions can be illustrated as follows (<xref ref-type="bibr" rid="B28">Chakravarty et al., 2012b</xref>; <xref ref-type="bibr" rid="B34">2012c</xref>, <xref ref-type="bibr" rid="B37">2011</xref>, and 2010a):<disp-formula id="e21">
<mml:math id="m44">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>O</mml:mi>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>6</mml:mn>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2192;</mml:mo>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>8</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>O</mml:mi>
<mml:msup>
<mml:mi>H</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:msup>
<mml:mtext>&#x2003;</mml:mtext>
<mml:msup>
<mml:mi>E</mml:mi>
<mml:mi>o</mml:mi>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1.05</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>V</mml:mi>
</mml:mrow>
</mml:math>
<label>(21)</label>
</disp-formula>
<disp-formula id="e22">
<mml:math id="m45">
<mml:mrow>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>H</mml:mi>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>3</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>e</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2192;</mml:mo>
<mml:mi>T</mml:mi>
<mml:mi>c</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>2</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>O</mml:mi>
<mml:mtext>&#x2003;</mml:mtext>
<mml:msup>
<mml:mi>E</mml:mi>
<mml:mi>o</mml:mi>
</mml:msup>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.738</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>V</mml:mi>
</mml:mrow>
</mml:math>
<label>(22)</label>
</disp-formula>
</p>
<p>It can be observed that the <sup>99m</sup>TcO<sub>4</sub>
<sup>&#x2212;</sup> species have a higher electrochemical reduction potential than the <sup>99</sup>MoO<sub>4</sub>
<sup>2-</sup> ions, which offers a positive advantage in facilitating the separation step.</p>
<p>The process starts with the dissolution of the irradiated <sup>99</sup>Mo target in a strong alkaline electrolyte (pH &#x223c; 13). Then, a constant potential is applied and adjusted for a certain period to permit the <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> species to be electro-deposited on the surface of the cathode electrode. After that, this cathode is removed from the working cell and transferred to a new cell, where the deposited <sup>99m</sup>Tc can be stripped back and redissolved in a saline solution by applying a high reverse potential (reverse electrode polarity) for a short period. By this technique, <sup>99m</sup>Tc can be oxidized back to the solution in the form of <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup>. Eventually, <sup>99m</sup>Tc eluate is allowed to pass through an alumina column to minimize the <sup>99</sup>Mo contamination level.</p>
<p>In order to achieve a satisfactory <sup>99m</sup>Tc separation yield, some parameters have to be well-optimized during the electrolysis process. For instance, careful attention should be devoted to adjusting the effective potential, proper selection of suitable electrodes and electrolysis medium candidates, and successful control of the electrolyte pH and separation time.</p>
<p>The applied potential is the crucial factor for a successful extraction. Generally, the electrochemical separation can be performed by either applying a constant current (galvanostatic) or a constant potential (potentiostatic) conditions. However, the potentiostatic condition offers favorable <sup>99m</sup>Tc deposition and, in the meantime, limits the precipitation of <sup>99</sup>Mo and/or any other contaminants. The electrolysis potential should be adjusted to be more negative than the formal reduction potential of <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> species and less negative than the electrochemical reduction potential of <sup>99</sup>MoO<sub>4</sub>
<sup>2-</sup> ions. Therefore, the optimum reduction potential for the <sup>99m</sup>Tc generator system should be in the region of:<disp-formula id="equ5">
<mml:math id="m46">
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mn>1.05</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>V</mml:mi>
<mml:mo>&#x3e;</mml:mo>
<mml:mi>e</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>y</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>s</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>p</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3e;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>0.738</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>V</mml:mi>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
<p>Additionally, it needs to be fully compatible with the used electrolyte to avoid any possibility of chemical degradation during the separation process. Several classes of electrolytes of organic or aqueous origin can be used. The aqueous electrolytes show higher radiation stability during the course of the electrolysis compared to organic liquids, which results in fewer chemical impurities associated with the produced <sup>99m</sup>Tc radioactive solution. However, their use is usually associated with the evolution of hydrogen gas, which lowers the pH of the electrolyte medium and may decrease the separation performance. For the working electrodes, they need to be chemically inert with considerable electrochemical and radiation resistance. The temperature of the medium should be adjusted sufficiently below the electrolyte boiling point to avoid its rapid evaporation, which results in unacceptable <sup>99m</sup>Tc solution purity. The reaction time should be established to achieve the highest possible <sup>99m</sup>Tc yield in the shortest period to minimize <sup>99m</sup>Tc radioactivity loss (<xref ref-type="bibr" rid="B28">Chakravarty et al., 2012b</xref>; <xref ref-type="bibr" rid="B34">2012c</xref>, <xref ref-type="bibr" rid="B37">2011</xref>; <xref ref-type="bibr" rid="B30">2010a</xref>; <xref ref-type="bibr" rid="B29">2010b</xref>).</p>
<p>Based on this method, <xref ref-type="bibr" rid="B30">Chakravarty et al., 2010a</xref>, reported the production of <sup>99m</sup>Tc from a <sup>99</sup>Mo/<sup>99m</sup>Tc generator. The daughter extraction was performed in an electrochemical cell by applying a constant potential of 5&#xa0;V in sodium hydroxide electrolyte (pH &#x223c; 13). The electrolysis process lasted for approximately 1&#xa0;hour. Hence, the <sup>99m</sup>Tc selectively accumulated on the platinum electrode (cathode). The <sup>99m</sup>Tc deposited was recovered in a 0.9% saline solution. Then, it was purified with the use of an alumina column (<xref ref-type="bibr" rid="B30">Chakravarty et al., 2010a</xref>).</p>
<p>The prospect of <sup>99</sup>Mo/<sup>99m</sup>Tc electrochemical-based generators provide an adequate <sup>99m</sup>Tc yield in a non-carrier added form with a satisfactory purity level for radiopharmaceutical applications. In addition, their production capacity neither relies on the amount of the used sorbent, nor the extractant volume. Nevertheless, this production strategy is implicated with some opposing weaknesses that preclude its practical medical use. For example, the electrolysis step is accompanied by the evolution of oxygen and hydrogen gases, which may pose an explosion hazard. In addition, the oxygen gas may inhibit the reduction of <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> species, which drastically decreases the separation yield. Moreover, the working electrodes require tedious cleaning processes directly after each separation cycle. Furthermore, it is a relatively time-consuming production technique, including different consecutive separation and purification steps, which consequently result in a marked loss of <sup>99m</sup>Tc radioactivity. Finally, the procedure needs high shielding requirements to reduce the exposure dose to the working personnel. For these reasons, this strategy strongly requires a very rigorous operating regime with a high degree of safety and precautionary measures and well-trained operators with high technical awareness of electro- and radiochemistry fundamentals.</p>
</sec>
<sec id="s3-2-3-4">
<title>3.2.3.4 Supported Liquid Membrane generators</title>
<p>This generator system can be introduced as a modification or an updated version of the solvent extraction method (<xref ref-type="bibr" rid="B53">Dhami et al., 2007</xref>; <xref ref-type="bibr" rid="B55">Dutta and Mohapatra, 2013</xref>; <xref ref-type="bibr" rid="B38">Chang, 2016</xref>; <xref ref-type="bibr" rid="B51">Davarkhah et al., 2018</xref>). It involves the separation of <sup>99m</sup>Tc species from <sup>99</sup>Mo with the use of a membrane as a semi-stationary phase and two other mobile phases that are located on both sides. These three compartments can be described as follows (<xref ref-type="bibr" rid="B172">Sastre et al., 1998</xref>; <xref ref-type="bibr" rid="B41">Chaudry, 2000</xref>; <xref ref-type="bibr" rid="B197">Yassine, 2000</xref>):<list list-type="simple">
<list-item>
<p>1. The primary aqueous solution (the feeding phase): It consists of the <sup>99</sup>Mo/<sup>99m</sup>Tc mixture.</p>
</list-item>
<list-item>
<p>2. The stationary porous membrane: This membrane is of hydrophobic nature and serves as a barrier between the other two liquids. It is incorporated with an organic liquid of a high selective tendency for <sup>99m</sup>Tc and delivers the <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> ions from the feed solution to the receiving liquid. Meanwhile, it restricts the flow of <sup>99</sup>Mo species.</p>
</list-item>
<list-item>
<p>3. The eluate receiving solution (the stripping phase): this partition contains the recovered <sup>99m</sup>Tc.</p>
</list-item>
</list>
</p>
<p>The extraction process is performed in three simultaneous steps. In the first step, the <sup>99m</sup>Tc species are selectively collected from the feed mixture by the extractant. Then, they travel through the membrane to the other side, where they are eventually exchanged with another species from the clean receiving solution. This journey of <sup>99m</sup>Tc from the primary solution to the membrane and from the membrane to the receiving solution is only controlled by separation reaction kinetics without the help of any external driving force. Therefore, it is only attributed to the concentration difference on both sides of the membrane.</p>
<p>Many different supported liquid membrane frameworks have been studied to separate <sup>99m</sup>Tc on the laboratory scale (<xref ref-type="bibr" rid="B172">Sastre et al., 1998</xref>; <xref ref-type="bibr" rid="B75">Gyves and Rodr&#xed;guez, 1999</xref>; <xref ref-type="bibr" rid="B41">Chaudry, 2000</xref>; <xref ref-type="bibr" rid="B197">Yassine, 2000</xref>; <xref ref-type="bibr" rid="B42">Chen et al., 2001</xref>). Nonetheless, a number of inherent practical difficulties still ask for more research efforts. For instance, it is a time-consuming strategy and involves the loss of the majority of <sup>99m</sup>Tc radioactivity attributable to the remarkably slow extraction kinetics. In addition, it supplies unsatisfactory <sup>99m</sup>Tc separation yield with high <sup>99</sup>Mo breakthrough and organic chemical impurities due to the low radiation resistance of the organic liquids and limited life-course of the used membrane. Furthermore, it generates substantial amounts of radioactive waste.</p>
</sec>
<sec id="s3-2-3-5">
<title>3.2.3.5 Column chromatographic generators</title>
<p>Several <sup>99</sup>Mo/<sup>99m</sup>Tc generator production strategies have been explored and developed over the last few decades. Nevertheless, the column chromatography-based generator type has attracted considerable interest as a reliable source to supply <sup>99m</sup>Tc ready for nuclear medicine investigations. As a result, the chromatographic column generator is considered the most predominant choice for the hospitals and nuclear medicine departments owing to many valuable benefits, including (<xref ref-type="bibr" rid="B142">Nawar and T&#xfc;rler, 2019</xref>):<list list-type="simple">
<list-item>
<p>&#x2022; One-step process: The <sup>99m</sup>Tc radioactivity can be extracted in only one step, effectively minimizing the radioactive decay losses.</p>
</list-item>
<list-item>
<p>&#x2022; Simple to use: The operation is feasible, user-friendly, and does not involve any operational difficulties or chemical and radiation hazards.</p>
</list-item>
<list-item>
<p>&#x2022; Safe to use: The small generator size facilitates its shielding. Thereby, it can be handled and eluted safely with a minimum radiation dose to the operators.</p>
</list-item>
<list-item>
<p>&#x2022; Rapid elution process: The generator offers a short elution time due to the fast separation kinetics of the daughter.</p>
</list-item>
<list-item>
<p>&#x2022; High elution efficiency: The generator system provides a high separation yield of <sup>99m</sup>Tc from its parent mixture with a favorable carrier-free grade.</p>
</list-item>
<list-item>
<p>&#x2022; High eluate purity: The <sup>99m</sup>Tc solution can be collected free from <sup>99</sup>Mo with high chemical, radiochemical, and radionuclidic purity (without any need for post-elution purification steps).</p>
</list-item>
<list-item>
<p>&#x2022; Small elution volume: The generator is designed to give the entire <sup>99m</sup>Tc radioactivity yield in a very minute quantity with a high radioactive concentration adequate for immediate use, which avoids any further concentration challenges.</p>
</list-item>
<list-item>
<p>&#x2022; Reproducible <sup>99m</sup>Tc supply: The generator is capable of frequent multiple elutions with sustainable and stable supply in terms of <sup>99m</sup>Tc yield and purity over its lifetime.</p>
</list-item>
<list-item>
<p>&#x2022; Marginal generation of radioactive waste: It is reflected in a clean working environment and the absence of any contamination risk.</p>
</list-item>
</list>
</p>
<p>In generic terms, this generator system consists of two phases, i.e., a stationary phase (the sorbent material) and an external liquid phase (the eluent solution). The central concept is built on the retention of <sup>99</sup>Mo radionuclide on a column incorporated with proper sorbent material. Then, the <sup>99</sup>Mo decays to yield <sup>99m</sup>Tc, followed by the elution of the generated daughter with a suitable isotonic saline solution. The separation of the <sup>99m</sup>Tc species is mainly based on the difference between their low retention affinity on the column material and their high solubility in the eluent solution. The parent <sup>99</sup>Mo exists in the molybdate form, <inline-formula id="inf20">
<mml:math id="m47">
<mml:mrow>
<mml:mmultiscripts>
<mml:mtext>M</mml:mtext>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:msubsup>
<mml:mrow>
<mml:mtext>oO</mml:mtext>
</mml:mrow>
<mml:mn>4</mml:mn>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>, which in a weakly acidic medium, polymerizes to polymoybdate species, as follows (<xref ref-type="bibr" rid="B49">Dash and Chakravarty, 2016</xref>; <xref ref-type="bibr" rid="B142">Nawar and T&#xfc;rler, 2019</xref>):<disp-formula id="e23">
<mml:math id="m48">
<mml:mrow>
<mml:mn>7</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mrow>
<mml:mn>2</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>8</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>H</mml:mi>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x21cc;</mml:mo>
<mml:mmultiscripts>
<mml:mrow>
<mml:msub>
<mml:mstyle displaystyle="true">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:mstyle>
<mml:mn>7</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mn>24</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>6</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>4</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>O</mml:mi>
</mml:mrow>
</mml:math>
<label>(23)</label>
</disp-formula>
</p>
<p>The formed species with six negative charges offer favorable conditions for interacting with the positively charged sorbent surface. After that, the polymoybdate <inline-formula id="inf21">
<mml:math id="m49">
<mml:mrow>
<mml:mmultiscripts>
<mml:mrow>
<mml:msub>
<mml:mstyle displaystyle="true">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:mstyle>
<mml:mn>7</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:msubsup>
<mml:mtext>O</mml:mtext>
<mml:mrow>
<mml:mn>24</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>6</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula> decays to form the technetium pertechnetate (<sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup>), which possesses only one negative charge. Hence, the binding ability of <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> becomes weaker than <sup>99</sup>Mo<sub>7</sub>O<sub>24</sub>
<sup>6-</sup> with the stationary phase (<xref ref-type="bibr" rid="B49">Dash and Chakravarty, 2016</xref>). Then, an isotonic saline solution is subsequently passed through the column to replace the weakly bound <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup> species with Cl<sup>&#x2212;</sup> ions to produce sodium pertechnetate (Na<sup>99m</sup>TcO<sub>4</sub>), leaving the <sup>99</sup>Mo on the column, according to the equations:<disp-formula id="e24">
<mml:math id="m50">
<mml:mrow>
<mml:mmultiscripts>
<mml:mrow>
<mml:msub>
<mml:mstyle displaystyle="true">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:mstyle>
<mml:mn>7</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mn>24</mml:mn>
</mml:mrow>
<mml:mrow>
<mml:mn>6</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:mrow>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>6</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2192;</mml:mo>
<mml:msub>
<mml:mi>R</mml:mi>
<mml:mn>6</mml:mn>
</mml:msub>
<mml:mmultiscripts>
<mml:mrow>
<mml:msub>
<mml:mstyle displaystyle="true">
<mml:mrow>
<mml:mi>M</mml:mi>
<mml:mi>o</mml:mi>
</mml:mrow>
</mml:mstyle>
<mml:mn>7</mml:mn>
</mml:msub>
</mml:mrow>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mrow>
<mml:mn>24</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mover accent="true">
<mml:mo>&#x2192;</mml:mo>
<mml:mrow>
<mml:msup>
<mml:mi>&#x3b2;</mml:mi>
<mml:mo>&#x2212;</mml:mo>
</mml:msup>
</mml:mrow>
</mml:mover>
</mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>R</mml:mi>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>5</mml:mn>
<mml:mo>&#xa0;</mml:mo>
<mml:msup>
<mml:mi>R</mml:mi>
<mml:mo>&#x2b;</mml:mo>
</mml:msup>
</mml:mrow>
</mml:math>
<label>(24)</label>
</disp-formula>
<disp-formula id="e25">
<mml:math id="m51">
<mml:mrow>
<mml:mi>R</mml:mi>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
<mml:msubsup>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
<mml:mo>&#x2212;</mml:mo>
</mml:msubsup>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>l</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2192;</mml:mo>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
<mml:mmultiscripts>
<mml:mi>T</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>c</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:math>
<label>(25)</label>
</disp-formula>
</p>
<p>The generator performance greatly depends on the sorption&#x2013;elution kinetics and the degree of the sorbent selectivity for the parent Mo (containing <sup>99</sup>Mo). Therefore, the careful selection of the column material is the prime factor for the success of this generator system. Favorable sorbent material should have a considerable selectivity for Mo and, at the same time, a very limited or no selective capability for <sup>99m</sup>Tc. Based on this parameter, an optimum separation environment can be established between the two radionuclides, and thereby, the <sup>99m</sup>Tc can be extracted in high purity. Furthermore, fast elution kinetics of the daughter can be obtained.</p>
<p>Moreover, the sorbent material should show a high sorption capacity for Mo (containing <sup>99</sup>Mo). The sorption capacity indicates the quantity of Mo the column material can retain. It mainly depends on the number of available active sites on the sorbent surface for the parent element. Higher sorption capacity is directly reflected by a lesser amount of column material needed to achieve the desirable radioactivity level. Consequently, it is translated to a higher radioactive concentration of the eluted <sup>99m</sup>Tc solution.</p>
<p>Furthermore, the column material needs to have a high radiation resistance and suitable chemical stability to withstand the intense radioactive irradiation and the chemical environments (<xref ref-type="bibr" rid="B142">Nawar and T&#xfc;rler, 2019</xref>). In this regard, varieties of column chromatographic generators have been developed. The differences among these generators are the sorbent material and the origin of <sup>99</sup>Mo. The following subsections highlight different column chromatographic generators approaches and their utilization to produce <sup>99m</sup>Tc for medical use.</p>
<sec id="s3-2-3-5-1">
<title>3.2.3.5.1 Alumina-based chromatographic generators</title>
<p>This strategy is the dominant option to afford a reliable and widespread supply of <sup>99m</sup>Tc for medical harnessing. The generator system consists of a small column filled with a few grams of acidic alumina (Al<sub>2</sub>O<sub>3</sub>) as a sorbent matrix. First, the parent <sup>99</sup>Mo is extracted from the fission mixture in an alkaline solution as a molybdate anion (<sup>99</sup>MoO<sub>4</sub>
<sup>2&#x2212;</sup>). Then, this solution is acidified to maintain favorable sorption conditions. After that, it is loaded on the pre-acidified column, and finally, the <sup>99m</sup>Tc can be easily eluted in the form of (<sup>99m</sup>TcO<sub>4</sub>
<sup>&#x2212;</sup>) using 0.9% NaCl solution (<xref ref-type="bibr" rid="B99">IAEA, 2013b</xref>; <xref ref-type="bibr" rid="B142">Nawar and T&#xfc;rler, 2019</xref>).</p>
<p>The earliest produced generator was first eluted with 1&#xa0;M HNO<sub>3</sub>. Then, the eluent was changed to HCl until Hammersmith Hospital-London reported the efficient use of the isotonic NaCl solution. These attempts were designed to provide a perfectly compatible eluate solution with the human biological system and to lower the contamination impurity level of <sup>99</sup>Mo in the eluted <sup>99m</sup>Tc solution (<xref ref-type="bibr" rid="B122">Matthews and Mallard, 1965</xref>; <xref ref-type="bibr" rid="B161">Richards et al., 1982</xref>).</p>
<p>As previously mentioned in <xref ref-type="sec" rid="s2-1-1">Section 2.1.1</xref>, the fission production method is associated with a variety of critical difficulties. In addition, it is only restricted to very few centers worldwide, and it is not formally adopted as an integrated routine production approach in developing countries. In order to overcome these challenges, alternative strategies have been proposed using neutron-capture-produced <sup>99</sup>Mo of low and medium-specific activity. <xref ref-type="fig" rid="F5">Figure 5</xref> graphically illustrates a comparison between the alumina generators based on neutron-capture-produced and fission-produced <sup>99</sup>Mo.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Comparison between the alumina generators based on neutron-capture-produced and fission-produced <sup>99</sup>Mo.</p>
</caption>
<graphic xlink:href="fchem-10-926258-g005.tif"/>
</fig>
<p>The first <sup>99m</sup>Tc generator, which was based on the loading with neutron-capture-produced <sup>99</sup>Mo onto the conventional alumina columns, was produced and commercially distributed by Nuclear Consultants Inc. of St Louis, which was merged afterward with Mallinckrodt and Union Carbide Nuclear Corporation in New York in 1966 (<xref ref-type="bibr" rid="B161">Richards et al., 1982</xref>). Owing to the distinctly limited sorption capacity of conventional alumina (2&#x2013;20&#xa0;mg Mo/g) (<xref ref-type="bibr" rid="B129">Molinsky, 1982</xref>) and the fairly low specific activity of <sup>99</sup>Mo, the effective practical implementation of this technology suffered from a variety of inherent roadblocks. These limitations include the vital need for considerable amounts of alumina to build a useful generator of a suitable radioactivity level, which results in the elution of the <sup>99m</sup>Tc in a relatively large volume with a very low Radioactive Concentration (RAC), which accompanies by more tedious post elution concentration steps. However, the use of enriched <sup>98</sup>Mo targets increase the radioactivity of the produced <sup>99</sup>Mo and accordingly improves the elution profile of the eluted <sup>99m</sup>Tc, the enriched <sup>98</sup>Mo target are costly and cannot be easily recycled (<xref ref-type="bibr" rid="B120">Maoliang, 1997</xref>; <xref ref-type="bibr" rid="B139">NAP, 2018</xref>). Therefore, these <sup>99m</sup>Tc generators, which were built on traditional alumina column and neutron-capture-produced <sup>99</sup>Mo, were abandoned.</p>
</sec>
<sec id="s3-2-3-5-2">
<title>3.2.3.5.2 Gel-type chromatographic generators</title>
<p>The possibility of using neutron-capture-produced <sup>99</sup>Mo to produce chromatographic <sup>99m</sup>Tc generators has promoted the need to explore the gel generator concept (<xref ref-type="bibr" rid="B60">Evans et al., 1987</xref>; <xref ref-type="bibr" rid="B133">Moore et al., 1987</xref>; <xref ref-type="bibr" rid="B27">Boyd, 1997</xref>; <xref ref-type="bibr" rid="B120">Maoliang, 1997</xref>). Generally, the gel generator strategy is a multi-step production approach based on using <sup>99</sup>Mo-labeled molybdate matrices as column materials. The preparation of these matrices involves many consecutive steps, such as the dissolution of the irradiated <sup>99</sup>Mo targets and the precipitation of insoluble solid material with the help of chemical reagents, followed by several filtrations, drying, fragmentation, and column packing steps. At this point, the column is ready for <sup>99m</sup>Tc elution (<xref ref-type="bibr" rid="B97">IAEA, 1999</xref>).</p>
<p>In more detail, the <sup>99</sup>Mo-molybdate matrices can be prepared <italic>via</italic> two main approaches:<list list-type="simple">
<list-item>
<p>&#x2022; Pre-irradiation formed gel technology: This method includes the preparation of an inactive molybdate gel matrix. After that, it is irradiated in the nuclear reactor and consecutively packed into a column for <sup>99m</sup>Tc extraction (<xref ref-type="bibr" rid="B140">Narasimhan et al., 1984</xref>; <xref ref-type="bibr" rid="B195">Vanaja et al., 1987</xref>; <xref ref-type="bibr" rid="B176">Shafiq and Yousif, 1995</xref>).</p>
</list-item>
<list-item>
<p>&#x2022; Post-irradiation formed gel technology: This route starts with the irradiation of the <sup>98</sup>Mo target. Then, the molybdate-<sup>99</sup>Mo matrix is precipitated from its solution as an insoluble gel material. After that, the dried precipitate is packed into a column for <sup>99m</sup>Tc elution (<xref ref-type="bibr" rid="B26">Boyd, 1982a</xref>, <xref ref-type="bibr" rid="B24">1982b</xref>, <xref ref-type="bibr" rid="B25">1987</xref>, <xref ref-type="bibr" rid="B27">1997</xref>; <xref ref-type="bibr" rid="B60">Evans et al., 1987</xref>; <xref ref-type="bibr" rid="B133">Moore et al., 1987</xref>; <xref ref-type="bibr" rid="B58">El-Kolaly, 1993</xref>; <xref ref-type="bibr" rid="B88">IAEA, 1995</xref>; <xref ref-type="bibr" rid="B105">Junior et al., 1998</xref>; <xref ref-type="bibr" rid="B130">Monroy-Guzman et al., 2003</xref>, <xref ref-type="bibr" rid="B132">2007</xref>, <xref ref-type="bibr" rid="B131">2008</xref>; <xref ref-type="bibr" rid="B171">Saraswathy et al., 2004</xref>; <xref ref-type="bibr" rid="B52">Davarpanah et al., 2009</xref>; <xref ref-type="bibr" rid="B135">Mostafa et al., 2016</xref>).</p>
</list-item>
</list>
</p>
<p>These technologies introduce some critical limitations. For example, the former method suffers from the degradation of the pre-formed gel. The intense radiation level in the reactor induces the reduction of Mo(VI) and Tc(VII) to lower oxidation states, which inevitably results in unsatisfactory elution performance and extremely low <sup>99m</sup>Tc elution yield owing to the retention of the <sup>99m</sup>Tc on the column matrix. Moreover, the irradiation of the entire material strongly leads to the production of undesirable radioactive impurities, which consequently lower the radionuclidic purity of the eluted <sup>99m</sup>Tc solution. The post-irradiation formed gel technology is a multi-step procedure that is hampered by the loss of <sup>99</sup>Mo radioactivity, generation of significant amounts of radioactive waste, and excessive radiation exposure to the working personnel (<xref ref-type="bibr" rid="B25">Boyd, 1987</xref>; <xref ref-type="bibr" rid="B60">Evans et al., 1987</xref>; <xref ref-type="bibr" rid="B199">Zaidi et al., 1990</xref>; <xref ref-type="bibr" rid="B171">Saraswathy et al., 2004</xref>; <xref ref-type="bibr" rid="B52">Davarpanah et al., 2009</xref>). In conclusion, the perceived need for high purity and an adequate radioactive concentration of the produced <sup>99m</sup>Tc from the generator set severe technical limitations on the mandatory minimum of the required specific activity of <sup>99</sup>Mo. As a result, this strategy could not have been able to afford a reliable supply of <sup>99m</sup>Tc for clinical use.</p>
</sec>
<sec id="s3-2-3-5-3">
<title>3.2.3.5.3 Generator systems using nanomaterial-based sorbents</title>
<p>Because of the fact that the sorbent material is the heart of column chromatographic generators, many recent studies have focused on developing a new generation of sorbents that possess a high <sup>99</sup>Mo sorption capacity to facilitate the efficient utilization of <sup>99</sup>Mo of low and medium-specific activity. These materials are fabricated on the basis of the nanotechnology. Nano-materials attracted considerable attention due to their unique characteristics and innovative applications in multi-disciplinary fields, such as the drug industry, water decontamination development, and different materials production technology (<xref ref-type="bibr" rid="B108">Kharisov et al., 2014</xref>). Currently, more than 1000 nanotechnology-based products have become commercially available (<xref ref-type="bibr" rid="B173">Sebastian et al., 2014</xref>).</p>
<p>Nanosorbents are size-dependent materials, and their properties not only depend on their chemical composition, but also on their nano-size range and shape. As the particle size decreases, the relative surface area increases, which results in a more significant number of active atoms present on the material surface. These active sites can be translated into a considerable chemical reactivity. In other words, since the chemical reactions occur at the surface, a certain quantity of nano-sized sorbents will be much more reactive than the same amount of macro or micro-scaled materials (<xref ref-type="bibr" rid="B20">Bhatia, 2016</xref>).</p>
<p>Based on the formerly mentioned strategies for preparing column chromatographic generators, it is pertinent to point out that the dominant practical challenge is the relatively low sorption capacity of the traditionally used sorbents. This low capacity requires high specific activity <sup>99</sup>Mo to produce <sup>99m</sup>Tc generators of a suitable radioactivity level. This <sup>99</sup>Mo can only be made available from the fission of <sup>235</sup>U. Some other technologies attempted using neutron-capture-produced <sup>99</sup>Mo. However, their applicability is associated with many potential limitations, as discussed above. These problems can be avoided with the use of nanosorbents. That is because reducing the particle size to the nano-scale range offers new opportunities and gives this group of sorbents a number of unique characteristics. For example, these sorbents exhibit novel physical and chemical properties, resulting in extraordinary sorption reactivity and rapid extraction kinetics. In addition, their high chemical and radiation stability draw a clear distinction between them and the conventional bulk material (<xref ref-type="bibr" rid="B15">Baron et al., 2008</xref>; <xref ref-type="bibr" rid="B198">Yousefi et al., 2012</xref>; <xref ref-type="bibr" rid="B108">Kharisov et al., 2014</xref>; <xref ref-type="bibr" rid="B205">Schmid, 2011</xref>). Therefore, the use of nanoparticle-based sorbents can offer the following advantages:<list list-type="simple">
<list-item>
<p>&#x2022; High parent sorption capacity and selectivity due to their large surface area and the increased number of active sites. Consequently, the preparation of a clinical-scale <sup>99</sup>Mo/<sup>99m</sup>Tc generator using neutron-capture-produced <sup>99</sup>Mo without the limitations of the sorbent capacity can possibly be achieved.</p>
</list-item>
<list-item>
<p>&#x2022; Simple <sup>99</sup>Mo loading process with a minor generation of radioactive waste.</p>
</list-item>
<list-item>
<p>&#x2022; Considerable chemical stability under different concentrations of acidic and basic solutions leads to the production of <sup>99m</sup>Tc with high chemical purity.</p>
</list-item>
<list-item>
<p>&#x2022; High radiation resistance prevents <sup>99</sup>Mo breakthrough and provides the eluted <sup>99m</sup>Tc with adequate radionuclidic purity for nuclear medicine applications.</p>
</list-item>
<list-item>
<p>&#x2022; Favorable elution performance with a sharp <sup>99m</sup>Tc elution profile, which supplies the <sup>99m</sup>Tc eluate with a high radioactive concentration and limits any need for additional concentration efforts.</p>
</list-item>
</list>
</p>
<p>
<xref ref-type="table" rid="T9">Table 9</xref> underlines several research attempts using different nanomaterial-based sorbents to develop <sup>99</sup>Mo/<sup>99m</sup>Tc generator systems (<xref ref-type="bibr" rid="B35">Chakravarty et al., 2008</xref>, <xref ref-type="bibr" rid="B36">2010c</xref>, <xref ref-type="bibr" rid="B32">2012a</xref>, <xref ref-type="bibr" rid="B33">2013</xref>; <xref ref-type="bibr" rid="B61">Fasih et al., 2016</xref>; <xref ref-type="bibr" rid="B141">Nawar, 2021</xref>). It can be observed that the new sorbents exhibit a much higher sorption capacity for <sup>99</sup>Mo compared to the commercially used alumina. Its sorption capacity ranges from (2&#x2013;20&#xa0;mg Mo/g) (<xref ref-type="bibr" rid="B129">Molinsky, 1982</xref>). Furthermore, the eluted <sup>99m</sup>Tc can be collected with adequate elution yield, radionuclidic, radiochemical, and chemical purity levels.</p>
<table-wrap id="T9" position="float">
<label>TABLE 9</label>
<caption>
<p>The summary of <sup>99</sup>Mo/<sup>99m</sup>Tc generators developed using nanosorbents: preparation, structural characterization, loading capacity, and elution quality control data.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="3" align="left">Nano-sorbents</th>
<th rowspan="3" align="center">Method of preparation</th>
<th rowspan="2" colspan="3" align="left">Structural characteristics</th>
<th rowspan="2" colspan="2" align="left">Sorption capacity, (mg Mo/g)</th>
<th rowspan="3" align="left">Activity of <sup>99</sup>Mo loaded, GBq (mCi)</th>
<th rowspan="3" align="left">Specific activity of <sup>99</sup>Mo used, GBq/g of Mo</th>
<th colspan="4" align="left">
<sup>99m</sup>Tc Elution performance</th>
<th rowspan="3" align="left">Reference</th>
</tr>
<tr>
<th rowspan="2" align="left">Elution yield, (%)</th>
<th rowspan="2" align="left">Level of <sup>99</sup>Mo impurity in <sup>99m</sup>Tc, (%)</th>
<th rowspan="2" align="left">Radio-chemical purity of <sup>99m</sup>TcO<sub>4</sub>
<sup>-</sup>, (%)</th>
<th rowspan="2" align="left">Level of chemical impurity in <sup>99m</sup>Tc, (&#x3bc;g/ml)</th>
</tr>
<tr>
<th align="left">Crystalline size, (nm)</th>
<th align="left">Pore size, (nm)</th>
<th align="left">Surface area, (m<sup>2</sup>.g<sup>&#x2212;1</sup>)</th>
<th align="left">Static</th>
<th align="left">Dynamic</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">CeO<sub>2</sub>
</td>
<td align="left">Controlled hydrolysis of Ce(NO<sub>3</sub>)<sub>3</sub>.6H<sub>2</sub>O under alkaline conditions</td>
<td align="left">3.54</td>
<td align="left">2.75</td>
<td align="left">187</td>
<td align="left">192 &#xb1; 10</td>
<td align="left">84 &#xb1; 6</td>
<td align="char" char="(">1.0 (27)</td>
<td align="left">&#x223c;5</td>
<td align="left">76.46 &#xb1; 1.1</td>
<td align="left">&#x3c;10<sup>&#x2013;3</sup>
</td>
<td align="left">&#x3e;99</td>
<td align="left">Ce &#x3c; 0.01</td>
<td align="left">
<xref ref-type="bibr" rid="B141">Nawar, (2021)</xref>
</td>
</tr>
<tr>
<td align="left">TiO<sub>2</sub>
</td>
<td align="left">Hydrolysis of TiCl<sub>4</sub> in isopropyl alcohol medium</td>
<td align="left">&#x223c;40</td>
<td align="left">0.005</td>
<td align="left">320</td>
<td align="left">141 &#xb1; 2</td>
<td align="left">78 &#xb1; 2</td>
<td align="char" char="(">0.74 (20)</td>
<td align="left">&#x223c;3</td>
<td align="left">&#x3e;84</td>
<td align="left">Not detected</td>
<td align="left">&#x2265;97.3</td>
<td align="left">Ti &#x3c; 0.01</td>
<td align="left">
<xref ref-type="bibr" rid="B61">Fasih et al. (2016)</xref>
</td>
</tr>
<tr>
<td align="left">Meso- Al<sub>2</sub>O<sub>3</sub>
</td>
<td align="left">Hydrolysis of Al(C<sub>3</sub>H<sub>8</sub>O)<sub>3</sub> in presence of glucose template, followed by calcination</td>
<td align="left">2 &#xb1; 1</td>
<td align="left">3 &#xb1; 1</td>
<td align="left">230 &#xb1; 10</td>
<td align="left">225 &#xb1; 20</td>
<td align="left">168 &#xb1; 12</td>
<td align="char" char="(">26 (700)</td>
<td align="left">18.5</td>
<td align="left">&#x3e;80</td>
<td align="left">&#x3c;10<sup>&#x2013;3</sup>
</td>
<td align="left">&#x3e;99</td>
<td align="left">Al &#x3c; 0.1</td>
<td align="left">
<xref ref-type="bibr" rid="B33">Chakravarty et al. (2013)</xref>
</td>
</tr>
<tr>
<td align="left">&#x3b3;-Al<sub>2</sub>O<sub>3</sub>
</td>
<td align="left">Mechanochemical reaction of aluminium nitrate with ammonium carbonate</td>
<td align="left">5 &#xb1; 1</td>
<td align="left">0.4 &#xb1; 0.2</td>
<td align="left">250 &#xb1; 10</td>
<td align="left">205</td>
<td align="left">150</td>
<td align="char" char="(">13.0 (350)</td>
<td align="left">11.1</td>
<td align="left">&#x3e;82</td>
<td align="left">&#x3c;10<sup>&#x2013;3</sup>
</td>
<td align="left">&#x3e;99</td>
<td align="left">Al &#x3c; 0.1</td>
<td align="left">
<xref ref-type="bibr" rid="B32">Chakravarty et al. (2012a)</xref>
</td>
</tr>
<tr>
<td align="left">t- ZrO<sub>2</sub>
</td>
<td align="left">Controlled hydrolysis of ZrOCl<sub>2</sub>.8H<sub>2</sub>O under alkaline conditions</td>
<td align="left">8 &#xb1; 2</td>
<td align="left">0.4 &#xb1; 0.1</td>
<td align="left">340 &#xb1; 20</td>
<td align="left">250 &#xb1; 10</td>
<td align="left">80</td>
<td align="char" char="(">9.25 (250)</td>
<td align="left">17.8</td>
<td align="left">&#x3e;85</td>
<td align="left">&#x3c;10<sup>&#x2013;4</sup>
</td>
<td align="left">&#x3e;99</td>
<td align="left">Zr &#x3c; 0.1</td>
<td align="left">
<xref ref-type="bibr" rid="B36">Chakravarty et al. (2010c)</xref>
</td>
</tr>
<tr>
<td align="left">Tip</td>
<td align="left">Controlled hydrolysis of TiCl<sub>4</sub> in isopropyl alcohol medium</td>
<td align="left">5 &#xb1; 1</td>
<td align="left">0.4 &#xb1; 0.1</td>
<td align="left">30 &#xb1; 2</td>
<td align="left">110</td>
<td align="left">75</td>
<td align="char" char="(">1.1 (30)</td>
<td align="left">&#x223c;6&#x2013;13</td>
<td align="left">75&#x2013;80</td>
<td align="left">&#x3c;10<sup>&#x2013;3</sup>
</td>
<td align="left">96.5&#x2013;99.8</td>
<td align="left">Ti &#x3c; 0.1</td>
<td align="left">
<xref ref-type="bibr" rid="B35">Chakravarty et al. (2008)</xref>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Even though some milestones have been achieved, it is of importance to recognize that this approach is still in its infancy, and further research areas need to be covered. The developed methods are not currently standard practice in <sup>99</sup>Mo/<sup>99m</sup>Tc generators. The generators capacities demonstrated in <xref ref-type="table" rid="T9">Table 9</xref> are not sufficient for clinical use. Future studies should intend to scale up for clinical use, which typically involves <sup>99</sup>Mo activities of 40&#x2013;700 GBq. These studies need to investigate the performance of the column matrices in terms of <sup>99m</sup>Tc purity and carefully assess its labeling efficacy using the conventional kit formulations. Since utilizing nano-sorbent materials and LSA <sup>99</sup>Mo represents a new method to produce <sup>99m</sup>Tc generators, local and international regulatory approvals are needed. This approval is a prerequisite before any clinical administration to the patients to prove that the quality and the efficacy of the produced <sup>99m</sup>Tc are equal or even show some advantages over the <sup>99m</sup>Tc obtained from the classical alumina column chromatographic generator containing fission-produced <sup>99</sup>Mo (i.e., purity and dose cost).</p>
</sec>
</sec>
</sec>
</sec>
<sec id="s3-3">
<title>3.3 Modified <sup>99</sup>Mo/<sup>99m</sup>Tc separation systems</title>
<sec id="s3-3-1">
<title>3.3.1 <sup>99m</sup>Tc master milker</title>
<p>Many recent studies have focused on improving the <sup>99</sup>Mo/<sup>99m</sup>Tc generator performance to provide an efficient extraction of <sup>99m</sup>Tc. In this context, a modified version of a column chromatographic <sup>99m</sup>Tc generator, namely the <sup>99m</sup>Tc Master Milker (TcMM), was designed by Kaken Inc. Mito; Japan in 2014 (<xref ref-type="bibr" rid="B186">Tatenuma et al., 2016a</xref>, <xref ref-type="bibr" rid="B184">2014</xref>). The TcMM technique is a new separation concept, which can provide a local supply of <sup>99m</sup>Tc solution recovered from <sup>99</sup>Mo of low and medium-specific activity. The idea is mainly built on the separation of <sup>99m</sup>Tc from its parent through the use of three different column materials; Activated Carbon (AC), Ion Exchange Resin (IER), and activated acidic Alumina (AL) columns. <xref ref-type="fig" rid="F6">Figure 6</xref> illustrates the TcMM process scheme.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>The schematic illustration of the TcMM process.</p>
</caption>
<graphic xlink:href="fchem-10-926258-g006.tif"/>
</fig>
<p>In more detail, TcMM is a multi-step process that involves the separation of <sup>99m</sup>Tc from <sup>99</sup>Mo in six primary stages, as follows (<xref ref-type="bibr" rid="B174">Sekimoto et al., 2017</xref>; <xref ref-type="bibr" rid="B185">Tatenuma et al., 2016b</xref>, <xref ref-type="bibr" rid="B184">2014</xref>):</p>
<sec id="s3-3-1-1">
<title>3.3.1.1 Preparation of the <sup>99</sup>Mo solution</title>
<p>Following the delivery of the irradiated <sup>99</sup>Mo targets, a radioactive <sup>99</sup>Mo/<sup>99m</sup>Tc mixture is prepared by dissolving the irradiated targets in 2M NaOH according to the following reaction:<disp-formula id="e26">
<mml:math id="m52">
<mml:mrow>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mn>3</mml:mn>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mn>2</mml:mn>
<mml:mi>N</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>O</mml:mi>
<mml:mi>H</mml:mi>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2192;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mi>N</mml:mi>
<mml:msub>
<mml:mi>a</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mmultiscripts>
<mml:mi>M</mml:mi>
<mml:mprescripts/>
<mml:none/>
<mml:mrow>
<mml:mn>99</mml:mn>
</mml:mrow>
</mml:mmultiscripts>
<mml:mi>o</mml:mi>
<mml:msub>
<mml:mi>O</mml:mi>
<mml:mn>4</mml:mn>
</mml:msub>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x2b;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>H</mml:mi>
<mml:mn>2</mml:mn>
</mml:msub>
<mml:mi>O</mml:mi>
</mml:mrow>
</mml:math>
<label>(26)</label>
</disp-formula>
</p>
</sec>
<sec id="s3-3-1-2">
<title>3.3.1.2 Sorption of <sup>99m</sup>Tc</title>
<p>The formed Na<sub>2</sub>
<sup>99</sup>MoO<sub>4</sub> solution is allowed to pass through a stainless steel column loaded with 5&#xa0;g of AC, by which a particularly selective extraction of <sup>99m</sup>Tc can take place. The AC column has high sorption efficiency towards <sup>99m</sup>Tc compared to <sup>99</sup>Mo and other radio-contaminants present in the solution. The reason for this selective sorption behavior capability is still under investigation.</p>
</sec>
<sec id="s3-3-1-3">
<title>3.3.1.3 Removal of <sup>99</sup>Mo impurities</title>
<p>During the second step, small amounts of <sup>99</sup>Mo contaminants may be adsorbed on the activated charcoal column. In order to remove these impurities, three successive elution steps have to be performed. In the first step, the column is rinsed with a sufficient amount of water. Then, <sup>99</sup>Mo is eluted with sodium hydroxide solution. Finally, the column is rewashed with water to remove any residual quantities of <sup>99</sup>Mo and NaOH. The flushed <sup>99</sup>Mo solution can be allowed to decay to be reused again. This step may be repeated many times until the <sup>99</sup>Mo no longer has enough activity to be utilized.</p>
</sec>
<sec id="s3-3-1-4">
<title>3.3.1.4 Elution of <sup>99m</sup>Tc</title>
<p>In this step, the stainless steel column containing the activated carbon is heated up to 80&#x2013;90&#xb0;C. In the meantime, a sufficient amount of water is passed through the column. Hence, the <sup>99m</sup>Tc radioactivity can be collected as a warm, weakly alkaline solution.</p>
</sec>
<sec id="s3-3-1-5">
<title>3.3.1.5 Treatment of the <sup>99m</sup>Tc eluate</title>
<p>The obtained solution from the previous step is mixed with sodium chloride solution to form a 0.9% saline solution.</p>
</sec>
<sec id="s3-3-1-6">
<title>3.3.1.6 Refining and purification of <sup>99m</sup>Tc</title>
<p>After completing the elution process (step 4), the <sup>99m</sup>Tc solution may still contain some undesirable radio-impurities such as <sup>92m</sup>Nb, <sup>95</sup>Nb, and <sup>96</sup>Nb, which arise from the neutron activation of stable radioisotopes of molybdenum, in addition to the parent <sup>99</sup>Mo. In order to purify the <sup>99m</sup>Tc eluate from these radio-contaminants, additional purification steps have to be carried out. Therefore, the resulting <sup>99m</sup>Tc solution from step 5 is allowed to pass through two successive columns; IER and AL columns, respectively.</p>
<p>The TcMM technology offers a new possibility for separating highly purified <sup>99m</sup>Tc from <sup>99</sup>Mo of low and medium-specific activity. The produced <sup>99m</sup>Tc shows high labeling efficacy with several pharmaceutical kits. Nevertheless, this technology still requires approval for making human-use <sup>99m</sup>Tc radiopharmaceuticals. The TcMM can utilize <sup>99</sup>Mo radioactivity in the range of kBq to TBq and produce <sup>99m</sup>Tc of a maximum of 500&#xa0;Ci (18.5 TBq) per batch (<xref ref-type="bibr" rid="B186">Tatenuma et al., 2016a</xref>, <xref ref-type="bibr" rid="B184">2014</xref>). However, the produced <sup>99m</sup>Tc can only be distributed locally to the usage sites near the separation centers. In addition, the loss of some of the <sup>99m</sup>Tc radioactivity during the multi-separation and purification steps and the transportation to more distant usage sites is a marked disadvantage.</p>
</sec>
</sec>
<sec id="s3-3-2">
<title>3.3.2 Northstar radiogenix</title>
<p>Another new modified version of the <sup>99m</sup>Tc generator is the Radiogenix system, which was designed as a closed system by Northstar Medical Isotopes, LLC, Beloit, Wisconsin; United States (<xref ref-type="bibr" rid="B79">Harvey, 2019</xref>). Northstar has received approval from the US Food and Drug Administration (FDA) for using the Radiogenix system to supply <sup>99m</sup>Tc for nuclear medicine applications (<xref ref-type="bibr" rid="B79">Harvey, 2019</xref>; <xref ref-type="bibr" rid="B107">Karcz, 2019</xref>). Northstar Radiogenix is an automated, computer-controlled platform designed to separate <sup>99m</sup>Tc daughter from non-uranium produced <sup>99</sup>Mo of low specific activity in a highly alkaline solution.</p>
<p>Radiogenix is based on separating <sup>99m</sup>Tc with the use of two different separation cartridges, namely the Primary Separation Cartridge (PSC) and <sup>99m</sup>Tc Product Cartridge (TPC) (<xref ref-type="bibr" rid="B148">Northstar, 2020</xref>). Once the irradiated Mo targets are received, they are dissolved, and the <sup>99</sup>Mo solution is contained inside the source vessel. After that, the <sup>99</sup>Mo/<sup>99m</sup>Tc mixture is pumped through PSC containing Polyethylene Glycol (PEG)-based Aqueous Biphasic Extraction Chromatography (ABEC) resin. This resin selectively retains the <sup>99m</sup>Tc, and the parent, <sup>99</sup>Mo, passes through into the transfer vessel (<xref ref-type="bibr" rid="B163">Rogers et al., 1997</xref>; <xref ref-type="bibr" rid="B134">Morley et al., 2012</xref>; <xref ref-type="bibr" rid="B6">ANL, 2016</xref>). Then, with a stripping solution, <sup>99m</sup>Tc is washed off from the ABEC resin and passed through the TPC into the <sup>99m</sup>Tc collection vial. This step ensures the purification of <sup>99m</sup>Tc from any <sup>99</sup>Mo impurities. Eventually, the <sup>99</sup>Mo is returned to the source vessel for reuse (<xref ref-type="bibr" rid="B148">Northstar, 2020</xref>). When the <sup>99</sup>Mo solution reaches its expiration date and is no longer usable, it is returned to the manufacturer, primarily when enriched Mo targets are used (<xref ref-type="bibr" rid="B7">ANL, 2020</xref>).</p>
<p>Northstar Radiogenix is a high-tech technology that provides high-quality <sup>99m</sup>Tc concentrations similar to the high-specific activity-based generators. Nevertheless, it has a physically large design. Moreover, since this method involves a different system and new protocol, the main question is whether the nuclear medicine community will be willing to adopt this approach in the near future.</p>
</sec>
</sec>
</sec>
<sec id="s4">
<title>4 Summary, conclusions, and future perspectives</title>
<p>This paper highlights the fundamental role of <sup>99m</sup>Tc in medical investigations and its potential production strategies. <sup>99m</sup>Tc (T<sub>1/2</sub> &#x3d; 6.01&#xa0;h) is the most widely used diagnostic radionuclide in nuclear medicine. The <sup>99m</sup>Tc labeled radiopharmaceuticals are prepared mostly in-house by using kit formulations. <sup>99m</sup>Tc is conveniently derived from <sup>99</sup>Mo/<sup>99m</sup>Tc generator systems. The parent <sup>99</sup>Mo (T<sub>1/2</sub> &#x3d; 65.94&#xa0;h) is obtained by chemical separation from neutron-irradiated <sup>235</sup>U targets, by which Gram quantities of highly enriched <sup>235</sup>U targets are irradiated in the thermal spectrum of research reactors. Then, it is shipped to special processing facilities, where the <sup>99</sup>Mo is chemically separated and purified. The obtained specific activity of <sup>99</sup>Mo is very high. Nonetheless, the process is associated with generating substantial amounts of nuclear waste, and the handling of <sup>235</sup>U generates serious proliferation issues. Furthermore, the global <sup>99</sup>Mo supply is fragile and insecure, as it only relies on few aging nuclear reactors. Since the <sup>99m</sup>Tc supply depends significantly on the fission-produced <sup>99</sup>Mo availability, it seriously suffered during renewed emergency periods, such as the past <sup>99</sup>Mo production crisis and the current COVID-19 pandemic. To solve this challenge, many alternative ideas were put forward to mediate the problem. However, the commercial aspect should not be overlooked. These new methods to supply <sup>99m</sup>Tc should be competitive in terms of production volume, price, and ease of applicability for the end-user. One method is to obtain <sup>99m</sup>Tc by direct cyclotron production via the <sup>100</sup>Mo (p,2n)<sup>99m</sup>Tc reaction. However, many nuclear medicine departments are hard to persuade to switch from the column <sup>99m</sup>Tc generators and kit formulations to the <sup>99m</sup>Tc-radiopharmaceuticals produced in centralized radiopharmacies that obtain <sup>99m</sup>Tc by this route. Mainly, its supply advantage is limited to the centers close to the production site, and the daily transport costs can develop into a significant cost factor. In addition, this strategy still seeks to design a realistic supply plan that can deal with the production difficulties and find innovative logistic solutions to meet rapid product delivery requirements. Thereby, this strategy is not clearly the answer for a routine <sup>99m</sup>Tc supply.</p>
<p>In order to establish a sufficient <sup>99m</sup>Tc supply sustainably, two challenges need to be optimized:<list list-type="simple">
<list-item>
<p>&#x2022; First, enhance the <sup>99</sup>Mo economy by guaranteeing a reliable and decentralized worldwide supply source of Low Specific Activity (LSA) <sup>99</sup>Mo. This concept can be made available by fostering the neutron irradiation of <sup>98</sup>Mo targets in nuclear power reactors. Commercial nuclear power reactors provide intense neutron fluxes. More importantly, high fluxes of epi-thermal neutrons are available. Due to the activation of <sup>98</sup>Mo solely, no chemical separation is required, and consequently, very marginal quantities of radioactive waste are generated. In addition, this method is proliferation-resistant, as no fissile materials are involved. Moreover, it needs less technical arrangements and financial budgets compared to the uranium fission approach. Another promising approach aims at producing <sup>99</sup>Mo through photonuclear reactions through the <sup>100</sup>Mo(&#x3b3;,n)<sup>99</sup>Mo reaction. The currently available specific activity is about 6&#xa0;Ci/g of <sup>99</sup>Mo after a 24&#xa0;h bombardment. The <sup>99</sup>Mo produced has a low specific activity. Therefore, the issue of the low sorption capacity of the conventional sorbents persists (2&#x2013;20&#xa0;mg Mo/g).</p>
</list-item>
<list-item>
<p>&#x2022; Second, the key lies in developing a new generation of column materials that possess high sorption capacity and selectivity to recompense for the low specific activity of the obtained <sup>99</sup>Mo. A promising approach is the development of a chromatographic column <sup>99m</sup>Tc generator with the use of nanomaterial-based sorbents. The use of nanomaterial-based sorbents deserves considerable attention due to their high sorption capacity, which arises from their large surface area, high radiation resistance, and chemical stability compared to conventionally used sorbents. These unique characteristics could be the cornerstone towards developing a new generation of <sup>99</sup>Mo/<sup>99m</sup>Tc generators that produce <sup>99m</sup>Tc with high purity and radioactivity concentration adequate for existing kit formulations. Consequently, this approach would encourage the possibility of using <sup>99</sup>Mo of low specific activity without the limitations of the sorbent capacity.</p>
</list-item>
</list>
</p>
<p>Since the <sup>99m</sup>Tc production techniques are usually selected based on different economic, technical, and logistical circumstances, the proposed solution in this article is inexpensive, realistic, and could be implemented in a short period. Furthermore, it has the potential to ensure a secure supply source of clinical-grade <sup>99m</sup>Tc for millions of patients worldwide, especially for many countries which do not have access to fission <sup>99</sup>Mo technology.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Author contributions</title>
<p>MN suggested the idea, collected the data, and drafted the original manuscript. Furthermore, MN planned for the acquisition of the financial support for the project leading to this publication. AT supervised the project, performed calculations on nuclear reactions, and reviewed the original manuscript.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>The research was funded by the Swiss National Science Foundation (grant number CRSII5_180352). MN gratefully acknowledges the funding support of the Swiss Government Excellence fellowships program (fellowship No: 2017.1028).</p>
</sec>
<ack>
<p>The authors would like to thank Dr. Alaa El-Daoushy (Egyptian Atomic Energy Authority) for her fruitful discussion and comments. Furthermore, the authors wish to acknowledge Dr. Abdallah Zaki (University of Geneva) for his valuable assistance in drafting some figures. Finally, the authors would like to thank Dr. Mehran Vagheian (University of Bern) for his contribution to calculating the <sup>99</sup>Mo production yield in photonuclear reactions.</p>
</ack>
<sec sec-type="COI-statement" id="s7">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s8">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abderrahim</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Baeten</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bruyn</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Heyse</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schuurmans</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wagemans</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>MYRRHA, a multipurposehybrid research reactor for high-end applications</article-title>. <source>Nucl. Phys. News</source> <volume>20</volume> (<issue>1</issue>), <fpage>24</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1080/10506890903178913</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Ache</surname>
<given-names>H. G.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Production techniques of fission molybdenum-99</article-title>. <source>Radiochim. Acta.</source> <volume>41</volume> (<issue>2-3</issue>), <fpage>65</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1987.41.23.65</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>1965</year>). <article-title>An improved technetium-99m generator for medical applications</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>16</volume> (<issue>5</issue>), <fpage>332</fpage>&#x2013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(65)90058-X</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Anders</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1960</year>). <article-title>The radiochemistry of technetium, National Academy of Sciences &#x2014;National Research Council, Nuclear Science Series: NAS-NS 3021, U.S.A.</article-title> <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.osti.gov/servlets/purl/4073069">https://www.osti.gov/servlets/purl/4073069</ext-link>
</comment>. </citation>
</ref>
<ref id="B5">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Ling</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Schlyer</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>C. S.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>A Short History of Nuclear Medicine</article-title>,&#x201d; in <source>Radiopharmaceutical chemistry</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Lewis</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Windhorst</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Zeglis</surname>
<given-names>B. M.</given-names>
</name>
</person-group> (<publisher-loc>Cham, Switzerland</publisher-loc>: <publisher-name>Springer Nature Switzerland AG</publisher-name>), <fpage>11</fpage>&#x2013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-98947-1_2</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="book">
<collab>ANL</collab> (<year>2016</year>). <source>Argonne National Laboratory Report</source>. <comment>ANL/NE-16/43. Available at: <ext-link ext-link-type="uri" xlink:href="https://publications.anl.gov/anlpubs/2017/04/134741.pdf">https://publications.anl.gov/anlpubs/2017/04/134741.pdf</ext-link>
</comment>.<article-title>Development of ABEC Column for Separation of Tc-99 from Northstar Dissolved Target Solution</article-title> </citation>
</ref>
<ref id="B7">
<citation citation-type="book">
<collab>ANL</collab> (<year>2020</year>). <source>Argonne National Laboratory Report</source>. <comment>ANL-20/20</comment>.<article-title>Recycling Isotopically Enriched Mo from the RadioGenix Waste Stream</article-title> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anwar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rosskelly</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Harpen</surname>
<given-names>P. V.</given-names>
</name>
<name>
<surname>Lathrop</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rosselly</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1968</year>). <article-title>Pertechnetate production from <sup>99</sup>Mo by liquid-liquid extraction</article-title>. <source>J. Nucl. Med.</source> <volume>9</volume>, <fpage>298</fpage>&#x2013;<lpage>299</lpage>. </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>&#xc7;ay&#x131;r</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>K&#xf6;yba&#x15f;&#x131;o&#x11f;lum</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Karabacak</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>&#xc7;akal</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Four a Typical Parathyroid Adenomas Detected by Dual Phase Tc-99m MIBI SPECT</article-title>. <source>Mol. Imaging Radionucl. Ther.</source> <volume>29</volume> (<issue>1</issue>), <fpage>33</fpage>&#x2013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.4274/mirt.galenos.2019.09326</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkins</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Radiopharmaceuticals</article-title>. <source>Phys. Rep.</source> <volume>21</volume> (<issue>6</issue>), <fpage>315</fpage>&#x2013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/0370-1573(75)90013-7</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>&#xc1;vila-S&#xe1;nchez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ferro-Flores</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez-Mancilla</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ocampo-Garcia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bravo-Villegas</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Luna-Gutierrez</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Synthesis and preclinical evaluation of the <sup>99m</sup>Tc-/<sup>177</sup>Lu-CXCR4-L theranostic pair for <italic>in vivo</italic> chemokine-4 receptor-specific targeting</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>324</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-020-07043-6</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>A system for the routine production of concentrated technetium-99m by solvent extraction of molybdenum-99</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>22</volume> (<issue>8</issue>), <fpage>483</fpage>&#x2013;<lpage>485</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(71)90170-0</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bandeira</surname>
<given-names>J. V.</given-names>
</name>
<name>
<surname>Sabino</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Aun</surname>
<given-names>P. E.</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>V. L.</given-names>
</name>
<name>
<surname>Agudo</surname>
<given-names>E. G.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Development of a technique for using <sup>99m</sup>Tc as an absorbable tracer for hydrodynamic studies of fine sediments in suspension</article-title>. <source>Appl. Radiat. Isot.</source> <volume>57</volume> (<issue>1</issue>), <fpage>85</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/s0969-8043(02)00068-4</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
<name>
<surname>Ramamoorthy</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Evolution of Tc-99m in Diagnostic Radiopharmaceuticals</article-title>. <source>Semin. Nucl. Med.</source> <volume>31</volume> (<issue>4</issue>), <fpage>260</fpage>&#x2013;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1053/snuc.2001.26205</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Campbellm</surname>
<given-names>F. W.</given-names>
</name>
<name>
<surname>Streeterm</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Xianom</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Comptonm</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Facile Method for the Construction of Random Nanoparticle Arrays on a Carbon Support for the Development of Well-defined Catalytic Surfaces</article-title>. <source>Int. J. Electochem. Sci.</source> <volume>3</volume> (<issue>5</issue>), <fpage>556</fpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.electrochemsci.org/papers/vol3/3050556.pdf">http://www.electrochemsci.org/papers/vol3/3050556.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaver</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Hupf</surname>
<given-names>H. B.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>Production of 99m Tc on a medical cyclotron: A feasibility study.</article-title> <source>J. Nucl. Med.</source> <volume>12</volume> (<issue>11</issue>), <fpage>739</fpage>&#x2013;<lpage>741</lpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://jnm.snmjournals.org/content/12/11/739.full.pdf">http://jnm.snmjournals.org/content/12/11/739.full.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berne</surname>
<given-names>P. P.</given-names>
</name>
<name>
<surname>Thereska</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Simulation of a radiotracer experiment by flow and detection-chain modelling: A first step towards better interpretation</article-title>. <source>Appl. Radiat. Isot.</source> <volume>60</volume> (<issue>6</issue>), <fpage>855</fpage>&#x2013;<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2003.12.010</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Bertsche</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Accelerator Production Options for <sup>99</sup>Mo, University of North Texas Libraries, United States</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://digital.library.unt.edu/ark:/67531/metadc845983/">https://digital.library.unt.edu/ark:/67531/metadc845983/</ext-link>
</comment>. </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatia</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Turel</surname>
<given-names>Z. R.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>Solvent extraction of <sup>99m</sup>Tc/VII/ with methylene blue into nitrobenzene</article-title>. <source>J. Radioanalytical Nucl. Chem. Lett.</source> <volume>135</volume> (<issue>2</issue>), <fpage>77</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1007/BF02163538</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Bhatia</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). &#x201c;<article-title>Nanoparticles types, classification, characterization, fabrication methods and drug delivery applications</article-title>,&#x201d; in <source>Natural polymer drug delivery systems</source> (<publisher-loc>Cham, Switzerland</publisher-loc>: <publisher-name>Springer International Publishing</publisher-name>), <fpage>33</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-41129-3_2</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Binney</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Scherpdz</surname>
<given-names>R. I.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>A review of the delayed fission neutron technique</article-title>. <source>Nucl. Instrum. Methods</source> <volume>154</volume> (<issue>3</issue>), <fpage>413</fpage>&#x2013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/0029-554X(78)90069-1</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borroto</surname>
<given-names>J. I.</given-names>
</name>
<name>
<surname>Dominguez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Griffith</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fick</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leclerc</surname>
<given-names>J. P.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Technetium-99m as a tracer for the liquid RTD measurement in opaque anaerobic digester: Application in a sugar wastewater treatment plant</article-title>. <source>Chem. Eng. Process. Process Intensif.</source> <volume>42</volume> (<issue>11</issue>), <fpage>857</fpage>&#x2013;<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1016/S0255-2701(02)00109-5</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boschi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Pasquali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Uccelli</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons</article-title>. <source>Drug Dev. Ind. Pharm.</source> <volume>43</volume> (<issue>9</issue>), <fpage>1402</fpage>&#x2013;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.1080/03639045.2017.1323911</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>1982b</year>). <article-title>Molybdenum-99:Technetium-99m generator</article-title>. <source>Radiochim. Acta</source> <volume>30</volume> (<issue>3</issue>), <fpage>123</fpage>&#x2013;<lpage>145</lpage>. </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Technetium Generators: Status and Prospects</article-title>. <source>Radiochim. Acta.</source> <volume>41</volume> (<issue>2-3</issue>), <fpage>59</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1987.41.23.59</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>1982a</year>). <article-title>Technetium-99m generators &#x2013; The available options</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>33</volume> (<issue>10</issue>), <fpage>801</fpage>&#x2013;<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90121-1</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The gel generator: A viable alternative source of <sup>99m</sup>Tc for nuclear medicine</article-title>. <source>Appl. Adiat. Isot.</source> <volume>48</volume> (<issue>8</issue>), <fpage>1027</fpage>&#x2013;<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1016/S0969-8043(96)00298-9</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
</person-group> (<year>2012b</year>). <article-title>Electrochemical Separation is an Attractive Strategy for Development of Radionuclide Generators for Medical Applications</article-title>. <source>Curr. Radiopharm.</source> <volume>5</volume> (<issue>3</issue>), <fpage>271</fpage>&#x2013;<lpage>287</lpage>. <pub-id pub-id-type="doi">10.2174/1874471011205030271</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010b</year>). <article-title>Post elution concentration of <sup>188</sup>Re by an electrochemical method</article-title>. <source>Appl. Radiat. Isot.</source> <volume>68</volume> (<issue>12</issue>), <fpage>2302</fpage>&#x2013;<lpage>2305</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2010.06.022</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010a</year>). <article-title>A novel electrochemical technique for the production of clinical grade <sup>99m</sup>Tc using (n, &#x3b3;) <sup>99</sup>Mo</article-title>. <source>Nucl. Med. Biol.</source> <volume>37</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2009.08.010</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Role of Nanoporous Materials in Radiochemical Separations for Biomedical Applications</article-title>. <source>J. Nanosci. Nanotechnol.</source> <volume>13</volume> (<issue>4</issue>), <fpage>2431</fpage>&#x2013;<lpage>2450</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2013.7349</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
</person-group> (<year>2012a</year>). <article-title>Preparation of clinical-scale <sup>99</sup>Mo/<sup>99m</sup>Tc column generator using neutron activated low specific activity <sup>99</sup>Mo and nanocrystalline &#x3b3;-Al<sub>2</sub>O<sub>3</sub> as column matrix</article-title>. <source>Nucl. Med. Biol.</source> <volume>39</volume> (<issue>7</issue>), <fpage>916</fpage>&#x2013;<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2012.03.010</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mazumder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Mesoporous Alumina (MA) based double column approach for development of a clinical scale <sup>99</sup>Mo/<sup>99</sup>mTc generator using (n, &#x3b3;) <sup>99</sup>Mo: An enticing application of nanomaterial</article-title>. <source>Ind. Eng. Chem. Res.</source> <volume>52</volume> (<issue>33</issue>), <fpage>11673</fpage>&#x2013;<lpage>11684</lpage>. <pub-id pub-id-type="doi">10.1021/ie401042n</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012c</year>). <article-title>An electrochemical procedure to concentrate <sup>99m</sup>Tc availed from a zirconium [<sup>99</sup>Mo] molybdate gel generator</article-title>. <source>Appl. Radiat. Isot.</source> <volume>70</volume> (<issue>2</issue>), <fpage>375</fpage>&#x2013;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2011.09.024</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gandhi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Polymer Embedded Nanocrystalline Titania Sorbent for <sup>99</sup>Mo-<sup>99m</sup>Tc Generator</article-title>. <source>J. Nanosci. Nanotechnol.</source> <volume>8</volume> (<issue>9</issue>), <fpage>4447</fpage>&#x2013;<lpage>4452</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2008.280</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tyagi</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010c</year>). <article-title>Practicality of Tetragonal Nano-Zirconia as a Prospective Sorbent in the Preparation of <sup>99</sup>Mo/<sup>99m</sup>Tc Generator for Biomedical Applications</article-title>. <source>Chromatographia</source> <volume>72</volume> (<issue>9</issue>), <fpage>875</fpage>&#x2013;<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1365/s10337-010-1754-z</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Venkatesh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>A novel electrochemical <sup>99</sup>Mo/<sup>99m</sup>Tc generator</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>290</volume> (<issue>1</issue>), <fpage>45</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-011-1113-z</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Types of bulk liquid membrane and its membrane resistance in heavy metal removal and recovery from wastewater</article-title>. <source>Desalination Water Treat.</source> <volume>57</volume> (<issue>42</issue>), <fpage>19785</fpage>&#x2013;<lpage>19793</lpage>. <pub-id pub-id-type="doi">10.1080/19443994.2015.1102772</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Barua</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>De</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Mitra</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Pharmaceutical grade sodium [<sup>99m</sup>Tc] pertechnetate from low specific activity <sup>99</sup>Mo using an automated <sup>99</sup>Mo/<sup>99m</sup>Tc-TCM-autosolex generator</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>302</volume>, <fpage>781</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-014-3211-1</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Barua</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A simple and rapid technique for recovery of <sup>99m</sup>Tc from low specific activity (n, &#x3b3;)<sup>99</sup>Mo based on solvent extraction and column chromatography</article-title>. <source>Appl. Radiat. Isot.</source> <volume>68</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2009.07.024</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudry</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Acid effect on <sup>99m</sup>Tc and <sup>99</sup>Mo mutual separation and their transport across supported liquid membrane extraction system Czechoslov</article-title>. <source>J. Phys.</source> <volume>50</volume> (<issue>2</issue>), <fpage>271</fpage>&#x2013;<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1023/A:1022894825658</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Boerrigter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Veltkamp</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Technetium(VII) transport across supported liquid membranes (SLMs) containing 2-nitrophenyl octyl ether (NPOE)</article-title>. <source>Radiochim. Acta</source> <volume>89</volume> (<issue>8</issue>), <fpage>523</fpage>&#x2013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1524/ract.2001.89.8.523</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tomasberger</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Solvent extraction of Tc(VII) by the mixture of TBP and 2-nitrophenyl octyl ether</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>247</volume> (<issue>3</issue>), <fpage>519</fpage>&#x2013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010622208450</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="thesis">
<person-group person-group-type="author">
<name>
<surname>Childs</surname>
<given-names>B. C.</given-names>
</name>
</person-group> (<year>2017</year>). <source>Volatile Technetium Oxides: Implications for Nuclear Waste Vitrification</source>. <comment>PhD thesis</comment> (<publisher-loc>Las Vegas</publisher-loc>: <publisher-name>University of Nevada</publisher-name>). <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://digitalscholarship.unlv.edu/thesesdissertations/2958">https://digitalscholarship.unlv.edu/thesesdissertations/2958</ext-link>
</comment>.</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christian</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Petti</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Kirkham</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>R. G.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Advances in Sublimation Separation of Technetium from Low-Specific-Activity Molybdenum-99</article-title>. <source>Ind. Eng. Chem. Res.</source> <volume>39</volume> (<issue>9</issue>), <fpage>3157</fpage>&#x2013;<lpage>3168</lpage>. <pub-id pub-id-type="doi">10.1021/ie9903792</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Cols</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Cristinin</surname>
<given-names>P. R.</given-names>
</name>
<name>
<surname>Manzini</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>2000</year>). &#x201c;<article-title>Mo&#x2013;99 From Low&#x2013;Enriched Uranium</article-title>,&#x201d; in <conf-name>Presented in part at International Meeting on Reduced Enrichment for Research and Test Reactors</conf-name>, <conf-loc>Argentina</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://inis.iaea.org/collection/NCLCollectionStore/_Public/42/024/42024785.pdf">https://inis.iaea.org/collection/NCLCollectionStore/_Public/42/024/42024785.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B47">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Conner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sedlet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiencek</surname>
<given-names>T,C.</given-names>
</name>
<name>
<surname>McGann</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Vandegrift</surname>
<given-names>G. F.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). &#x201c;<article-title>Production of Mo-99 from LEU targets acid-side processing</article-title>,&#x201d; in <conf-name>Presented in part at International Meeting on Reduced Enrichment for Research and Test Reactors</conf-name>, <conf-loc>Las Vegas, Nevada, U.S.A</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://inis.iaea.org/collection/NCLCollectionStore/_Public/32/025/32025774.pdf">https://inis.iaea.org/collection/NCLCollectionStore/_Public/32/025/32025774.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crasta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Naik</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suryanarayana</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Prajapati</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Jagadisan</surname>
<given-names>K. C.</given-names>
</name>
<name>
<surname>Thakare</surname>
<given-names>S. V.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Photo-neutron cross-section of <sup>100</sup>Mo</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>290</volume>, <fpage>367</fpage>&#x2013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-011-1247-z</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Nanomaterial based adsorbent: Promises, opportunities, and challenges to develop column chromatography radionuclide generators for nuclear medicine</article-title>. <source>Sep. Purif. Rev.</source> <volume>46</volume> (<issue>2</issue>), <fpage>91</fpage>&#x2013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1080/15422119.2016.1205089</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chakravarty</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pillai</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Wagh</surname>
<given-names>D. N.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Development of a <sup>99</sup>Mo/<sup>99m</sup>Tc generator using alumina microspheres for industrial radiotracer applications</article-title>. <source>Appl. Radiat. Isot.</source> <volume>70</volume> (<issue>1</issue>), <fpage>51</fpage>&#x2013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2011.07.012</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davarkhah</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Farahmand</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Samadfam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tavasoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zaheri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shamsipur</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Selective separation of yttrium(III) through a liquid membrane system using 2-thenoyltrifluoroacetone as an extractant carrier</article-title>. <source>Chem. Pap.</source> <volume>72</volume> (<issue>6</issue>), <fpage>1487</fpage>&#x2013;<lpage>1497</lpage>. <pub-id pub-id-type="doi">10.1007/s11696-018-0407-9</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davarpanah</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Nosrati</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Fazlali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Boudani</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Khoshhosn</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Maragheh</surname>
<given-names>M. G.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Influence of drying conditions of zirconium molybdate gel on performance of <sup>99m</sup>Tc gel generator</article-title>. <source>Appl. Radiat. Isot.</source> <volume>67</volume> (<issue>10</issue>), <fpage>1796</fpage>&#x2013;<lpage>1801</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2009.06.011</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhami</surname>
<given-names>P. S.</given-names>
</name>
<name>
<surname>Naik</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Dudwadkar</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Kannan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Achuthan</surname>
<given-names>P. V.</given-names>
</name>
<name>
<surname>Moorthy</surname>
<given-names>A. D.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Studies on the development of a two stage SLM system for the separation of carrier-free <sup>90</sup>Y using KSM-17 and CMPO as carriers</article-title>. <source>Sep. Sci. Technol.</source> <volume>42</volume> (<issue>5</issue>), <fpage>1107</fpage>&#x2013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1080/01496390601174323</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dilworth</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Pascu</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2015</year>). &#x201c;<article-title>The radiopharmaceutical chemistry of technetium and rhenium</article-title>,&#x201d; in <source>The chemistry of molecular imaging</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Long</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>W. T.</given-names>
</name>
</person-group> (<publisher-loc>Hoboken, New Jersey</publisher-loc>: <publisher-name>John Wiley &#x26; Sons</publisher-name>), <fpage>137</fpage>&#x2013;<lpage>164</lpage>. </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohapatra</surname>
<given-names>P. K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Studies on the separation of <sup>90</sup>Y from <sup>90</sup>Sr by solvent extraction and supported liquid membrane using TODGA: Role of organic diluent</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>295</volume> (<issue>3</issue>), <fpage>1683</fpage>&#x2013;<lpage>1688</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-012-2233-9</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckelman</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Coursey</surname>
<given-names>B. M.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Technetium-99m: Generators, chemistry and preparation of radiopharmaceuticals</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>33</volume> (<issue>10</issue>), <fpage>793</fpage>&#x2013;<lpage>806</lpage>. </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckelman</surname>
<given-names>W. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Unparalleled Contribution of Technetium-99m to Medicine Over 5 Decades</article-title>. <source>JACC Cardiovasc. Imaging</source> <volume>2</volume> (<issue>3</issue>), <fpage>364</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcmg.2008.12.013</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Kolaly</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>A <sup>99</sup>Mo/<sup>99m</sup>Tc generator based on the use of zirconium molybdophosphate-<sup>99</sup>Mo gel</article-title>. <source>J. Radioanalytical Nucl. Chem. Articles</source> <volume>170</volume> (<issue>2</issue>), <fpage>293</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1007/BF02041464</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vecchi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pupillo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Taibi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uccelli</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Boschi</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Evaluation of <sup>99</sup>Mo and <sup>99m</sup>Tc Productions Based on a High-Performance Cyclotron</article-title>. <source>Sci. Technol. Nucl. Installations</source> <volume>2013</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1155/2013/972381</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Evans</surname>
<given-names>J. V.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Shying</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Sodeau</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Zirconium molybdate gel as generator for technetium-99m: The concept and its evaluation</article-title>. <source>Int. J. Radiat. Appl. Instrum. Part A. Appl. Radiat. Isotopes</source> <volume>38</volume> (<issue>1</issue>), <fpage>19</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90230-9</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fasih</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Sakr</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Ayoub</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Preparation and evaluation of nano-crystalline titania as sorbent for <sup>99</sup>Mo/<sup>99m</sup>Tc generator</article-title>. <source>Sep. Sci. Technol.</source> <volume>51</volume> (<issue>13</issue>), <fpage>2115</fpage>&#x2013;<lpage>2121</lpage>. <pub-id pub-id-type="doi">10.1080/01496395.2016.1202976</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fauquex</surname>
<given-names>P. F.</given-names>
</name>
<name>
<surname>Flaschel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Renken</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>H. P.</given-names>
</name>
<name>
<surname>Friedli</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>1983</year>). <article-title>
<sup>24</sup>Na and <sup>99m</sup>Tc tracers applied to the characterization of liquid&#x2013;solid fluidized bed and hydraulic transport reactors</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>34</volume> (<issue>10</issue>), <fpage>1465</fpage>&#x2013;<lpage>1468</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708x(83)90048-0</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="book">
<collab>Framatome</collab> (<year>2019a</year>). <source>Framatome GmbH / PS-G-0708-ENG-201910</source>. <publisher-loc>Courbevoie, France</publisher-loc>: <publisher-name>Framatome</publisher-name>. </citation>
</ref>
<ref id="B66">
<citation citation-type="book">
<collab>Framatome</collab> (<year>2019b</year>). <source>Framatome GmbH / PS-G-0733-ENG-2019</source>. <publisher-loc>Courbevoie, France</publisher-loc>: <publisher-name>Framatome</publisher-name>. </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gagnon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>B&#xe9;nard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ruth</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Schaffer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J. S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Cyclotron production of <sup>99m</sup>Tc: Experimental measurement of the <sup>100</sup>Mo(p, x)<sup>99</sup>Mo, <sup>99m</sup>Tc and <sup>99g</sup>Tc excitation functions from 8 to 18 MeV</article-title>. <source>Nucl. Med. Biol.</source> <volume>38</volume> (<issue>6</issue>), <fpage>907</fpage>&#x2013;<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2011.02.010</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Preparation and evaluation of <sup>99m</sup>Tc-labeled HYNIC-palbociclib analogs for cyclin-dependent kinase 4/6-positive tumor imaging</article-title>. <source>Eur. J. Med. Chem.</source> <volume>188</volume>, <fpage>112032</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.112032</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gedeonov</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Nosov</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>NOBIUM-93-M production with the help of the reaction</article-title>. <source>Isotopenpraxis Isotopes Environ. Health Stud.</source> <volume>25</volume> (<issue>7</issue>), <fpage>294</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1080/10256018908624135</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Gerlit</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1956</year>). &#x201c;<article-title>Some chemical properties of technetium</article-title>,&#x201d; in <conf-name>Presented in part at Conference Peaceful Uses of Atomic Energy, Geneva</conf-name>. </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grummitt</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wilkinson</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1946</year>). <article-title>Fission Products of <sup>235</sup>U</article-title>. <source>Nature</source> <volume>158</volume> (<issue>4005</issue>), <fpage>163</fpage>. <pub-id pub-id-type="doi">10.1038/158163a0</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu&#xe9;rin</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rodrigue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rousseau</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Dumulon-Perreault</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Lecomte</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Cyclotron production of 99mTc: An approach to the medical isotope crisis.</article-title> <source>J. Nucl. Med.</source> <volume>51</volume> (<issue>4</issue>), <fpage>13N</fpage>&#x2013;<lpage>16N</lpage>. </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guillaume</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brihaye</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Generators for short-lived gamma and positron emitting radionuclides: Current status and prospects</article-title>. <source>Int. J. Radiat. Appl. Instrum. Part B. Nucl. Med. Biol.</source> <volume>13</volume> (<issue>2</issue>), <fpage>89</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2897(86)90223-0</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gumiela</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Cyclotron production of <sup>99m</sup>Tc: Comparison of known separation technologies for isolation of <sup>99m</sup>Tc from molybdenum targets</article-title>. <source>Nucl. Med. Biol.</source> <volume>58</volume>, <fpage>33</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2017.11.001</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gyves</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Miguel</surname>
<given-names>E. R.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Metal ion separations by supported liquid membranes</article-title>. <source>Ind. Eng. Chem. Res.</source> <volume>38</volume> (<issue>6</issue>), <fpage>2182</fpage>&#x2013;<lpage>2202</lpage>. <pub-id pub-id-type="doi">10.1021/ie980374p</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hallaba</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>El-Asrag</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>1975</year>). <article-title>Kurze originalmitteilungen on the sublimation of <sup>99m</sup>Te from irradiated molybdenum trioxide</article-title>. <source>Isotopenpraxis Isotopes Environ. Health Stud.</source> <volume>11</volume> (<issue>8</issue>), <fpage>290</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1080/10256017508543805</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanemaayer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Benard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>K. R .</given-names>
</name>
<name>
<surname>Klug</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kovacs</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leon</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Solid targets for <sup>99m</sup>Tc production on medical cyclotrons</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>299</volume> (<issue>2</issue>), <fpage>1007</fpage>&#x2013;<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-013-2626-4</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haroon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nichita</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>PHWR Reactivity Device Incremental Macroscopic Cross Sections and Reactivities for a Molybdenum-Producing Bundle and a Standard Bundle</article-title>. <source>Nucl. Technol.</source> <volume>208</volume> (<issue>2</issue>), <fpage>246</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1080/00295450.2021.1929768</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>NorthStar: The new producer and distributor of Mo-99</article-title>,&#x201d; in <conf-name>Presented at the 2019 NNSA Mo-99 Stakeholders Meeting</conf-name>, <conf-loc>Chicago, IL, USA</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://mo99.ne.anl.gov/2019stakeholders/pdfs/2.3_Harvey.pdf">https://mo99.ne.anl.gov/2019stakeholders/pdfs/2.3_Harvey.pdf</ext-link>.</comment> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Prelas</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Molybdenum-99 production pathways and the sorbents for <sup>99</sup>Mo/<sup>99m</sup>Tc generator systems using (n, &#x3b3;) <sup>99</sup>Mo: A review</article-title>. <source>SN Appl. Sci.</source> <volume>2</volume>, <fpage>1782</fpage>. <pub-id pub-id-type="doi">10.1007/s42452-020-03524-1</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Hermanne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>T&#xe1;rk&#xe1;nyi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Tak&#xe1;cs</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). &#x201c;<article-title>Production of medically relevant radionuclides with medium energy deuterons</article-title>,&#x201d; in <conf-name>Presented in part at International Conference on Nuclear Data for Science and Technology</conf-name>. <pub-id pub-id-type="doi">10.1051/ndata:07153</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hetherington</surname>
<given-names>E. L. R.</given-names>
</name>
<name>
<surname>Boyd</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>1999</year>). &#x201c;<article-title>Production technologies for molybdenum-99 and technetium-99m</article-title>,&#x201d; in <source>IAEA-TECDOC-1065</source> (<publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>), <fpage>19</fpage>&#x2013;<lpage>22</lpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/te_1065_prn.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/te_1065_prn.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidalgo</surname>
<given-names>J. U.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Wooten</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>1967</year>). <article-title>Prediction of Technetium-99m Yield from Molybdenum-99 Generators</article-title>. <source>J. Nucl. Med.</source> <volume>8</volume> (<issue>6</issue>), <fpage>426</fpage>&#x2013;<lpage>429</lpage>. </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Celler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grimes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>B&#xe9;nard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ruth</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Theoretical dosimetry estimations for radioisotopes produced by proton-induced reactions on natural and enriched molybdenum targets</article-title>. <source>Phys. Med. Biol.</source> <volume>57</volume> (<issue>6</issue>), <fpage>1499</fpage>&#x2013;<lpage>1515</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/57/6/1499</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tanguay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Schaffer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>B&#xe9;nard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ruth</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Molybdenum target specifications for cyclotron production of <sup>99m</sup>Tc based on patient dose estimates</article-title>. <source>Phys. Med. Biol.</source> <volume>61</volume> (<issue>2</issue>), <fpage>542</fpage>&#x2013;<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1088/0031-9155/61/2/542</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Airey</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Duran</surname>
<given-names>E. B.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>Sombrito</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Using radiotracer techniques for coastal hydrodynamic model evaluation</article-title>. <source>J. Environ. Radioact.</source> <volume>76</volume> (<issue>1-2</issue>), <fpage>195</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/j.jenvrad.2004.03.026</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Hyde</surname>
<given-names>E. K.</given-names>
</name>
</person-group> (<year>1964</year>). <source>The Nuclear Properties of the Heavy Elements: Fission Phenomena. vol 3</source>. <publisher-loc>New Jersey</publisher-loc>: <publisher-name>Prentice-Hall International Series in Chemistry, Prentice-Hall, Englewood Cliffs</publisher-name>. </citation>
</ref>
<ref id="B88">
<citation citation-type="book">
<collab>IAEA</collab> (<year>1995</year>). <source>Alternative technologies for <sup>99m</sup>Tc generators: Final report of a co-ordinated research programme 1990-1994. IAEA TECDOC-582</source>. <publisher-loc>Vienna</publisher-loc>: <publisher-name>Austria International Atomic Energy Agency</publisher-name>. <comment>Avaialble at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/publications/PDF/te_852_prn.pdf">https://www-pub.iaea.org/MTCD/publications/PDF/te_852_prn.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B89">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2017</year>). <source>Cyclotron Based Production of Technetium-99m: IAEA Radioisotopes and Radiopharmaceuticals Reports No. 2</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/P1743_web.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/P1743_web.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B90">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2015</year>). <source>Feasibility of producing molybdenum-99 on a small scale using fission of low enriched uranium or neutron activation of natural molybdenum. Technical reports series, in Technical Report Series No. 478</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/trs478web-32777845.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/trs478web-32777845.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B91">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2008</year>). <source>Handbook of Nuclear Data for Safeguards: Database Extensions, International Nuclear Data Committee</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/sgnucdat/safeg2008.pdf">https://www-nds.iaea.org/sgnucdat/safeg2008.pdf</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www-nds.iaea.org/sgnucdat/c1.htm#ref">https://www-nds.iaea.org/sgnucdat/c1.htm&#x23;ref</ext-link>
</comment>. </citation>
</ref>
<ref id="B92">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2011</year>). <source>IAEA Helps to Close Radioisotope Production Gap</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.iaea.org/newscenter/news/iaea-helps-close-radioisotope-production-gap">https://www.iaea.org/newscenter/news/iaea-helps-close-radioisotope-production-gap</ext-link>
</comment>. </citation>
</ref>
<ref id="B93">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2002</year>). <source>IAEA Safeguards Glossary (2001 Edition). International Nuclear Verification Series No. 3</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B94">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2005</year>). <source>Management of High Enriched Uranium for Peaceful Purposes: Status and Trends. IAEA-TECDOC-1452</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B95">
<citation citation-type="book">
<collab>IAEA</collab> (<year>1998</year>). <source>Management of radioactive waste from <sup>99</sup>Mo production. IAEA-TECDOC-1051</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B96">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2013a</year>). <source>Non-HEU production technologies for Molybdenum-99 and Technetium-99m. IAEA Nuclear Energy Series No. NF-T-5.4</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1589_web.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1589_web.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B97">
<citation citation-type="book">
<collab>IAEA</collab> (<year>1999</year>). <source>Production Technologies for Molybdenum-99 and Technetium-99m</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B98">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2018</year>). <source>Quality Control in the Production of Radiopharmaceuticals. IAEA TECDOC SERIES: IAEA-TECDOC-1856</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Aganecy</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/TE-1856web.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/TE-1856web.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B99">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2013b</year>). <source>Radiotracer generators for industrial applications: IAEA Radiation Technology Series No. 5</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1579_web.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1579_web.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B100">
<citation citation-type="book">
<collab>IAEA</collab> (<year>2009</year>). <source>Technetium-99m Radiopharmaceuticals: Status and Trends</source>. <publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>International Atomic Energy Agency</publisher-name>. <comment>IAEA Radioisotopes and Radiopharmaceuticals Series No. 1. Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1405_web.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/Pub1405_web.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B101">
<citation citation-type="web">
<collab>IBA</collab> (<year>2022</year>). <article-title>Ready to accelerate into the future? CYCLONE<sup>&#xae;</sup>IKON by IBA: Louvain-la-Neuve, Belgium</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.iba-radiopharmasolutions.com/sites/default/files/2021-08/Cyclone%20IKON%20Final%20R01%20_LD.pdf">https://www.iba-radiopharmasolutions.com/sites/default/files/2021-08/Cyclone%20IKON%20Final%20R01%20_LD.pdf</ext-link> (Accessed 6 8, 2022)</comment>. </citation>
</ref>
<ref id="B102">
<citation citation-type="book">
<collab>IBA</collab> (<year>2018</year>). <source>RHODOTRON&#xae; TT300-HE Datasheet</source>. <comment>Personal communication</comment>. </citation>
</ref>
<ref id="B103">
<citation citation-type="book">
<collab>ICRP</collab> (<year>2015</year>). <source>Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances</source>. <publisher-loc>Ontario, Canada</publisher-loc>: <publisher-name>ICRP publication 128</publisher-name>. </citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ejaz</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Solvent extraction of technetium(VII) by 4-(5-nonyl)pyridine and its separation from uranium and some fission products</article-title>. <source>J. Radioanal. Chem.</source> <volume>23</volume> (<issue>1-2</issue>), <fpage>51</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1007/BF02514344</pub-id> </citation>
</ref>
<ref id="B105">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Junior</surname>
<given-names>J. A. O.</given-names>
</name>
<name>
<surname>Lima</surname>
<given-names>A. L. V. P.</given-names>
</name>
<name>
<surname>Da Silva</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Da Silva</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Nieto</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>De Velosa</surname>
<given-names>A. C.</given-names>
</name>
</person-group> (<year>1998</year>). &#x201c;<article-title>Preparation of a gel of zirconium molybdate for use in the generators of <sup>99</sup>Mo-<sup>99m</sup>Tc prepared with <sup>99</sup>Mo produced by the <sup>98</sup>Mo(n,&#x3b3;)<sup>99</sup>Mo reaction</article-title>,&#x201d; in <conf-name>Presented in part at International Meeting on Reduced Enrichment for Research and Test Reactors</conf-name>, <conf-loc>Sao Paulo, Brazil</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://inis.iaea.org/collection/NCLCollectionStore/_Public/35/040/35040284.pdf">https://inis.iaea.org/collection/NCLCollectionStore/_Public/35/040/35040284.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kantzas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zarabi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bhargava</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Application of gamma camera imaging and SPECT systems in chemical processes</article-title>. <source>Chem. Eng. J.</source> <volume>77</volume> (<issue>1-2</issue>), <fpage>19</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/S1385-8947(99)00148-5</pub-id> </citation>
</ref>
<ref id="B107">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Karcz</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>NNSA&#x2019;s Mo-99 program: Accelerating reliable, non-HEU Mo-99 production capabilities in the United States</article-title>,&#x201d; in <conf-name>Presented at the 2019 NNSA Mo-99 Stakeholders Meeting</conf-name>, <conf-loc>Chicago, IL, USA</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://mo99.ne.anl.gov/2019stakeholders/pdfs/1.1_Karcz.pdf">https://mo99.ne.anl.gov/2019stakeholders/pdfs/1.1_Karcz.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kharisov</surname>
<given-names>B. I.</given-names>
</name>
<name>
<surname>Kharissova</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Berdonosov</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Radioactive Nanoparticles and their Main Applications: Recent Advances</article-title>. <source>Recent Pat. Nanotechnol.</source> <volume>8</volume> (<issue>2</issue>), <fpage>79</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.2174/187221050802140618143846</pub-id> </citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knapp</surname>
<given-names>F. F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Baum</surname>
<given-names>R. P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Radionuclide generators &#x2013; A new renaissance in the development of technologies to provide diagnostic and therapeutic radioisotopes for clinical applications</article-title>. <source>Curr. Radiopharm.</source> <volume>5</volume> (<issue>3</issue>), <fpage>175</fpage>&#x2013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.2174/1874471011205030175</pub-id> </citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knapp</surname>
<given-names>F. F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Mirzadeh</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>The continuing important role of radionuclide generator systems for nuclear medicine</article-title>. <source>Eur. J. Nucl. Med.</source> <volume>21</volume> (<issue>10</issue>), <fpage>1151</fpage>&#x2013;<lpage>1165</lpage>. <pub-id pub-id-type="doi">10.1007/BF00181073</pub-id> </citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Konheiser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seidl</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brachem</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Study of the uncertainties due to position change of the PWR aeroball measurement system</article-title>. <source>J. Nucl. Sci. Technol.</source> <volume>53</volume> (<issue>11</issue>), <fpage>1715</fpage>&#x2013;<lpage>1722</lpage>. <pub-id pub-id-type="doi">10.1080/00223131.2016.1151840</pub-id> </citation>
</ref>
<ref id="B204">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishichayan</surname>
</name>
<name>
<surname>Bhike</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Finch</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Tonchev</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Tornow</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Photofission cross-section ratio measurement of <sub>235</sub>U/<sub>238</sub>U using monoenergetic photons in the energy range of 9.0&#x2013;16.6 MeV</article-title>. <source>Nucl. Instrum. Methods. Phys. Res. A</source> <volume>854</volume>, <fpage>40</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.nima.2017.02.043</pub-id> </citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lagunas-Solar</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Kiefer</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Carvacho</surname>
<given-names>O. F.</given-names>
</name>
<name>
<surname>Lagunas</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>Y. P.</given-names>
</name>
</person-group> (<year>1991</year>). <article-title>Cyclotron production of NCA <sup>99m</sup>Tc and <sup>99</sup>Mo: An alternative non-reactor supply source of instant <sup>99m</sup>Tc and <sup>99</sup>Mo&#x2192;<sup>99m</sup>Tc generators</article-title>. <source>Int. J. Radiat. Appl. Instrum. Part A. Appl. Radiat. Isotopes</source> <volume>42</volume> (<issue>7</issue>), <fpage>643</fpage>&#x2013;<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(91)90035-Y</pub-id> </citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lamson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hotte</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Ice</surname>
<given-names>R. D.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>Practical generator kinetics</article-title>. <source>J. Nucl. Med. Technol.</source> <volume>4</volume>, <fpage>21</fpage>&#x2013;<lpage>26</lpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://tech.snmjournals.org/content/jnmt/4/1/21.full.pdf">https://tech.snmjournals.org/content/jnmt/4/1/21.full.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B114">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavi</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1978</year>). <article-title>The study of conditions for the preparation and application of <sup>99</sup>Mo/<sup>99m</sup>Tc generators starting from irradiated molybdenum metal</article-title>. <source>J. Radioanal. Chem.</source> <volume>42</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1007/BF02520623</pub-id> </citation>
</ref>
<ref id="B115">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebeda</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>van Lier</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>&#x160;tursa</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>R&#xe1;li&#x161;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zyuzin</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Assessment of radionuclidic impurities in cyclotron produced 99mTc</article-title>. <source>Nucl. Med. Biol.</source> <volume>39</volume> (<issue>8</issue>), <fpage>1286</fpage>&#x2013;<lpage>1291</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2012.06.009</pub-id> </citation>
</ref>
<ref id="B116">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lebowitz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Radionuclide Generator Systems</article-title>. <source>Semin. Nucl. Med.</source> <volume>4</volume> (<issue>3</issue>), <fpage>257</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/S0001-2998(74)80013-9</pub-id> </citation>
</ref>
<ref id="B117">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leggett</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Giussani</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>A bio kinetic model for systemic technetium in adult humans</article-title>. <source>J. Radiol. Prot.</source> <volume>35</volume> (<issue>2</issue>), <fpage>297</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1088/0952-4746/35/2/297</pub-id> </citation>
</ref>
<ref id="B118">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Magill</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dreher</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Soti</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2022</year>). <source>Karlsruher Nuklidkarte: Chart of the nuclides 11th Edition</source>. <publisher-loc>Karlsruher, Germany</publisher-loc>: <publisher-name>Nucleonica GmbH</publisher-name>. </citation>
</ref>
<ref id="B119">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mang&#x2019;era</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ogbomo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zriba</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fitzpatrick</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pellerin</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Processing and evaluation of linear accelerator-produced <sup>99</sup>Mo/<sup>99m</sup>Tc in Canada</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>305</volume>, <fpage>79</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-015-3997-5</pub-id> </citation>
</ref>
<ref id="B120">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Maoliang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1997</year>). &#x201c;<article-title>Production of gel-type Tc-99m generator for nuclear medicine</article-title>,&#x201d; in <conf-name>Presented in part of Lecture of IAEA Expert Mission for Brazil</conf-name>, <conf-loc>Sao Paulo, Brazil</conf-loc>. </citation>
</ref>
<ref id="B121">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martini</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Boschi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cicoria</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zagni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Corazza</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uccelli</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals</article-title>. <source>Appl. Radiat. Isot.</source> <volume>139</volume>, <fpage>325</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2018.05.033</pub-id> </citation>
</ref>
<ref id="B122">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matthews</surname>
<given-names>C. M. E.</given-names>
</name>
<name>
<surname>Mallard</surname>
<given-names>J. R.</given-names>
</name>
</person-group> (<year>1965</year>). <article-title>Distribution of <sup>99m</sup>Tc and tumor/brain concentrations in rats</article-title>. <source>J. Nucl. Med.</source> <volume>6</volume> (<issue>6</issue>), <fpage>404</fpage>&#x2013;<lpage>408</lpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://jnm.snmjournals.org/content/6/6/404.full.pdf+html">http://jnm.snmjournals.org/content/6/6/404.full.pdf&#x2b;html</ext-link>
</comment>. </citation>
</ref>
<ref id="B123">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mel&#xe9;ndez-Alafort</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ferro-Floresm</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>De Nardo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paiusco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Negri</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced <sup>99m</sup> Tc</article-title>. <source>Med. Phys.</source> <volume>46</volume> (<issue>3</issue>), <fpage>1437</fpage>&#x2013;<lpage>1446</lpage>. <pub-id pub-id-type="doi">10.1002/mp.13393</pub-id> </citation>
</ref>
<ref id="B124">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Metello</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>99mTc-Technetium Shortage: Old Problems Asking for New Solutions</article-title>. <source>J. Med. Imaging Radiat. Sci.</source> <volume>46</volume> (<issue>3</issue>), <fpage>256</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmir.2015.07.003</pub-id> </citation>
</ref>
<ref id="B125">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikaeili</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Erfani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shafiei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kobarfard</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Abdi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sabzevari</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Development of a <sup>99m</sup>Tc-Labeled CXCR4 Antagonist Derivative as a New Tumor Radiotracer</article-title>. <source>Cancer biother. Radiopharm.</source> <volume>33</volume> (<issue>1</issue>), <fpage>17</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1089/cbr.2017.2226</pub-id> </citation>
</ref>
<ref id="B126">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1995</year>). &#x201c;<article-title>Procedure for production of <sup>99m</sup>Tc sublimation generators based on eutectic SiC&#x2013;MoO<sub>3</sub>&#x2013;V<sub>2</sub>O<sub>5</sub>
</article-title>,&#x201d; in <source>Alternative technologies for <sup>99m</sup>Tc generators</source> (<publisher-loc>Vienna</publisher-loc>: <publisher-name>Internatoinal Atomic Energy Agency</publisher-name>), <fpage>44</fpage>&#x2013;<lpage>46</lpage>. </citation>
</ref>
<ref id="B127">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minh</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Lengyel</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1989</year>). <article-title>On the separation of molybdenum and technetium crown ether as extraction agent</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>135</volume> (<issue>6</issue>), <fpage>403</fpage>&#x2013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1007/BF02164767</pub-id> </citation>
</ref>
<ref id="B128">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chandak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lad</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baruaet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Clinical Efficacy of Sodium [<sup>99m</sup>Tc] Pertechnetate from Low Specific Activity <sup>99</sup>Mo/<sup>99m</sup>Tc Autosolex Generator in Hospital Radiopharmacy Centre</article-title>. <source>Nucl. Med. Rev. Cent. East. Eur.</source> <volume>23</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.5603/NMR.a2020.0001</pub-id> </citation>
</ref>
<ref id="B129">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molinski</surname>
<given-names>V. J.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>A review of <sup>99m</sup>Tc generator technology</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>33</volume> (<issue>10</issue>), <fpage>811</fpage>&#x2013;<lpage>819</lpage>. <pub-id pub-id-type="doi">10.1016/0020-708X(82)90122-3</pub-id> </citation>
</ref>
<ref id="B130">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monroy-Guzman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Diaz-Archundia</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Effect of Zr:Mo ratio on <sup>99m</sup>Tc generator performance based on zirconium molybdate gels</article-title>. <source>Appl. Radiat. Isot.</source> <volume>59</volume> (<issue>1</issue>), <fpage>27</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/s0969-8043(03)00150-7</pub-id> </citation>
</ref>
<ref id="B131">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monroy-Guzman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>D&#xed;az-Archundia</surname>
<given-names>L. V.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Cort&#xe9;s</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>
<sup>99</sup>Mo/<sup>99m</sup>Tc generators performances prepared from zirconium molybdate gels</article-title>. <source>J. Braz. Chem. Soc.</source> <volume>19</volume>, <fpage>380</fpage>&#x2013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1590/S0103-50532008000300003</pub-id> </citation>
</ref>
<ref id="B132">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monroy-Guzman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>O. C.</given-names>
</name>
<name>
<surname>Vel&#xe1;zquez</surname>
<given-names>H. D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Titanium molybdate gels as matrix of <sup>99</sup>Mo/<sup>99m</sup>Tc generators</article-title>. <source>J. Nucl. Radiochem. Sci.</source> <volume>8</volume> (<issue>1</issue>), <fpage>11</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.14494/jnrs2000.8.11</pub-id> </citation>
</ref>
<ref id="B133">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>P. W.</given-names>
</name>
<name>
<surname>Shying</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Sodeau</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>J. V.</given-names>
</name>
<name>
<surname>Maddalena</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Farrington</surname>
<given-names>K. H.</given-names>
</name>
<etal/>
</person-group> (<year>1987</year>). <article-title>Zirconium molybdate gel as a generator for technetium-99m&#x2014;II. High activity generators</article-title>. <source>Int. J. Radiat. Appl. Instrum. Part A. Appl. Radiat. Isotopes</source> <volume>38</volume> (<issue>1</issue>), <fpage>25</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/0883-2889(87)90231-0</pub-id> </citation>
</ref>
<ref id="B134">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morley</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Dodd</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gagnon</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hanemaayer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McQuarrie</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>An automated module for the separation and purification of cyclotron-produced <sup>99m</sup>TcO<sub>4</sub>
<sup>&#x2212;</sup>
</article-title>. <source>Nucl. Med. Biol.</source> <volume>39</volume> (<issue>4</issue>), <fpage>551</fpage>&#x2013;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2011.10.006</pub-id> </citation>
</ref>
<ref id="B135">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mostafa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Saber</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>El-Sadek</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Nassar</surname>
<given-names>M. Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Preparation and performance of <sup>99</sup>Mo/<sup>99m</sup>Tc chromatographic column generator based on zirconium molybdosilicate</article-title>. <source>Radiochim. Acta</source> <volume>104</volume> (<issue>4</issue>), <fpage>257</fpage>&#x2013;<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1515/ract-2015-2488</pub-id> </citation>
</ref>
<ref id="B136">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hatsukawa</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Production of <sup>99</sup>Mo for Nuclear Medicine by <sup>100</sup>Mo(n, 2n)<sup>99</sup>Mo</article-title>. <source>J. Phys. Soc. Jpn.</source> <volume>78</volume> (<issue>3</issue>), <fpage>033201</fpage>. <pub-id pub-id-type="doi">10.1143/JPSJ.78.033201</pub-id> </citation>
</ref>
<ref id="B137">
<citation citation-type="book">
<collab>NAP</collab> (<year>2009</year>). <source>Medical Isotope Production without Highly Enriched Uranium</source>. <publisher-loc>Washington D.C., U.S.A.</publisher-loc>: <publisher-name>National Academies of Sciences, Engineering, and Medicine</publisher-name>. </citation>
</ref>
<ref id="B138">
<citation citation-type="book">
<collab>NAP</collab> (<year>2016</year>). <source>Molybdenum-99 for Medical Imaging</source>. <publisher-loc>Washington D.C., U.S.A.</publisher-loc>: <publisher-name>National Academies of Sciences, Engineering, and Medicine</publisher-name>. </citation>
</ref>
<ref id="B139">
<citation citation-type="book">
<collab>NAP</collab> (<year>2018</year>). <source>Opportunities and approaches for supplying molybdenum-99 and associated medical isotopes to global markets: proceedings of a symposium</source>. <publisher-loc>Washington D.C., U.S.A.</publisher-loc>: <publisher-name>National Academies of Sciences, Engineering, and Medicine</publisher-name>. </citation>
</ref>
<ref id="B140">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narasimhan</surname>
<given-names>D. V. S.</given-names>
</name>
<name>
<surname>Vanaja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>1984</year>). <article-title>A new method for <sup>99m</sup>Tc generator preparation</article-title>. <source>J. Radioanalytical Nucl. Chem. Lett.</source> <volume>85</volume> (<issue>6</issue>), <fpage>345</fpage>&#x2013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1007/BF02164058</pub-id> </citation>
</ref>
<ref id="B141">
<citation citation-type="thesis">
<person-group person-group-type="author">
<name>
<surname>Nawar</surname>
<given-names>M. F.</given-names>
</name>
</person-group> (<year>2021</year>). <source>Development of a New Generation of <sup>99m</sup>Tc radionuclide generators Based on Low Specific Activity <sup>99</sup>Mo</source>. <comment>Ph.D. thesis</comment> (<publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>University of Bern</publisher-name>).</citation>
</ref>
<ref id="B142">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Nawar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>T&#xfc;rler</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). &#x201c;<article-title>Development of New Generation of <sup>99</sup>Mo/<sup>99m</sup>Tc Radioisotope Generators to Meet the Continuing Clinical Demands</article-title>,&#x201d; in <conf-name>Presented in part at 2nd International Conference on Radioanalytical and Nuclear Chemistry (RANC 2019)</conf-name>, <conf-loc>Budapest, Hungary</conf-loc>. </citation>
</ref>
<ref id="B143">
<citation citation-type="book">
<collab>NEA</collab> (<year>2017</year>). <source>Medical isotope supply review: <sup>99</sup>Mo/<sup>99m</sup>Tc market demand and production capacity projection 2017-2022. Nuclear Development NEA/SEN/HLGMR</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>Nuclear Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B144">
<citation citation-type="book">
<collab>NEA</collab> (<year>2019</year>). <source>The Supply of Medical Radioisotopes: 2019 Medical Isotope Demand and Capacity projection for the 2019-2024 period. Nuclear Development NEA/SEN/HLGMR</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>Nuclear Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.oecd-nea.org/med-radio/docs/sen-hlgmr2019-1.pdf">https://www.oecd-nea.org/med-radio/docs/sen-hlgmr2019-1.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B145">
<citation citation-type="book">
<collab>NEA</collab> (<year>2010</year>). <source>The supply of medical radioisotopes: review of potential molybdenum-99/technetium-99m production technologies. Nuclear Development NEA/SEN/HLGMR</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>Nuclear Energy Agency</publisher-name>. </citation>
</ref>
<ref id="B146">
<citation citation-type="book">
<collab>NEA</collab> (<year>2011</year>). <source>The Supply of Medical Radioisotopes: the path to reliability, NEA No. 6985. Nuclear Development NEA/SEN/HLGMR</source>. <publisher-loc>Paris, France</publisher-loc>: <publisher-name>Nuclear Energy Agency</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.oecd-nea.org/med-radio/reports/med-radio-reliability.pdf">https://www.oecd-nea.org/med-radio/reports/med-radio-reliability.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B147">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noronha</surname>
<given-names>O. P. D.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Solvent extraction technology of <sup>99</sup>Mo&#x2013;<sup>99m</sup>Tc generator system. An Indian experience: Process design considerations</article-title>. <source>Isotopenpraxis Isotopes Environ. Health Stud.</source> <volume>22</volume> (<issue>2</issue>), <fpage>53</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1080/10256018608623597</pub-id> </citation>
</ref>
<ref id="B148">
<citation citation-type="web">
<collab>Northstar</collab> (<year>2020</year>). <article-title>Licensing Guidance for Medical Use Licensees, Medical Use Permittees, and Commercial Nuclear Pharmacies</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.nrc.gov/docs/ML2000/ML20009C049.pdf">https://www.nrc.gov/docs/ML2000/ML20009C049.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B149">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osso</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Catanoso</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Barrio</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brambilla</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Teodoro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dias</surname>
<given-names>C. R. B. R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Technetium-99m: New Production and Processing Strategies to Provide Adequate Levels for SPECT Imaging</article-title>. <source>Curr. Radiopharm.</source> <volume>5</volume> (<issue>3</issue>), <fpage>178</fpage>&#x2013;<lpage>186</lpage>. <pub-id pub-id-type="doi">10.2174/1874471011205030178</pub-id> </citation>
</ref>
<ref id="B150">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Osso</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>F. F.</given-names>
</name>
</person-group> (<year>2011</year>). <source>Sampson&#x2019;s Textbook of Radiopharmacy</source>. <edition>4th edition</edition>. <publisher-loc>London, U.K.</publisher-loc>: <publisher-name>Pharmaceutical Press</publisher-name>. </citation>
</ref>
<ref id="B151">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Owen</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Manchester</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Ballinger</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Buscombe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Denton</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). &#x201c;<article-title>Options for U.K. Technetium-99m production using accelerators</article-title>,&#x201d; in <conf-name>Presented in part at 5th International Particle Accelerator Conference</conf-name>, <conf-loc>Dresden, Germany</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://accelconf.web.cern.ch/IPAC2014/papers/thoab02.pdf">https://accelconf.web.cern.ch/IPAC2014/papers/thoab02.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B152">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parihar</surname>
<given-names>A, S.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bhansali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karthikeyan</surname>
<given-names>M. B. B. S.</given-names>
</name>
<name>
<surname>Vadi</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Hepato-cardiac juxtaposition secondary to right hemi-diaphragmatic eventration on <sup>99m</sup>Tc-Sestamibi myocardial perfusion scintigraphy</article-title>. <source>J. Nucl. Cardiol.</source> <volume>28</volume> (<issue>2</issue>), <fpage>750</fpage>&#x2013;<lpage>751</lpage>. <pub-id pub-id-type="doi">10.1007/s12350-020-02033-3</pub-id> </citation>
</ref>
<ref id="B153">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paterson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Druce</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Killen</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Six problems with the 6-day Curie and a solution</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>305</volume> (<issue>1</issue>), <fpage>13</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-015-4050-4</pub-id> </citation>
</ref>
<ref id="B154">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavlovi&#x107;</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Pavlovi&#x107;</surname>
<given-names>M. R. P.</given-names>
</name>
<name>
<surname>Bartl</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Stevanovi&#x107;</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Radak</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Optimization of injected radiotracer volume for flow rate measurement in closed conduits</article-title>. <source>Hem. Ind.</source> <volume>74</volume> (<issue>5</issue>), <fpage>305</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.2298/HEMIND20050325P</pub-id> </citation>
</ref>
<ref id="B155">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perrier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Segr&#xe8;</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>1937</year>). <article-title>Some Chemical Properties of Element 43</article-title>. <source>J. Chem. Phys.</source> <volume>5</volume> (<issue>9</issue>), <fpage>712</fpage>&#x2013;<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1063/1.1750105</pub-id> </citation>
</ref>
<ref id="B156">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pillai</surname>
<given-names>M. R. A.</given-names>
</name>
<name>
<surname>Dash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Knapp</surname>
<given-names>F. F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Sustained Availability of <sup>99m</sup>Tc: Possible Paths Forward</article-title>. <source>J. Nucl. Med.</source> <volume>54</volume> (<issue>2</issue>), <fpage>313</fpage>&#x2013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.112.110338</pub-id> </citation>
</ref>
<ref id="B157">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimlott</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Sutherland</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Molecular tracers for the PET and SPECT imaging of disease</article-title>. <source>Chem. Soc. Rev.</source> <volume>40</volume> (<issue>1</issue>), <fpage>149</fpage>&#x2013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1039/b922628c</pub-id> </citation>
</ref>
<ref id="B158">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaim</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The present and future of medical radionuclide production</article-title>. <source>Radiochim. Acta</source> <volume>100</volume> (<issue>8-9</issue>), <fpage>635</fpage>&#x2013;<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1524/ract.2012.1966</pub-id> </citation>
</ref>
<ref id="B159">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qaim</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Theranostic radionuclides: Recent advances in production methodologies</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>322</volume> (<issue>3</issue>), <fpage>1257</fpage>&#x2013;<lpage>1266</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-019-06797-y</pub-id> </citation>
</ref>
<ref id="B160">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1965</year>). <source>The Technetium-99m Generator</source>. <publisher-loc>Upton, NY, USA</publisher-loc>: <publisher-name>BNL-9601 Brookhaven National Lab</publisher-name>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www.osti.gov/servlets/purl/4589063">https://www.osti.gov/servlets/purl/4589063</ext-link>
</comment>. </citation>
</ref>
<ref id="B161">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>S. C.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>Technetium-99m: An historical perspective</article-title>. <source>Int. J. Appl. Radiat. Isot.</source> <volume>33</volume> (<issue>10</issue>), <fpage>793</fpage>&#x2013;<lpage>799</lpage>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://inis.iaea.org/search/search.aspx?orig_q=RN:14755407">https://inis.iaea.org/search/search.aspx?orig_q&#x3d;RN:14755407</ext-link>
</comment>. </citation>
</ref>
<ref id="B162">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Mebrahtu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lapi</surname>
<given-names>S. E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cyclotron production of <sup>99m</sup>Tc using <sup>100</sup>Mo<sub>2</sub>C targets</article-title>. <source>Nucl. Med. Biol.</source> <volume>40</volume> (<issue>7</issue>), <fpage>939</fpage>&#x2013;<lpage>945</lpage>. <pub-id pub-id-type="doi">10.1016/j.nucmedbio.2013.06.005</pub-id> </citation>
</ref>
<ref id="B163">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rogers</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Bond</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>E. P.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>New Technetium-99M Generator Technologies Utilizing Polyethylene Glycol-Based Aqueous Biphasic Systems</article-title>. <source>Sep. Sci. Technol.</source> <volume>32</volume> (<issue>1&#x2013;4</issue>), <fpage>867</fpage>&#x2013;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1080/01496399708003234</pub-id> </citation>
</ref>
<ref id="B164">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruth</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Accelerating production of medical isotopes</article-title>. <source>Nature</source> <volume>457</volume> (<issue>7229</issue>), <fpage>536</fpage>&#x2013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1038/457536a</pub-id> </citation>
</ref>
<ref id="B165">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruth</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The medical isotope crisis: How we got here and where we are going</article-title>. <source>J. Nucl. Med. Technol.</source> <volume>42</volume> (<issue>4</issue>), <fpage>245</fpage>&#x2013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.2967/jnmt.114.144642</pub-id> </citation>
</ref>
<ref id="B166">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruth</surname>
<given-names>T. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The Shortage of Technetium-99m and Possible Solutions</article-title>. <source>Annu. Rev. Nucl. Part. Sci.</source> <volume>70</volume>, <fpage>77</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-nucl-032020-021829</pub-id> </citation>
</ref>
<ref id="B167">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryabchikov</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Skuridin</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Nesterov</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Chibisov</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Golovkov</surname>
<given-names>V. M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Obtaining molybdenum-99 in the IRT-T research reactor using resonance neutrons</article-title>. <source>Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. Atoms</source> <volume>213</volume>, <fpage>364</fpage>&#x2013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-583X(03)01592-1</pub-id> </citation>
</ref>
<ref id="B168">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Saha</surname>
<given-names>G. B.</given-names>
</name>
</person-group> (<year>1992</year>). <source>Fundamentals of Nuclear Pharmacy</source>. <edition>3rd edition</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlage</publisher-name>. </citation>
</ref>
<ref id="B169">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakr</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Nawar</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Fasih</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>El-Bayoumy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abd El-Rehim</surname>
<given-names>H. A.</given-names>
</name>
</person-group> (<year>20172017</year>). <article-title>Nano-Technology Contributions towards the Development of High Performance Radioisotope Generators: The Future Promise to Meet the Continuing Clinical Demand</article-title>. <source>Appl. Radiat. Isot.</source> <volume>129</volume>, <fpage>67</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2017.08.012</pub-id> </citation>
</ref>
<ref id="B170">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Sameh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ache</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1989</year>). <source>Production techniques of fission <sup>99</sup>Mo. IAEA-TECDOC-515: Fission Molybdenum for Medical Use</source> in <conf-name>Proceedings of a technical committee meeting, Inertnational Atomic Energy Agency (EAEA)</conf-name>, <conf-loc>Karlsruhe, Germany</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://www-pub.iaea.org/MTCD/Publications/PDF/te_515_prn.pdf">https://www-pub.iaea.org/MTCD/Publications/PDF/te_515_prn.pdf</ext-link>
</comment>.</citation>
</ref>
<ref id="B171">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saraswathy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sarkar</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Arjun</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Nandy</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Ramamoorthy</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>
<sup>99m</sup>Tc gel generators based on zirconium molybdate-<sup>99</sup>Mo: III: Influence of preparatory conditions of zirconium molybdate-<sup>99</sup>Mo gel on generator performance</article-title>. <source>Radiochim. Acta</source> <volume>92</volume> (<issue>4-6</issue>), <fpage>259</fpage>&#x2013;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1524/ract.92.4.259.35585</pub-id> </citation>
</ref>
<ref id="B172">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sastre</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shukla</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Improved techniques in liquid membrane separations: An overview</article-title>. <source>Sep. Purif. Methods</source> <volume>27</volume> (<issue>2</issue>), <fpage>213</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1080/03602549809351641</pub-id> </citation>
</ref>
<ref id="B205">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Schmid</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2011</year>). <source>Nanoparticles: From theory to application. 2nd edition</source>. <publisher-loc>New Jersey</publisher-loc>: <publisher-name>John Wiley &#x0026; Sons</publisher-name>. </citation>
</ref>
<ref id="B173">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebastian</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Arruebo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Santamaria</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Reaction engineering strategies for the production of inorganic nanomaterials</article-title>. <source>Small</source> <volume>10</volume> (<issue>5</issue>), <fpage>835</fpage>&#x2013;<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1002/smll.201301641</pub-id> </citation>
</ref>
<ref id="B174">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekimoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tatenuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tsuguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tadokoro</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Separation and purification of <sup>99m</sup>Tc from <sup>99</sup>Mo produced by electron linear accelerator</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>311</volume> (<issue>2</issue>), <fpage>1361</fpage>&#x2013;<lpage>1366</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-016-4959-2</pub-id> </citation>
</ref>
<ref id="B175">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selivanova</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Lavall&#xe9;e</surname>
<given-names>&#xc9;.</given-names>
</name>
<name>
<surname>Senta</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Caouette</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sader</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>van Lier</surname>
<given-names>E. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Radioisotopic Purity of Sodium Pertechnetate <sup>99m</sup>Tc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications</article-title>. <source>J. Nucl. Med.</source> <volume>56</volume> (<issue>10</issue>), <fpage>1600</fpage>&#x2013;<lpage>1608</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.115.156398</pub-id> </citation>
</ref>
<ref id="B176">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafiq</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Yousif</surname>
<given-names>Z. M.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Characteristics and behavior of a <sup>99</sup>Mo/<sup>99m</sup>Tc generator using irradiated titanium molybdate as column matrix</article-title>. <source>J. Radioanalytical Nucl. Chem. Lett.</source> <volume>199</volume> (<issue>3</issue>), <fpage>173</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1007/BF02162365</pub-id> </citation>
</ref>
<ref id="B177">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skuridin</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Chibisov</surname>
<given-names>E. V.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Development of a small-size extractor for separation of the <sup>99</sup>Mo/<sup>99m</sup>Tc couple</article-title>. <source>Radiochemistry</source> <volume>52</volume> (<issue>1</issue>), <fpage>90</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1134/S1066362210010200</pub-id> </citation>
</ref>
<ref id="B178">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stolarz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kowalska</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Jasi&#x144;ski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Janiak</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Samorajczyk</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Molybdenum targets produced by mechanical reshaping</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>305</volume> (<issue>3</issue>), <fpage>947</fpage>&#x2013;<lpage>952</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-015-3956-1</pub-id> </citation>
</ref>
<ref id="B179">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Syarip</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sutondo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Budisantoso</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Susiantini</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Design and Development of Subcritical Reactor by Using Aqueous Fuel for <sup>99</sup>Mo Production</article-title>. <source>Proc. Pak. Acad. Sci. Pak. Acad. Sci. A Phys. Comput. Sci.</source> <volume>55</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>26</lpage>. </citation>
</ref>
<ref id="B180">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tachimori</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1971</year>). <article-title>Preparation of Tc-99m by direct adsorption from organic solution</article-title>. <source>J. Nucl. Sci. Technol.</source> <volume>8</volume> (<issue>7</issue>), <fpage>357</fpage>&#x2013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1080/18811248.1971.9735346</pub-id> </citation>
</ref>
<ref id="B181">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tak&#xe1;cs</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sz&#x171;cs</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>T&#xe1;rk&#xe1;nyi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hermanne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sonck</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Evaluation of proton induced reactions on <sup>100</sup>Mo: New cross sections for production of <sup>99m</sup>Tc and <sup>99</sup>Mo</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>257</volume> (<issue>1</issue>), <fpage>195</fpage>&#x2013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1023/A:1024790520036</pub-id> </citation>
</ref>
<ref id="B182">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarkanyi</surname>
<given-names>F. T.</given-names>
</name>
<name>
<surname>Ignatyuk</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Hermanne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Capote</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>B. V.</given-names>
</name>
<name>
<surname>Engle</surname>
<given-names>J. W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Recommended nuclear data for medical radioisotope production: Diagnostic gamma emitters</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>319</volume> (<issue>2</issue>), <fpage>487</fpage>&#x2013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1007/s10967-018-6142-4</pub-id> </citation>
</ref>
<ref id="B183">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taskaev</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Taskaeva</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nikolov</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Extraction generator for [<sup>99m</sup>Tc] sodium pertechnetate production</article-title>. <source>Appl. Radiat. Isot.</source> <volume>46</volume> (<issue>1</issue>), <fpage>13</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/0969-8043(94)00098-K</pub-id> </citation>
</ref>
<ref id="B184">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatenuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsuguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Komatsuzaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>A mass-production process of a highly pure medical use <sup>99m</sup>Tc from natural isotopic Mo(n, &#x3b3;)<sup>99</sup>Mo without using uranium</article-title>. <source>Radioisotopes</source> <volume>63</volume> (<issue>11</issue>), <fpage>501</fpage>&#x2013;<lpage>513</lpage>. <pub-id pub-id-type="doi">10.3769/radioisotopes.63.501</pub-id> </citation>
</ref>
<ref id="B185">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Tatenuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tatenuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsuguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sekimoto</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2016b</year>). &#x201c;<article-title>Generator of Highly Concentrated Pure <sup>99m</sup>Tc from Low Specific Activity <sup>99</sup>Mo Produced by Reactor and/or Electron Linear Accelerator</article-title>,&#x201d; in <conf-name>Presented in part at Mo-99 Topical Meeting</conf-name>, <conf-loc>Missouri, U.S.A</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://mo99.ne.anl.gov/2016/pdfs/papers/S9P9_Paper_Tatenuma.pdf">https://mo99.ne.anl.gov/2016/pdfs/papers/S9P9_Paper_Tatenuma.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B186">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Tatenuma</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ueda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kurosawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016a</year>). <source>Method of recovering enriched radioactive technetium and system therefor, U.S. Patent 9236153&#x2013;B2</source>. </citation>
</ref>
<ref id="B187">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thyn</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zitny</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Radiotracer applications for the analysis of complex flow structure in industrial apparatuses</article-title>. <source>Nucl. Instrum. Methods Phys. Res. Sect. B Beam Interact. Mater. Atoms</source> <volume>213</volume>, <fpage>339</fpage>&#x2013;<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/s0168-583x(03)01648-3</pub-id> </citation>
</ref>
<ref id="B188">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Tucker</surname>
<given-names>W. D.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Murrenhoff</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1958</year>). <source>Methods of Preparation of Some Carrier-Free Radioisotopes Involving Sorption on Alumina</source>. <publisher-loc>Upton, NY, USA</publisher-loc>: <publisher-name>BNL-3746, Brookhaven National Lab.</publisher-name> <pub-id pub-id-type="doi">10.2172/4305138</pub-id> </citation>
</ref>
<ref id="B189">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Tur</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2000</year>). &#x201c;<article-title>Linear Electron Accelerator for the Medical Isotopes Production</article-title>,&#x201d; in <conf-name>Proceedings of EPAC 2000</conf-name>. <conf-loc>Vienna: Austria</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://accelconf.web.cern.ch/e00/PAPERS/WEP2B12.pdf">https://accelconf.web.cern.ch/e00/PAPERS/WEP2B12.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B190">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>T&#xfc;rler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vagheian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>L&#xfc;thi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <source>High Power Converter Target Assembly, Related Facility and Method to Produce Bremsstrahlung for Photonuclear Reactions, EP21212627.0</source>. </citation>
</ref>
<ref id="B191">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Urbano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Scimeca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tancredi</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bonanno</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schillaci</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<sup>99m</sup>Tc-sestamibi breast imaging: Current status, new ideas and future perspectives</article-title>. <source>Semin. Cancer Biol.</source> <volume>84</volume>, <fpage>302</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2020.01.007</pub-id> </citation>
</ref>
<ref id="B192">
<citation citation-type="thesis">
<person-group person-group-type="author">
<name>
<surname>Vagehian</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <source>A point Source High Power Converter Target to Produce Bremsstrahlung for Photonuclear Reaction</source>. <comment>Ph.D. thesis</comment> (<publisher-loc>Bern, Switzerland</publisher-loc>: <publisher-name>University of Bern</publisher-name>).</citation>
</ref>
<ref id="B193">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallabhajosula</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Picard</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stritzke</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mena</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Heliman</surname>
<given-names>R. S.</given-names>
</name>
<etal/>
</person-group> (<year>1989</year>). <article-title>Technetium-99m ECD: A New Brain Imaging Agent: <italic>In-vivo</italic> Kinetics and Biodistribution Studies in Normal Human Subjects</article-title>. <source>J. Nucl. Med.</source> <volume>30</volume> (<issue>5</issue>), <fpage>599</fpage>&#x2013;<lpage>604</lpage>. </citation>
</ref>
<ref id="B194">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Marck</surname>
<given-names>S, C.</given-names>
</name>
<name>
<surname>Koning</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Charlton</surname>
<given-names>K. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The options for the future production of the medical isotope <sup>99</sup>Mo</article-title>. <source>Eur. J. Nucl. Med. Mol. Imaging</source> <volume>37</volume>, <fpage>1817</fpage>&#x2013;<lpage>1820</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-010-1500-7</pub-id> </citation>
</ref>
<ref id="B195">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanaja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ramamoorthy</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iyer</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Mani</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Development of a New <sup>99m</sup>Tc Generator Using Neutron Irradiated Titanium Molybdate as Column Matrix</article-title>. <source>Radiochim. Acta.</source> <volume>42</volume> (<issue>1</issue>), <fpage>49</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1987.42.1.49</pub-id> </citation>
</ref>
<ref id="B196">
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Buchholz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vandegrift</surname>
<given-names>G. F.</given-names>
</name>
</person-group> (<year>1995</year>). &#x201c;<article-title>Processing of LEU targets for <sup>99</sup>Mo production-testing and modification of the Cintichem process</article-title>,&#x201d; in <conf-name>Presented in part at International Meeting on Reduced Enrichment for Research and Test Reactors</conf-name>, <conf-loc>Paris, France</conf-loc>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.rertr.anl.gov/MO99/WU95.pdf">http://www.rertr.anl.gov/MO99/WU95.pdf</ext-link>
</comment>. </citation>
</ref>
<ref id="B197">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yassine</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Separation of <sup>99m</sup>Tc from <sup>99</sup>Mo by Using TOPO-kerosene supported liquid membrane</article-title>. <source>J. Radioanal. Nucl. Chem.</source> <volume>246</volume> (<issue>3</issue>), <fpage>665</fpage>&#x2013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1023/A:1006700130611</pub-id> </citation>
</ref>
<ref id="B198">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yousefi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Khanchi</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Ahmadi</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Rofouei</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Yavari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Davarkhah</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Cerium(III) molybdate nanoparticles: Synthesis, characterization and radionuclides adsorption studies</article-title>. <source>J. Hazard. Mat.</source> <volume>215-216</volume>, <fpage>266</fpage>&#x2013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhazmat.2012.02.064</pub-id> </citation>
</ref>
<ref id="B199">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Karim</surname>
<given-names>H. M. A.</given-names>
</name>
<name>
<surname>Arif</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quershi</surname>
<given-names>H. I.</given-names>
</name>
<name>
<surname>Qaim</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Stocklin</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Fission Neutron Spectrum Averaged Cross Sections of some Threshold Reactions on Molybdenum: Estimation of Radioactive Impurities in (n, &#x3b3;)-Produced <sup>99</sup>Mo-<sup>99m</sup>Tc Generator System</article-title>. <source>Radiochim. Acta.</source> <volume>49</volume> (<issue>3</issue>), <fpage>107</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1990.49.3.107</pub-id> </citation>
</ref>
<ref id="B200">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhuikov</surname>
<given-names>B. L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Production of medical radionuclides in Russia: Status and future &#x2014; a review</article-title>. <source>Appl. Radiat. Isot.</source> <volume>84</volume>, <fpage>48</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/j.apradiso.2013.11.025</pub-id> </citation>
</ref>
<ref id="B201">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Zolle</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2007</year>). <source>Technetium-99m Radiopharmaceuticals: Preparation and Quality Control in Nuclear Medicine</source>. <publisher-loc>Berlin, Germany</publisher-loc>: <publisher-name>Springer</publisher-name>. </citation>
</ref>
<ref id="B202">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zsinka</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>
<sup>99m</sup>Tc sublimation generators</article-title>. <source>Radiochim. Acta.</source> <volume>41</volume> (<issue>2-3</issue>), <fpage>91</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1524/ract.1987.41.23.91</pub-id> </citation>
</ref>
<ref id="B203">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zykov</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Romanovskii</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Wester</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Bartenev</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Korpusov</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Filyanin</surname>
<given-names>A. T.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Use of extraction generator for preparing a <sup>99m</sup>Tc radiopharmaceutical</article-title>. <source>Radiochemistry</source> <volume>43</volume> (<issue>3</issue>), <fpage>297</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1023/A:1012820811058</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>